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Abstract
Pre-clinical biomaterial development and testing have traditionally relied on 2D
in vitro, or complex in vivo assays. It is essential for the cell environment to
match the natural tissue in terms of matrix density, architecture, components
(including stress/strains) for tissue models to behave in a natural manner. The
aim of this project is to improve existing in vitro models for the biomaterial
testing.
Plastically compressed collagen hydrogels were used to create a simple
and accessible 3D model. Improvement in hydrogel stiffness was achieved
using pre-crosslinked, polymeric collagen, as a starting material. Hydrogels
were formed by blending polymeric and monomeric collagens, which delayed
the aggregation of collagen fibrils, and enabled cell incorporation at physiolog-
ical pH.
Plastic compression of the novel hydrogel resulted in stiffer constructs; how-
ever, during compression, cells were exposed to reversible (i.e. using mobile
macromolecules) increases in cell-damaging fluid shear stresses.
In the material degradation model, it was found that the release rates of
PLGA degradation products were influenced by cells in the collagen matrix;
and differed significantly between 2D (24 hours) and 3D (7 days) models.
Imaging of cells cultured within the biomaterial also demonstrate the up-take
of biomaterials within cells within the model after 10 days in culture.
Nanoparticle drug delivery via hyaluronan nanoparticle (HA-NP) was im-
3
4proved by increasing blockage at the fluid leaving surface (FLS). The HA-NP
was designed to gradually release trapped simvastatin, which was measured
indirectly via BMP2 production over time. Although results were inconclusive,
initial experiments demonstrated sustained BMP2 production by cells over 5-9
days.
This work has demonstrated novel ways to improve the stiffness of the
model construct, and an improved understanding of particle movement within
the hydrogel during plastic compression. The models for biomaterial test-
ing have demonstrated that it was possible to track biomaterials in the con-
struct/cells over time, enabling real-time monitoring of the biomaterial and cells
at the implant site.
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Chapter 1
Introduction
Tissue engineering (TE) was described by Langer and Vacanti (1993) as “an
interdisciplinary field that applies the principles of engineering and life sciences
toward the development of biological substitutes that restore, maintain, or im-
prove tissue function or a whole organ”. This still holds true for many TE appli-
cations, yet it is clear the field has evolved beyond this scope, to encompass
biological substitutes that are aimed at replicating tissue environment and func-
tion in vitro (as a tissue model) for use as a tool in the study of basic cell biology
and cell/tissue response to external stimuli (i.e. drugs, biomaterials, etc.).
One of the main approaches/aims in TE is to produce off-the-shelf tissue re-
placements that can replace impaired or lost tissue function, when wound heal-
ing is limited by the regeneration capacity in humans (i.e. leading to scar tissue
which can impede tissue function). The complexity of whole organ means that
current engineered constructs cannot replace the “whole unit”. Instead, they
are designed at the tissue level to only ‘fix’ parts of a damaged organ/tissue.
These repairs can be performed using autologous, allogeneic or xenogenic
transplants; but when there is a lack of healthy donor tissue, or concerns of
donor site morbidity or large injury sites, artificial implant constructs can be-
come an important tool in restoring lost tissue function.
23
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The success rates in recovering tissue function varies depending on the
complexity of the tissue structure and the level of cell involvement (i.e. in bioin-
tegration) in the tissue function (i.e. it is easier to create the physical scaffold
for tissue such as tendons and cornea which does not have a high reliance on
cells to function). However, the mechanisms underlying the cell involvement
in tissue repair and biointegration of tissue implants is complex and not fully
understood. An improved understanding of cell behaviour and environmen-
tal cues which trigger such responses within biological tissues is essential to
achieve improved post-implant outcomes.
In order to have better control over cell behaviour, TE requires an interdis-
ciplinary approach to the design of implant materials.
Many current TE implants are able to achieve partial restoration of tissue
function, with the caveat of potential scarring at the implant site and suscep-
tibility to material failure over time. This is particularly the case if the implant
material is insufficiently integrated with the surrounding tissue.
Modern approaches to produce a functional tissue that is designed to re-
place tissue lost to trauma or disease, now acknowledge the need for cell in-
volvement for long term success of the implanted construct. However, the diffi-
culty in engineering a successful construct lies in the difficulty in understanding
cell behaviour within their natural environment, and the ability to use this knowl-
edge to control cell behaviour within an artificial construct. This means that
a trial-and-error approach to the development of biomaterial formulation and
structure is adopted, to create an implant which can stimulate a physiological
cell response.
This is where model systems (in vivo and in vitro (supplemented with com-
putational and mathematical models); further discussed in section 1.3) are
needed to test and screen biomaterials for the efficient development of im-
proved biomaterials, used to replace lost tissue function. Additionally, tissue
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models designed to act like natural tissues can be used to help understand
and predict human tissue response to stimuli (i.e. implant biomaterials, drugs,
etc.). These model systems can be thought of as a stand alone screening tool,
designed with selected tissue specific features/variables found in native tis-
sues (at the right amount and location); which can be used to further develop
implantable biological substitutes, and can be used to study cell interaction
with its extracellular matrix (ECM), other cells and implant biomaterials. This
approach has so far been useful and important in understanding cell response
(i.e. growth factor secretion, gene regulation, matrix remodeling, etc.) to me-
chanical and chemical characteristics of biomaterials.
A particular focus of this thesis will be to develop tissue models which can
help improve the efficiency and efficacy of biomaterial development, by screen-
ing and selecting for material compositions and/or physical properties that lead
to improved cell response and implant outcome.
The understanding of cell interaction with its extracellular matrix, and resul-
tant cell response are key to producing reliable tissue models. These models
are especially relevant for later stages of biomaterial development, where the
availability of a reliable in vitro screening platform for biomaterials will increase
efficiency of data gathering, and minimise the use of animal models (and as-
sociated ethical, time and cost implications); especially when there is also the
question of human relevance in animal models. In short, there is a need for a
reliable, relevant (representative of the cell interaction within the target tissue)
and accessible platform to test and develop biomaterials.
1.1 Research motivations
The main motivation for this research is for the advancement of current 3-
Dimensional (3D), in vitro tissue modeling platforms. This is in the context of
CHAPTER 1. INTRODUCTION 26
improving in vitro 3D models, for the testing of biomaterials (for its possible
effects on the local tissue upon implantation. Studies of particular interest are:
• Material longevity within the body
• Degradation and remodeling rates of materials in a tissue-like environ-
ment
• Cell response and behaviour within the material over time
• Effect of biomaterial on surrounding tissue/cells over time
Although, much of the tissue responses to biomaterials are traditionally
tested in vivo (animal model), there are various limitations to the use of ani-
mal models (please see section 1.3.1).
As discussed further in section 1.2, many current biomaterials are com-
posed of synthetic materials. Yet, a full understanding of the effects of syn-
thetic materials on the body, particularly at the cellular level, is often lacking.
Although many in vitro and in vivo models already exist to gauge the safety and
efficiency of biomaterial implants, there is still a need for an in vitro, human rel-
evant, tissue model that is simple, accessible, reproducible and quick to
produce. In particular, there is a need for a species and tissue specific model
which allows for:
• The simplification and isolation of test variables
• Easy monitoring and testing of the model
• The study of biomaterial effects on human tissues, especially its cells,
over a extended period of time in a natural-tissue like ECM environment
With the aim to:
• Produce a replicable and reliable tissue model
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• Increase model relevance to human tissue
• Improve tissue specificity (by incorporating tissue relevant cell types, or
physical characteristics into the material)
• Increase productivity (i.e. higher throughput)
• Reduce time, effort and resources in biomaterial testing
The main purpose of this research is to engineer a tissue-like construct that
is capable of producing and predicting native soft-tissue responses to bioma-
terials (which are highly dependent on resident cells). These constructs must
be able to react to external stimuli in a tissue-like manner (i.e. a skin model
should behave like skin (in health and in disease) in terms of gene regulation,
protein composition and/or cell responses).
Since the natural tissue is often too complex to reproduce and analyse, the
aim is not to create identical tissue mimics. However, most tissues can be
simplified and be defined by its predominant physical and chemical features
(i.e. matrix stiffness, cell/matrix density, matrix alignment, presence of other
proteins and growth factors). The strategy is therefore to produce in vitro tis-
sue models by incorporate these engineerable features into the basic collagen
scaffold to produce “tissue specific” models.
The approach is to use the minimum number of these “building blocks”
(physiochemical cues) to direct cells into behaving in a physiological manner.
1.2 Tissue engineering – biomaterials as implants
or tissue models?
Although tissue implants are made to mimic tissue function and can, to an
extent, replace lost or impaired tissues, they are not generally used as tissue
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models. So, what is the difference between tissue modeling platforms and
implant materials?
The answer is that they are usually made with different priorities in mind.
There are very different requirements in the engineering of materials intended
for tissue modeling, versus those intended as replacement tissues as an im-
plantable material. Materials in tissue modeling, most typically, are used as a
platform for understanding the basic biological response/mechanisms to an ex-
ternal stimuli (i.e. drugs, biomaterials). This is especially important in modern
research where there is an almost infinite number of possible test variables.
The testing of multiple variables would imply the priority for any model tissue
is to be highly reproducible, with low variation between batches. To facilitate
the generation of useful information from the models, it must be relevant to
the target tissue, be easy to manipulate and is simple enough (in terms of
its components) to understand the influence of individual variables on the test
outcome; the option to build/increase complexity within the model will also be
beneficial.
This contrasts with the priorities of tissues engineered for implantation (i.e.
skin, bone, tendon grafts) where they must, first and foremost, be safe and
biocompatible. The reproducibility of the construct is not often expected, as
patient-derived cells are notoriously difficult to control. Nevertheless, it is as-
sumed (in a cell-dense construct) that resident cells will create the necessary
architecture, proteins and micro-environments, to replace the implanted scaf-
fold material, as the new tissue gains biological function and integrate with
surrounding tissues over time.
It is essential to make this distinction, and to make clear that this research
is focused on the development of in vitro tissue models. Therefore the priorities
for the model constructs are reproducibility, and relevance to target tissues.
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1.3 Current types of tissue-models – in vivo and
in vitro
Many tissue models exist to test and predict tissue response to an implant
material. This section aims to provide an overview of the current approaches,
and its associated advantages and disadvantages; to ultimately justify the need
for developing next-generation, 3-dimentional, in vitro model systems.
1.3.1 In vivo models
The term in vivo is defined as processes performed or taking place within a
living organism, and in biological research it often refers to animal models used
to study biological processes and mechanisms within a complete and intact
system.
For example, a common in vivo assays for bone-replacement biomaterials
is the bone defect models, where part of the animal bone is surgically removed
and replaced by biomaterials in a live animal model (Li et al., 2015). One of the
advantages of an in vivo model is that implanted biomaterials will be subjected
to physiological mechanical loading and biological reactions (i.e. inflammation)
until the construct is removed for analysis.
The variables tested in vivo typically include the toxicity of new components
and its effects on all organs/tissues of the body. However, the drawbacks as-
sociated with animal models include its complexity and limited accessibility.
This means that tissue assays (apart from blood tests or skin biopsy etc.) are
typically end-point, and require a large number of animals to study a range of
variables, or temporal changes to the biomaterial and the surrounding tissue
over time. This poses ethical, cost and time issues which needs to be justified.
The majority of the animal models in biomaterial research (especially in the
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early stages of pre-clinical trial research) are laboratory mice because of the
relative ease to introduce genetic modifications (i.e. disease specific models
with similar pathologies to human disease), and reduced cost, space and time
implications compared to other mammalian models. Typically, pre-clinical tri-
als in vivo progress onto large animal models (with an improved resemblance
to human physiology), only after preliminary tests in smaller animal models.
The problem comes when the mice/rat model “inaccurately” predicts human
tissue responses and give rise to false positive and negative results, leading
to the abandonment of potentially useful biomaterials, whilst further develop-
ing materials which may potentially be non-compatible with humans (which are
bound to fail with further testing) (Ennever et al., 1987) (McGonigle and Rug-
geri, 2014). This questions whether the heavy reliance on animal models for
biomaterial (and drug) testing can be justified.
Nevertheless, it is important to acknowledge that animals models are indis-
pensable in testing systemic effects and overall safety of drugs/biomaterials,
especially over a long period of time. But prior to this stage of biomaterial test-
ing, reliable in vitro tests are needed to provide human tissue specific screen-
ing of biomaterials (to reduce false positive and negative results of material
effect on the tissue) during their development.
1.3.2 In vitro models – 2-Dimensional VS 3-Dimensional
In vitro (or “in glass”) refers to experiments carried out away from the intact
living organism. The major benefit to isolating cells for culture in vitro is that
it allows for a simpler model with isolated test variables, and easy access to
the tissue components for analysis. In vitro models can refer to tissue sections
(i.e. lung sections/biopsy) or cells, cultured both on (most typically coated
tissue culture plastic (TCP)) and within a cell-adherent material. However, this
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is where a distinction must be drawn between 2-dimensional (2D) (i.e. cells on
coated culture plates, matrigel surface, etc) and 3-dimensional (3D) (i.e. cells
within a biomaterial) culture systems.
2D systems typically refer to cell mono-layers cultured on a stiff and flat
surface (i.e. tissue culture plastic). Examples of 3D soft tissue models in-
clude electrospun poly(ester urethane)ureas (Courtney et al., 2006) and 3D
full thickness skin models based on silk and collagen (with studies of cross-
talk between cell types in the skin model) (Bellas et al., 2012); where cells are
embedded within a biomaterial.
The main differences for cells seeded in 2D culture and the natural tissue
are:
• Spatial cues (including cell-matrix, cell-cell attachments)
• Substrate stiffness
• Concentration gradients (i.e. nutrients and growth factors)
In terms of mechanical properties, the stiffness of the cell substrate is no-
tably different between 2D and 3D systems. Substrate stiffness is important
as cells can exert and sense contractile forces via its cytoskeleton from the
attached substrate. This ultimately affects cell behaviour such as migration,
differentiation, etc. (Discher et al., 2005). Cell seeded in 2D cultures are usu-
ally attached to ultra-stiff tissue culture plastic, with very high resistance to cell
contraction in one plane, whilst other surfaces are surrounded by a fluid en-
vironment, which offers little cell attachment sites, and even less resistance
to cell exerted contractile forces (although it should be said that this is until
cells (i.e. fibroblasts) on a 2D surface naturally produce ECM proteins, and
transform their 2D environment into 3D over time). This contrasts with a true
3D environment where physiological stimulation is from all dimensional planes
surrounding the cell.
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As an example, studies comparing cell activity within 2D and 3D ex vivo
lung cancer models (decellularised matrix seeded with human alveolar based
epithelial adenocarcinoma A549 cell-line) have differences in cell proliferation
and apoptosis rates. Differences in the metalloproteinase expression between
the 2D and 3D models were also noted, where MMPs-1, -2 and -10 were at
increased levels in 3D, and MMP-9 was only found in the 3D model. Impor-
tantly, cells nodules, the hallmark of lung cancer, were only formed within 3D
constructs (Mishra et al., 2012).
The differences between findings from 2D and 3D in vitro models highlights
the importance of cell-cell and cell-matrix interactions (Nyga et al., 2011), and
other culture environment factors, such as the perfusion of the construct (i.e.
microfluidics) (van Duinen et al., 2015). Just taking cell migration as an exam-
ple, the changes in ECM topography (i.e. alignment of matrix and the ECM
ligand density available for cell attachment) has been found to affect the mi-
gration rate and the extent of cell spreading and polarity. In 3D, the size of the
interfibrillar space also dictate the rate of migration (Doyle et al., 2013) (Cukier-
man et al., 2001). Also, in terms of cell signalling, an upregulation in myosin II
activity and cell migration rates can be seen within 3D matrices (Doyle et al.,
2009).
The concentration of essential nutrients available to cells in 2D and 3D will
differ due to the density of the culture environment. In 2D, the culture media
(and so nutrients) are freely available to at least part of the cell surface. Within
a 3D system, nutrients used up by cells will have to diffuse through the dense
matrix, resulting in a concentration gradient for nutrients between the cells and
the culture media outside the matrix. Although, note that the matrix can add to
the complex cell signalling system by acting as a reservoir for soluble growth
factors (Hynes, 2009).
In most cases, a 3D in vitro model system can be engineered to represent
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a natural tissue environment as cells are naturally found embedded within the
ECM (a 3D environment; with exceptions i.e. epi-/endothelial cells) composed
of a wide range of ECM proteins; which supports cells within a structured scaf-
fold and present environmental cues to interstitial cells (i.e. cell-matrix and
cell-cell interactions, growth factors and cytokines).
Designing 3D in vitro matrices
Again, since cells in 2D (especially those cultured on TCP) receive non-physiological
stimulation from their environment, their response/behaviour are unlikely to
predict complex, natural, tissue responses. Therefore there is a need for 3D
models with a cell environment representative of the natural tissue.
When designing the 3D model, it is especially important to consider:
• What the cell senses - is it 3D for the cell?
• What are the predominant environmental cues for cells in the target tissue
Cells are typically several tens of micrometer in size. The surrounding ma-
terial/matrix must therefore also be in the same scale for cells to truly be em-
bedded within a 3D environment. For example, if cells are embedded within
a scaffold with pores measuring hundreds of micrometer, the smaller cells will
only attach to part of the pore circumference. 3D spatial cues will therefore be
lacking as cells are attached in one plane - effectively becoming a 2D surface
to the cells.
Cells in 3D receive feedback regulation from its surrounding matrix. They
respond, for example, to matrix stiffness, alignment, topography and chemical
cues (i.e. the concentration of oxygen, nutrients and proteins). It is therefore
clear that the structure and topography of cell substrate material has impli-
cation on cell behaviour, making it essential to consider the material used to
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create the tissue model. It is important not to forget different tissue types (i.e.
musculoskeletal, cardiac, kidneys, liver, skin, etc.) will involve different tissue
organisation, components and cell-types; which will need to be taken into ac-
count when developing tissue-specific models.
1.3.3 Synthetic and natural materials in tissue engineering
Synthetic polymers are popular scaffold materials as they have highly control-
lable chemical compositions, and both physical and mechanical properties (i.e.
typically much stronger than natural polymer derived materials, and can be de-
signed to match the mechanical strength of host tissues). Additionally they
are generally cost efficient to produce, have good availability and many syn-
thetic polymers are already clinically approved for use within the body for other
applications (i.e. PLGA are approved by the FDA for drug delivery).
Although there is a high degree of control over physical features and chem-
ical composition of the material, the synthetic material itself will not integrate
with the existing tissue in the body. In most modern TE applications, the syn-
thetic polymers is used to deliver (or encourage cell migration into the scaf-
fold), and support cells until it is eventually replaced by the cell-produced ECM;
which is necessary for implants to obtain biological function (indirect tissue en-
gineering (Brown, 2013b)). In such circumstances, the initial construct is usu-
ally non-physiological (apart from matching host tissue mechanical strength),
and will only mature into a tissue-like construct with time. The implication
of this is that the synthetic matrix would need to be designed with mechan-
ical/chemical cues (such as tissue-like stiffness, cell-attachment site density,
degradation rate, topography and/or growth factors and cytokines) to direct cell
behaviour, to encourage the production and retention of ECM proteins.
A frequent problem in synthetic materials is the low rate of ECM deposi-
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tion in vitro, meaning long periods in culture is necessary for its maturation
(i.e. newly synthesised collagen is only slowly incorporated into the bulk tissue
(Foroughi et al., 2008)). This could be due to the lack of molecular ’crowding’ at
the collagen deposition site because constructs are often culture in an environ-
ment which has limited macromolecule density (much lower than physiological
levels normally found in the ECM environment). With sufficient macromolecule
density in the culture environment, the excluded volume effect is found to accel-
erate the kinetics of protein assembly and fibril formation in vitro (Lareu et al.,
2007).
The production of cell-synthesised extracellular matrix (ECM) is also highly
dependent on the activity of resident cells. Once the synthetic material has de-
graded, the degradation products or active ingredients released from the bio-
materials will be in contact with the surrounding tissues. Yet often the effects of
such by-products on resident cells (of different cell-types), and the surround-
ing tissue, is not clear (i.e. is it carcinogenic or toxic to cells? does it cause
fibrosis?). To add to the complexity, primary cell sources (i.e. autologous cells
isolated from a patient) can have variable activity, with very different ECM pro-
duction rates. This means that degradation rates of a biomaterial needs to be
controllable (and customisable for each patient); especially in view of their use
in the clinical setting.
Nevertheless, the ability to customise synthetic materials means it is effec-
tive for use as implant materials - when the variables to control cell-behaviour
is known. This indirect tissue engineering method is, however, impractical for
use in high-throughput model systems due to the long culture period for the
ECM to be produced; not to mention the high level of cell dependency, leading
to the high variability expected in cell-produced ECM.
Natural materials on the other hand, may be better suited as a substrate for
model tissues. This is because the substrate is made of naturally existing pro-
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teins of the ECM which contain the cell attachment sites, and physiochemical
cues for cells. Examples of natural polymers used in TE include proteins nat-
urally found within the ECM environment, such as collagen (most commonly
types I and II), elastin, fibrinogen/fibrin and hyaluronic acid (at different quan-
tities, depending on tissue type). Cell-attachment proteins such as laminins
and fibronectins can easily be incorporated into protein scaffolds which will fur-
ther provide tissue-like cues to cells, although the requirements for these ECM
components will depend on the cell type incorporated into the tissue model.
This category also includes other naturally derived materials such as polysac-
charides and polyesters (Mano et al., 2007)) which can be extracted from non-
mammalian animals, microorganisms or plants.
The main advantages of using natural materials to support cells in tissue
models is that these molecules are naturally recognised by cells and are more
likely to stimulate physiological responses in cells (similar to the natural envi-
ronment i.e. migration, proliferation, remodeling of matrix). Additionally, many
natural matrix-forming proteins are able to spontaneously (at specific condi-
tions) form a scaffold in vitro (i.e. collagen hydrogels, fibrin scaffolds) because
they contain precise amino acid sequences and structure which are difficult to
replicate in the synthetic material.
However, there are also limitations to reconstituted proteins scaffolds. Par-
ticularly because these scaffolds are formed without cell involvement or cell-
directed control of the matrix architecture; which may in turn affect cell be-
haviour (Cheema et al., 2011). The lack of mechanical properties of hydro-
gel based scaffolds can also be a problem, as it is one of the many physi-
cal cues cells detect from the ECM. However scaffolds can be made stronger
by interventions such as chemical cross-linking of the protein. For example,
cross-linked gelatin or fibrinogen have been found to support muscle myoblast
cell line (C2C12) proliferation, despite initial cell damage due to cross-linking
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(Sando et al., 2011).
Examples of in vitro 3D models taken from the natural tissue (i.e. ex vivo)
includes the use of tissue sections or decellularised models (often top-down
approaches of material fabrication); where tissues maintain the complex tissue
structure whilst also having improved access for in vitro assays. For example,
a decellularised lung model (with in silico modeling) found that cells in 3D had
reduced proliferation rates (observed through ki-67 staining and cell counting)
and were able to demonstrate cell-type differences in response to drug treat-
ment (Stratmann et al., 2014) .
Although decellularised explanted lung tissue contain the complex tissue
structures (not currently reproducible in artificial 3D constructs), the culture of
these samples required constant perfusion and so currently have limited poten-
tial for up-scaling. Also since they are obtained from natural tissues, some vari-
ation between samples can be expected. On the other hand, 3D models built
artificially (bottom-up fabrication) are considerably simplified compared to ani-
mal tissue models (Mishra et al., 2012), but are a step forward from 2D models
and generally show improved physiological cell responses in drug screening
compared to traditional in vitro 2D models (as reviewed by Nam et al. (2015)).
1.3.4 Regulations and international standards for biomate-
rial testing
The International Organisation for Standardisation (ISO) have published guide-
lines and regulation for the use of medical devices in biological settings to en-
sure a standard of animal welfare (ISO 10993-2), and patient safety during
animal and clinical tests. ISO 10993 describes the international standards ex-
pected for biological evaluation of medical devices, with a total of 20 chapters
to date (August 2016).
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ISO 10993 aims to provide guidelines for the protection of patients from the
use of medical devices, including biomaterials, by providing guidance in the
systemic analysis and biological evaluation of medical devices (ISO 10993-1).
The regulations encompass both natural and synthetic materials designed for
long-term (i.e. more than 30 days) contact with human tissues, and is designed
to assess and manage the risks involved with prolonged contact between bio-
materials and human tissues.
Since the tissue models discussed in this thesis was not intended for direct
human tissue contact (i.e. not intended for implant), the guidelines in ISO
10993 do not directly apply to the collagen model material described in this
thesis. Instead, it describes potential test parameters for the model during in
vitro biomaterial testing. For example, ISO 10993-9 describes the need for in
vitro test on material degradation (may include chemical components used in
the manufacturing process), which can also be studied in 3D tissue models as
demonstrated in chapter 7 in this thesis. Other potential areas of application
of the 3D model is in the study of cell response to the biomaterial and its
components (i.e. cytotoxicity, genotoxicity and carcinogenicity; ISO 10993-5),
and material degradation due to chemical alterations to the medical device
(ISO 10993-13).
The successful implementation of 3D models as early biomaterial tests and
screening, outside of animal models, will help to reduce the need for in vivo
models. This thereby helps meet the principles of the National Centre for the
Replacement, Refinement and Reduction of Animals in Research (NC3Rs),
which aim to promote new technologies to replace, reduce and refine the use
of animal models in research.
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1.4 Collagen
Collagen is a family of proteins that is highly conserved between species dur-
ing evolution. Collagen molecules are composed of three polypeptide chains
arranged as a triple helix (Ramachandran and Kartha, 1954) (Ramachandran
and Kartha, 1955). The composition of each chain (also known as α-chains)
can vary, which is reflected in the chain nomenclature (i.e. α1, α2, etc.). To
date, at least 29 types of collagen have been identified, most of which can be
roughly divided into three groups depending on its function (Abraham et al.,
2011) (Khoshnoodi et al., 2006) (Gordon and Hahn, 2010):
• Fibril-forming collagens - most common are types I (found most predom-
inantly in load bearing tissues), II (cartilage) and XI (cartilage, interver-
tebral disc). All fibril forming collagens have long uninterrupted helical
domains capped with N- and C- terminals containing non-collagenous
propeptides, and provide the supporting matrix of most tissues
• Network-forming collagens - types IV (basement membranes), VIII (suben-
dothelium of vascular walls) and X (endochondrial growth plates) are ex-
amples of network-forming collagens found within the body
• Fibril-associated collagens (FACIT) - such as types IX (cartilage, cornea),
XII (dermis, tendons) and XIV (bone, dermis) can be found associated
with underlying collagen fibres
The tissue models used throughout this thesis is based on type-I collagen
- a type of fibril forming collagen.
This section aims to review current knowledge of the type-I collagen protein,
in particular, its chemical composition, structure and its interaction with cells.
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1.4.1 What is Type-I collagen?
Type-I collagen is one of the most abundant type of collagen in the body. It is a
fibril forming collagen, and provides the structural integrity in most connective
and load bearing tissues (skin, tendons, bones, etc).
The triple helix of each type-I collagen molecule is made of two α1, and one
α2 chains. Each chain is composed of ∼1050 amino acids, with the main body
of the chain consisting of repeating –Gly-X-Y– units; such that glycine (Gly) is
found at every third amino acid along the chain. Glycine at every third position
is important for an undistorted structure, as Gly at any other position is found
to be highly destabilising (Brodsky et al., 2008) (Persikov et al., 2000).
Since it is often difficult to study the intact collagen molecule due to its
tight structure (i.e. sterical hinderance), shorter fiber forming peptides (∼36
amino acid residues) with variations in the –Gly-X-Y– sequence have been
used to study the effect of amino acid sequence on its fiber forming propensi-
ties (O’Leary et al., 2011). Using these short sequences, it has been found that
Proline (Pro) and Hydroxyproline (Hyp) are most commonly found in the X and
Y positions respectively; with this configuration leading to the highest stability
of the collagen triple helix (Persikov et al., 2000). Deviations from this Gly-Pro-
Hyp sequence (i.e. to Gly-Pro-Pro) results in a less stable gel (Kar et al., 2006).
The importance of Hyp in the collagen molecules has been highlighted in early
studies in to the collagen molecule for stability (Gustavson, 1955) (Jimenez
et al., 1973) (Berg and Prockop, 1973).
In mammalian tissue, type-I collagen molecules are produced within fibrob-
lasts (and other cells, i.e. osteoblasts; depending on the tissue type), and
are secreted into the extracellular space before they can be assembled into
the ECM. Briefly, the biosynthesis of collagen molecules begin with the col-
lagen α-chain production. Translated collagen chains are modified by post-
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translational modification in the rough endoplasmic reticulum, where proline
and lysine residues (in the Y position) are hydroxylated to form hydroxyproline
and hydroxylisine. These hydroxilated amino acids are needed for triple helix
stability (Ramachandran et al., 1973) and for intermolecular cross-linking.
As the three α-chains come together to form a triple helix, interchain disul-
fide bonds at the C-terminal of the α-chain aligns the chains into conformation
(Doege and Fessler, 1986), allowing hydrogen bonds to hold the rest of the
chains together. Both water bridges (Brodsky et al., 2008) and electrostatic
interactions (Persikov et al., 2005) are also thought to have a role in stabilis-
ing the triple helix (i.e. the Hyp residue may form water bridges with carboxyl
groups of adjacent chains (Suzuki and Fraser, 1980)). The triple helix at this
stage is called the pro-collagen molecule (figure 1.1), and is packaged at the
golgi apparatus for secretion into the extracellular space.
For collagen molecules to aggregate and form fibrils, the pro-collagen molecule
must be cleaved at either ends of the molecule by N- and C-procollagen pro-
teinase (Kadler et al., 1987), so that a relatively short non-helical region (telopep-
tides) remain at either terminal. The cleavage of procollagen terminals re-
moves any steric hindrance, and enables the association of adjacent tropocol-
lagen molecules (widely used in hydrogel formation) in a “quarter staggered”
formation; such that adjacent and parallel collagen molecules are displaced
by approximately 1/4 of the molecule length, which measures 67 nm (a D
period). On an electron micrograph, this displacement can be observed as
distinct banding patterns on the collagen fibre (Williams et al., 1978). This as-
sociation of collagen molecules continue until fibres are formed (in vitro, fibres
typically measure about ∼20-40nm in diameter (Williams et al., 1978)).
Further processing of the fibre is then needed for collagen fibres to achieve
the level of mechanical strength found in natural tissues, so that it can support
cells and other proteins within the matrix.
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Figure 1.1: Schematic of procollagen processing derived from (Canty and
Kadler, 2005). Individual collagen chains produced within the cells forms a
triple helix through C-terminal disulfide bond formation. The resultant procol-
lagen molecule is further processed by N- and C-procollagen peptidase which
removes either terminals, allowing the collagen molecules to assemble into fib-
rils (with a quater-staggered arrangement) after secretion into the extracellular
space.
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1.4.2 Chemical alterations of the collagen structure – Cross-
linking
Collagen molecules immediately after fibrillogenesis are only held together by
weak labile bonds. For the collagen matrix to gain mechanical properties nor-
mally found in mature tissues, interfibrillar covalent cross-links between colla-
gen molecules is necessary (Yang et al., 2008).
Interfibrillar cross-linking
Collagen molecules are naturally cross-linked together via two distinct pro-
cesses. The first of which involves an enzymatic process mediated by lysyl
oxidase to form divalent (and subsequent trivalent) intermolecular cross-links
at defined sites along the collagen molecule. With age, non-enzymatic reac-
tion with glucose result in the formation of advanced glycation products (AGE),
leading to further cross-linking.
In enzymatic cross-linking, the residues involved will depend on the tissue
type (i.e. the level of lysine hydroxilation within the collagen molecule) and age
of the tissue. The majority of cross-links in adult skin and tendons are aldem-
ine based. Lysyl oxidase causes the oxidative deamination of -amino groups
of specific lysine residues of fibrils in the non-helical regions (telopeptides) of
the molecule. The resultant lysine-aldehyde then reacts with opposing -amino
groups of hydroxylysine in the helical region of the molecule. This type of cross-
link is called dehydrohydroxylysinonorleucine (deH-HLNL) (Bailey and Peach,
1968). These then spontaneously reacts with histidine to form Histidinohydrox-
ylysinonorleucine (HHL) (Yamauchi et al., 1987) which is a more stable trivalent
cross-link.
Although there are many potential cross-link mechanisms, it is clear that de-
ficiencies in hydroxilation or copper ions (causing decreased lysyl oxidase ac-
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tivity) lead to tissues with decreased mechanical properties (Dahl et al., 2005).
The second mechanism is through non-enzymatic cross-linking. Prolonged
incubation of collagen in excess glucose within an oxygen-rich environment
led to an increase in cross-linking and browning of collagen constructs (Kohn
et al., 1984). Reactive oxygen species was found to mediate glucose induced
collagen cross-linking (Fu et al., 1992) (Fu et al., 1994) by forming advanced
glycation products (AGE). The formation of AGEs is initiated by the formation
of a schiff base between glucose and a protein amino group (i.e. lysine side
chains), which then stabilises into an intermediate keto amine (amadori prod-
uct). Further glycolysis over time leads to the formation of glyoxal, methyl
glyoxal and 3-deoxyglycosone which reacts with ECM proteins to form AGEs
(Snedeker and Gautieri, 2014). Evidence suggests that soluble AGE can di-
rectly stimulate cross-link formation in collagen (instead of simply being an
end-product of cross-link formation) (Sajithlal et al., 1998).
However, for the direct engineering of collagen constructs in vitro, imme-
diate and efficient methods to improves construct mechanical properties is
usually needed. Artificial interfibrillar cross-linking of collagen fibrils (without
enzyme action) is possible with chemical (i.e. gluteraldehyde; including photo-
chemical agents such as riboflavin) or physical (i.e. dehydration) treatments.
The mechanism and residues involved in these artificial crosslinking methods
vary, but ultimately, all methods result in the interfibrillar cross-linking of col-
lagen fibrils. Compared to natural cross-linking methods, these methods ef-
ficiently increases mechanical properties of collagen based materials (Chan-
dran et al., 2012) (Olde Damink et al., 1996) (Chan and So, 2005), but will also
damage cells in the area of treatment.
Therefore, the current challenge is to introduce covalent cross-links into in
vitro constructs in a quick, and cell friendly manner; for the production of scaf-
folds with increased mechanical properties. This challenge will be addressed,
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and further discussed, in chapters 3 and 4.
1.4.3 In vitro collagen fibrillogenesis to produce hydrogels
Type-I collagen molecules in solution are surrounded by a water shell. When
fibrillogenesis is triggered at physiological conditions in vitro, collagen molecules
spontaneously assemble with neighboring molecules in a quarter staggered
arrangement to form fibers.
Electrostatic interactions and hydrogen bonds (i.e. involving bridging water
molecules) appear to be the driving force for fibrillogensis. Hodge and Schmitt
(1960) identified narrowly defined clustered of basic and acidic polar groups
on collagen molecules, which match the corresponding relative position on
an adjacent molecule when displaced at the quarter staggered arrangement.
The interprotein interactions are more likely to form in clusters, rather than
uniformly throughout the collagen molecule. This is because some amino acids
are better hydrogel bond donors (i.e. arginine and lysine) or receptors (i.e.
glutamine and aspartate) than others (Streeter and de Leeuw, 2011). Packing
of the collagen molecules optimises the alignment of hydrophobic side chains
(Hulmes et al., 1973). Hydrophobic interactions between collagen molecules
can potentially be stabilising (Streeter and de Leeuw, 2011), as a reduced
amount of water shell on non-polar groups encourages interaction between
adjacent collagen molecules.
The collagen fibrous matrix structure and organisation depend on the con-
ditions of assembly (Comper and Veis, 1977). Nevertheless, all collagen hy-
drogel formation process begin with a nucleation phase, where polymerisa-
tion of the collagen protein begins in small clusters. Fibres form as collagen
monomers in solution continue to aggregate, until fibrillogenesis is complete.
Turbidity assays of collagen hydrogels often describe this as the lag phase
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(before nucleation) and growth phase (formation of fibres), detected when the
collagen solution turns opaque during the latter stage.
The hydrogel at this stage assumes a loose mesh-like fibrous structure,
containing ∼ 0.2-0.6% (w/w) collagen protein, and mostly water in the interfib-
rillar space (with embedded cells, ECM proteins or biomaterials).
Factors currently known to influence collagen fibrillogenesis, and the stabil-
ity of resultant hydrogels include:
• Collagen molecule structure (with or without telopeptides) and composi-





• Presence of other proteins and macromolecules
Type-I collagen molecules used in hydrogel formation are usually native
acid-soluble collagen (tropocollagen; with telopeptides), or collagen molecules
cleaved of most of their telopeptide (atelocollagen). Both forms are derived
from natural tissues, but are extracted using different processes. Tropocolla-
gen normally extracted from young and growing tissues (using a weak acidic
solution) are ‘whole’ collagen molecules with the telopeptides intact. Atelocol-
lagen extracted from (usually insoluble) tissues using pepsin lack the complete
telopeptide sequences normally found at the terminals of collagen molecules.
Both are able to form hydrogels under similar physiological conditions, but at
different rates; and result in gels with different physical properties. For exam-
ple, atelocollagen has reduced ability to form well organised fibrils (Brennan
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and Davison, 1981), aggregation rates, resistance to collagenase treatment
(Walton et al., 2010) and thermal stability compared to tropocollagen derived
hydrogels (Snowden and Swann, 1979).
Gelling conditions - pH, temperature and salt concentrations
Fibrillogenesis is described as an entropy driven process and is usually best
at physiological temperature (∼37°c). Temperatures too high can potentially
denature the collagen protein into gelatin, whilst a low temperature will delay
fibrillogenesis. Indeed, Comper and Veis (1977) found that the temperature
can affect the nucleation (lag) phase of fibrillogenesis (but not the subsequent
growth phase of gel formation).
Salt (NaCl) concentrations have been shown to influence the nucleation
time (lag phase) during fibrillogenesis (Snowden and Swann, 1979); which may
be attributed to changes in electrastatic interactions needed in nuclei formation
(Comper and Veis, 1977). The presence of salts is important for the formation
of structrually defined fibrils (Harris and Reiber, 2007), as fibrils formed without
salts are less organised with spindle shaped aggregates.
Fibrillogenesis at neutral pH and physiological salt concentrations (pH6.5-
8; in the presence of 150mM salt) led to stable hydrogels with fibers displaying
the expected banding patterns, indicative of collagen molecule fusion with ad-
jacent molecules at perfect alignment. At low pH (∼pH 2-5), only poorly formed
fibrils were produced. At pH 9, banding patterns of fibrils were present, but par-
allel bundling of collagen molecules appeared to be looser (Harris and Reiber,
2007).
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Other molecules
The rate and extent of type-I collagen fibrillogenesis are susceptible to influ-
ence by other proteins and molecules, mainly, via changes in electrostatic in-
teractions.
Changes in electrostatic interactions due to the presence of anions (es-
pecially chloridion and sulphates) affected the rate and extent of fibrillogen-
esis, possibly by altering the density of the hydration layer around collagen
molecules. Although the exact effect depend on the type of anion and its con-
centration (Xing et al., 2011), the isoelectric point (pI) of collagen monomers
are highly influenced by ion species (Li and Douglas, 2013). Some effects on
the matrix structure and stability of the collagen structure was also noted.
Proteins naturally found within most tissues (i.e. proteoglycans and gly-
cosaminoglycans (GAGs)) can also impact on collagen hydrogel formation.
For example, GAGs such as dermatan sulphate added to the collagen solu-
tion prior to fibrillogenesis reduced nucleation time, increase rate of growth
phase and increased the overall extent of collagen precipitation (Snowden and
Swann, 1980) (Paderi et al., 2009). High density proteoglycans, on the other
hand, increased nucleation time, but had little effect on other parameters of
fibrillogenesis. They are also thought to exert influence on fibrillogenesis via
electrostatic interactions (Mathews, 1965), where negatively charges on the
polysaccharide interacts with the positive charges of the protein.
Another study found that the polysaccharide, ficoll, affected fibrillogenesis
by increasing the lag time during nucleation, increased fibre growth rates and
changed the architecture of the resultant matrix fibril (Dewavrin et al., 2014).
Other molecules, such as modified small leucine-rich proteoglycans (SLRPs)
were able to delay fibrillogenesis in a dose dependent manner (Paderi et al.,
2009).
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Why use collagen hydrogels?
The main advantage of using collagen hydrogels in TE is the possibility of
incorporating cells within an ECM-like matrix at time-zero (as the matrix is
being formed) without direct cell involvement.
The reason collagen hydrogels enables cells to behave in a physiological
manner is because they provide the interstitial cells with native tissue-like fluid
and solid components, mechanical properties, topographical features and ori-
entation cues - all of which changes with time in response to cell action (Brown,
2013a). The accessibility of the in vitro material will also enable the visualisa-
tion and study of cell-matrix interactions (i.e remodeling (Grinnell, 2003), cell
attachment (Jiang and Grinnell, 2005), migration (Grinnell et al., 2005)).
The collagen matrix can be made more complex by building additional fea-
tures into the basic hydrogel (bottom-up approach to TE (Brown, 2013b)). This
makes it possible to isolate variables and tailor the model with tissue-specific
features, which will ultimately impact on cell behaviour within the model tissue.
1.5 Plastically compressed hydrogels as tissue mod-
els
Cellular collagen hydrogels (typically containing >99% water) was first de-
scribed by Elsdale and Bard in 1972 (Elsdale and Bard, 1972), and have
since been a used to characterise cell behaviour within a 3D environment.
The super-hydrated hydrogels, consisting mostly of water, have only weak me-
chanical properties and can quickly be resorbed when placed in vivo (Tabata
et al., 2000). This means interstitial cells can potentially lose their surrounding
supportive matrix.
Plastic compression of collagen type-I hydrogels is a technique developed
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by Brown et al. (2005), where excess fluid trapped between fibrils of the hydro-
gel lattice during fibrillogenesis is expelled from the matrix by a combination of
compressive load, gravity and capillary action (fluid absorbed into contacting
blotting paper). This process increases collagen density within the construct
to physiological levels, without altering its chemical composition. It is termed
‘plastic’ because compression expels the liquid non-reversibly, and water does
not return to the collagen fibre lattice even on the removal of the compressive
load (Brown et al., 2005).
The advantage of using plastic compression is their cell-compatibility when
improving hydrogel collagen density. If, for example, the hydrogel is made from
a collagen solution with a density of ∼ 2mg.ml-1, the resultant hydrogel will
contain ∼ 0.2% collagen, and 99.8% water. With a single plastic compression,
collagen density typically increases at least 55 folds, to∼ 11−18% (w/w)(Brown
et al., 2005) (Abou Neel et al., 2006) (Cheema et al., 2008). The resultant
compressed collagen have been shown to persist for at least 5 weeks in vivo
(Mudera et al., 2007). Cells can remodel and migrate through the construct,
but the overall dimensions and shape remains relatively unchanged over the
culture period (Alekseeva et al., 2012b).
There are currently two standardised methods to produce plastically com-
pressed collagen gel, namely a) downward flow compression (Brown et al.,
2005) (figure 1.2) and b) upward flow compression ((Alekseeva et al., 2011))
(figure 1.3); each referring to the predominant direction of fluid flow during com-
pression. Both methods essentially result in compressed collagen constructs
with similar µ-structures (figure 1.4). However, downward flow compression
has the advantage of customisable shape and size of the final compressed
construct (as the hydrogel can be made in customised moulds), whilst the
upward flow method is optimised for constructs produced in multiwell-plates,
which allows for increased reproducibility and through-put.
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Figure 1.2: Schematic of downward flow compression of collagen hydrogels.
Hydrogels are transferred from their moulds onto blotting paper, protected on
either sides by nylon mesh (and a layer of metal mesh for easy handling). A
load is then applied from top of the gel to expel excess fluid from the hydrogel,
downwards onto the blotting paper.
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Figure 1.3: Setup for upward-flow plastic compression set within culture well-
plates. (a) Custom-machine for rolling Whatman chromatography paper (4cm
thick) to produce well-sized absorbent plungers. (b) Schematic of upward-flow
plastic compression where absorbent plungers and an external load are placed
onto the hydrogels (separated by blotting paper discs to protect the hydrogel).
Fluid flows out of the hydrogel and travels upwards into the plunger.
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Figure 1.4: Collagen hydrogel compresses into a thin membrane-like material
(typically between 50-150µm) with a mesh-like structure observable on the
hydrogel surface (bird’s-eye view (X-Y plane; SEM image). The cross-section
SEM image (Z plane; adapted from Hadjipanayi et al. (2011a)) reveals that
collagen fibrils are arranged into a lamellae-like micro-structure. The density of
collagen fibrils/lamellae is non-uniform throughout the hydrogel cross-section,
and is highest at the fluid leaving surface (annotated above; with schematic
representation of cell entrapment between collagen fibres within the construct).
CHAPTER 1. INTRODUCTION 54
In all studies within this thesis, upward flow compression is used on the
collagen hydrogels due to the high throughput potential and reproducibility,
important for in vitro tissue model systems. Briefly, the process begins from
the application of an absorbent paper discs and a plunger (made from a roll
of blotting paper) onto the hydrogel. Note that the amount of pressure/load
on the compression system only influences the compression rate at the initial
stages of compression (Hadjipanayi et al., 2011a). One specific feature of the
compressed collagen gel is the presence of a fluid leaving surface (FLS) (figure
1.4). This FLS consists of a dense concentration of collagen lamellae layers (1-
5µm thick, observed in the cross-section (z-plane) view of the compressed gel).
Although these lamellae are found throughout the thickness of the gel, their
density was highest towards the FLS (Brown et al., 2005). The high density
at the FLS, and so increased blockage/resistance to fluid outflow causes fluid
flow to reverse, and escape through other surfaces of the hydrogel (further
discussed in chapter 4, pg.125).
By default the surface opposite the FLS is the non-fluid leaving surface
(NFLS), and usually contains a collagen matrix that is relatively less dense
compared to the FLS. However, if the initial hydrogel thickness is high, a sec-
ondary FLS (with increased collagen density) forms in place of the NFLS, with
an associated increase in resistance to fluid outflow through the secondary
FLS. The finding that a secondary FLS forms at the surface directly opposite
the FLS (i.e. the NFLS), and not at the sides of the hydrogel, suggests that
fluid flow is subsequently directed towards the NFLS (i.e. the NFLS becomes
a secondary FLS so that both top and bottom surfaces of the hydrogel has
a high collagen density compared to the rest of the gel) (Tan, 2015). Note
again that the NFLS only becomes the secondary FLS in gels with a high initial
thickness, and can therefore be controlled to some extent, to create a defined
collagen matrix microstructure within the collagen hydrogel.
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The main advantages of using plastically compressed hydrogel constructs
is the relative ease and speed in producing cellular, collagen-dense constructs
(produced within minutes-hours, instead of weeks if reliant on cell migration
and cell-ECM production). Additionally, the resultant constructs are thin and
‘see-through’, allowing the real-time monitor of model tissues (figure 1.4). The
ECM structure (type-I collagen) is formed around the cells from time-zero (t0),
negating the dependence on cells to migrate into dense collagen structures,
and remodel (or produce) the ECM structure. Diverse cell types - such as
those derived from skin (Hadjipanayi et al., 2009b), muscle (Kayhanian et al.,
2009), bone (Bitar et al., 2008), vein (Hadjipanayi et al., 2011b) and nerves
(Georgiou et al., 2013) - have been successfully cultured within compressed
hydrogels.
Since cells are embedded within, and are supported by, a dense collagen
ECM, the cues received from the compressed collagen matrix will be compara-
ble (at least more physiological compared to 2D plastic plate cultures) to that of
their native environment. Here, collagen type-I acts as a structural scaffold to
which cells and other cell-influencing proteins/molecules can be incorporated
to increase the tissue specificity of the model. These external ECM cues can
then impact cell behaviour.
1.6 Interactions between cells and type-I collagen
For most cells, the ECM provides more than just structural support. Cells are
able to attach to, and sense their surrounding environment - including both
chemical and physical cues presented to the cells. For example, soluble growth
factors (as a chemical cue) can be bound to the ECM which regulates their dis-
tribution, activation and presentation to cells within the matrix (Hynes, 2009).
However, the main focus (in the first part) of this thesis is to create a physi-
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ological physical environment by creating cell substrates that can match the
natural tissue mechanical properties of stiff soft tissues; and in doing so, cre-
ate a model tissue which produces physiological cell response to implanted
biomaterials.
In terms of sensing their physical environment (i.e. matrix stiffness/ de-
formability and topography), cells interact with the ECM through attachment.
Mechanical stimuli are converted into chemical signals, which in turn affect cell
behaviour. This process of mechanotransduction can be via a range of cell-
matrix attachments, with integrins being the most prominent and studied group
of cell-matrix attachments.
Integrins are a family of cell surface receptors which link the cell external
and internal environment. They can work with other proteins such as cadherins
(involved in cell-cell attachment; (Gumbiner, 1996)), syndecans and selectins,
to name a few, in order to produce cell-cell and cell-matrix interactions which
are found in the natural tissue (Ramage, 2011).
The cell surface integrins α1β1, α2β1, α10β1 and α11β1 are known to as-
sociate with collagen molecules (White et al., 2004). The binding activity of
integrins to ECM is regulated from inside the cell, but requires the formation
of focal adhesion complexes to connect the cell internal and external environ-
ments. Focal adhesion and the process of mechanotransduction is complex
and involves many proteins (upwards of 180 proteins (Kuo, 2013)) and path-
ways. Binding of talin and other adaptor proteins to β-subunit of the integrins
has a key role in integrin activation within the cell (Legate and Fssler, 2009)
(Mason et al., 2012) (β-subunits of the integrins regulate integrin activation
through conformational change).
Binding of the integrins to the ECM proteins focuses clusters of integrin
molecules within the plasma membrane. After initial activation, focal adhe-
sions matures into multi-protein complexes at the cytoplasmic interface where
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actin filaments and other intracellular signaling molecules are recruited (Hynes,
2002).
The ability of cells to sense matrix stiffness, or more accurately their de-
formability, is partly dependent on the contractility of the actin-myosin cytoskele-
ton, which is transmitted to the ECM through integrins and focal adhesions.
Cells respond to the stiffness of their substrate by altering their cytoskeleton
organisation, cell-substrate adhesion and other processes which affect cell be-
haviour (Mason et al., 2012).
For example, focal adhesion size linearly depend on local force exerted
by cells. Mature focal adhesions elongate and orientate in the direction of
actin stress fibres and applied force. Cell-substrate adhesion increases due
to increased stiffness (Engler et al., 2004), and this change in adhesion al-
ters cell shape which help regulate polarisation and alignment of stress fibers
within cells (Zemel et al., 2010) (i.e. cells sense the tension of the material
(Marenzana et al., 2006)). Similarly, cells also respond to changes in colla-
gen fibril diameter and alignment (i.e. topography), and was found to increase
matrix synthesis on thicker fibrils (i.e. 300nm diameter fibrils instead of 30nm)
(Muthusubramaniam et al., 2012).
In order to produce a model that closely mimic the native tissue, it is impor-
tant to understand the causes of cell behaviour changes, and the factors which
cause physiological and tissue specific cell responses within the model.
1.6.1 Modeling of cell response within plastically compressed
collagen hydrogels
As discussed in section 1.6, cells (such as fibroblasts), attach and respond
to the cues provided by the collagen matrix. Examples (from the literature)
of cell behaviour studied/modeled within the plastically compressed collagen
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hydrogel 3D matrix are discussed below.
Cell viability
Cell viability is typically measured using live/dead cell staining and imaging
techniques (East et al., 2010) (Wong et al., 2013) within the compressed hydro-
gel. Without other interventions, the cell viability within collagen hydrogels after
plastic compression was found to be ≥ 90% (Brown et al., 2005), with many
studies reporting a higher percentage of viable cells (of different cell types)
within the compressed gel. This high level of viable cells is likely attributed
to the controlled compression of the sample, and the high permeability of the
construct to cell essential molecules (constructs typically ∼ 100µm thick). The
thin sample also means that cells can be easily visualised when embedded
within the matrix.
Generally, it is difficult to correlate the effects of cell-essential molecules,
such as oxygen, to cell behaviour in vivo (due to the presence of other con-
founding variables). The simplified in vitro tissue model therefore acts as a
powerful tool in studying the effect of oxygen concentrations (within a 3D con-
struct), on cells. For the measurement of oxygen permeability, and its effect
on cells, Ardakani et al. (2014) used a spiraled compressed cellular gel, with
oxygen probes to measure the partial pressure of oxygen in the core, middle
and outer layers of the construct. Cell viability within the construct remained
above 70% even at the core. Although the partial pressure of oxygen was many
times lower than the outer layers, this was not pathological. Another study by
Cheema et al. (2008) showed that the majority of cells (≥ 55%) remain alive
within the core of a spiral collagen hydrogel constructs, even with a relatively
low oxygen partial pressure, after 10 days in culture.
Anandagoda et al. (2012) also studied the effect of applying a layer of
hyaluronic acid (HA) adjacent to a cellular compressed gel layer (spiraled to-
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gether), and found a ∼ 88% cell viability at the HA-collagen gel interface. Cells
trapped in areas away from the HA saw a similar live cell count of ∼ 89%. The
model was able to show that the HA component swelled as the compressed
collagen gel got thinner, leading to the hypothesis that the dehydrating effect
of HA on the collagen gel component caused the (albeit small number of) cell
death, and the effect was therefore not due to toxicity of the HA material.
Migration
Migration of cells within the 3D construct with the appropriate directional cues,
can be an indication of the extent of cell attachment to the matrix and the pres-
ence of chemical (or physical) gradients (i.e. oxygen, growth factors). Within
the compressed hydrogel construct, cells migrated in response to oxygen con-
centration gradients (from an area of lower to higher partial pressure of oxygen)
(Ardakani et al., 2014). Non-proliferating cells were also found to aggregate
at the stiff-end of a construct which has been produced with a longitudinal
collagen density gradient (material stiffness range between 1057-2305 kPa),
demonstrating that cells will migrate in response to substrate stiffness (Hadji-
panayi et al., 2009c).
The ability for cells to migrate within the type-I collagen derived constructs
was also implied in the layer integration of hydrogels, as it was thought that
cells drag and bend collagen fibrils as they migrate between layers (Meshel
et al., 2005). Indeed, adhesive strength between two layers of collagen gels
increased with culture time for cellular constructs (6-fold increase by 1 week in
culture) (Hadjipanayi et al., 2009a), and not in its acellular equivalent. Since
cells migrate between contacting layers, the adhesion strength will also depend
on the contact surface area between the two layers (Marenzana et al., 2007)
(and presumably the level of cell activity and number of cells present).
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Proliferation
Cells naturally proliferate in growing tissues, and also for the maintenance
of cell populations during cell-turnover. Proliferation of cells within the colla-
gen hydrogel is typically measured through changes in the amount of total
cell metabolic activity over time, through imaging, or more reliably through the
quantification of total DNA content within the construct (as an end-point assay).
Within the collagen hydrogel, factors that influence proliferation rates in-
clude the initial cell seeding density; where a low density resulted in a relatively
high proliferation rate (compared to cells within samples containing a high ini-
tial cell density; MG63 osteosarcoma cell-lines used in this study) (Bitar et al.,
2008). This difference in cell proliferation rates was observed for up to 10 days,
possibly when cell density within the ‘low cell density samples’ increased to a
level where cell-cell inhibition occurred.
The link between high cell density and low proliferation rates was also ob-
served in a study by Hadjipanayi et al. (2009b). The study found that the matrix
stiffness surrounding the cells (not just the overall cell substrate) directly regu-
lated proliferation rates, such that a graded increase in proliferation rates was
seen with increasing collagen density.
Differentiation
The monitor of cell differentiation within the model will be essential to predict
tissue development over culture time, particularly when cell types with the po-
tential to differentiate into different lineages are involved.
For example, an obvious measure of long term success of an implant (other
than in cartilage and ligament tissues) is the development of a blood supply.
Previous studies have been able to demonstrate angiogenesis within the plas-
tically compressed constructs with the co-culture of human dermal fibroblasts
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(HDF) and human umbilical vein endothelial cells (HUVEC) (Hadjipanayi et al.,
2010). Here, physiological hypoxia was identified as a factor which encouraged
an angiogenic response, where endothelial cell clusters (positively stained for
CD31 and vWF) were formed by 1 week within the capillary like structures.
Others
Other interesting measures of cell behaviour within the plastically compressed
hydrogel include the regulation of protein/growth factor production, gene regu-
lation and matrix remodeling.
Cheema et al. (2008) showed that cells respond to reduced oxygen partial
pressures in their environment, by significantly increasing the level of vascular
endothelial growth factor (VEGF) expression (at a maximum 151-folds). Impor-
tantly, the model was able to reflect the temporal change in VEGF levels over
time, such that peak levels were seen at days 7 and 8, followed by an imme-
diate drop in VEGF expression. In this study, it was also observed that cells
may alter their consumption of oxygen in low oxygen environments. For exam-
ple, partial pressure within the core of a cell-dense construct increased from
∼ 25mmHg to ∼ 60mmHg over time, with no obvious changes in cell numbers
over several days in culture.
In terms of gene regulation by cells, Karamichos et al. (2008) showed that
cells (primary HBMSCs) respond to matrix stiffness, and that the amount of
serum within the collagen construct affected gene regulation and force gener-
ation. An increased matrix stiffness corresponded to a decrease in cell force
generation, and increased lag time before the onset of hydrogel contraction
(Karamichos et al., 2007). It was also found that the lag time to cell contrac-
tion, and the amount of force generated by cells, had some dependence on
the amount of fetal calf serum (FCS) present within the cell environment. In
the presence of 10% (v/v) FCS, an increase in matrix stiffness up-regulated
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COL3 and MMP2 expression; whilst in 20% FCS, MMP2, COL3 and COL1
were unaffected (or slightly down-regulated) by matrix stiffness (Karamichos
et al., 2008).
The remodeling of the matrix by cells can also be studied in vitro over time
within hydrogel constructs. The kinetics of collagen fibril (enzymatic) degrada-
tion is strain/load dependent, affecting the rate of MMP secretion and collagen
deposition (Hadi et al., 2012) (Collins et al., 2005). Over time in a cell-seeded
construct, the remodeling action of cells gradually loosens the matrix (Tan,
2015, p.215). The overall shape of the compressed collagen construct, how-
ever, remains unchanged even after cell remodeling (Alekseeva et al., 2012b).
All in all, the above models have shown that cells respond to hydrogel:
• Matrix stiffness
• Matrix/cell binding site density
• Chemical gradients (i.e. growth factors, oxygen)
• Cell density
• Topography
1.6.2 Further engineering of plastically compressed hydro-
gels
Plastically compressed collagen gel is used as the basic model for next-generation
models with added tissue-specific features. Therefore, it is important to review
all methods of compressed hydrogel manipulation already in the literature; in-
cluding chemical and physical features that has previously been incorporated
into the basic model. Many of these features designed to build an increasingly
complex model, to ultimately improve the relevance of the material to the target
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tissue. These features provide environmental cues that are designed to direct
cell behaviour, and can include chemical cues such as growth factors, cell-
attachment proteins; or physical cues such as the structure (i.e. topography,
anisotropy and alignment) and stiffness of the construct.
The examples listed below involve direct engineering of the collagen con-
struct (predominantly free of direct cell involvement), and means that changes
to the hydrogel (and therefore its effect on cells) are instant and controllable.
Mechanical properties
Multiple studies have shown the importance of matching native tissue and bio-
material stiffness for optimal construct-tissue integration (Moroni and Elisseeff,
2008). The mechanical properties of biomaterials are often quoted in stiffness
(Young’s modulus), shear modulus and the stress and strain until failure. A typ-
ical compressed collagen sheets have been reported to have a break strength
of 0.6 ± 0.11 MPa and a Young’s modulus of 1.5 ± 0.36 MPa (Brown et al.,
2005). This value is often short of the nature tissue strengths (where individual
hydrated collagen fibrils can have a Young’s modulus of 0.2-0.5 GPa (van der
Rijt et al., 2006).
Normally, standard methods to improve mechanical properties of collagen
materials will involve some form of chemical cross-linking, such as with genipin
or gluteraldehyde. However, the purpose of using plastically compressed hy-
drogels, instead of stiff and dense collagen materials (such as decelluarised
collagen sponges), is their good initial interstitial cell viability immediately after
fabrication. The use of harsh cross-linking methods defeats this purpose.
Photochemical cross-linking using photoactivated riboflavin is one possible
way to cross-link cellular gels, as they are only activated when illuminated with
blue light (Wong et al., 2013) (Rich et al., 2014). Topical application of riboflavin
and its subsequent cross-linking resulted in some interstitial cell survival, which
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then populate the hydrogel with time.
Alternatively, mechanical properties can be improved by further increas-
ing the density of collagen within the construct. Double compression (second
plastic compression of rolled compressed collagen sheet) achieved twice the
collagen density (increased from 12.6% to 23.1% collagen), and resulted in a
significantly increased break stress and modulus (Abou Neel et al., 2006).
Collagen fibril diameter within hydrogels was also reported to influence
mechanical properties of the hydrogel. Cyclic loading (cycles of 20% strain
and relaxation) encouraged side-to-side collagen fibril fusion in hydrogels, as
seen by the increase in cross-sectional fibril diameters. After 144 cycles, the
break stress, elastic modulus and break strain have increased 450%, 125%
and 133% respectively (Cheema et al., 2007a).
Mechanical properties of the construct can also be improved by incorporat-
ing a supporting biomaterial within the hydrogel. For example, a PLGA mesh
has been incorporated between collagen hydrogel layers before compression
(Ananta et al., 2012) to produce a material that is easier to handle. Similarly
Deng et al. (2014) have shown an increase in construct Young’s modulus, from
2.31MPa to 70MPa, after aligned PGA fibers were incorporated within the
hydrogel. This provided interstitial cells with temporary stress shielding from
externally applied force. However, since the increased strength of the construct
was dependent on the PGA fibers, the subsequent hydrolysis of the PGA (and
so the lost of fiber continuity) caused a sharp decrease in the Young’s modulus.
Anisotropy and topography
Another important consideration is the surface anisotropy and µ-structure of
the construct as perceived by resident cells. This can impact on cell align-
ment, differentiation and construct perfusion for the long-term survival of cells
within the construct.
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Anisotropy within the collagen construct has been produced at different hi-
erarchial/structural levels; from the nano-scale (i.e. alignment of the collagen
fibrils) up to the micron-scale (i.e. embossing channels onto the construct
during compression) (Kureshi et al., 2010). In the same study, alignment of
cells (WI38; lung fibroblast-like cells) parallel to embossed grooves was also
demonstrated.
Further guidance of cells within channels was explored using conical-shaped
channels, created from soluble phosphate glass fibres which ‘opened’ at dif-
ferent rates when the glass fibres began dissolving from the thinner end. This
produced a channel which opened towards the thicker end of the fiber with time
(Alekseeva et al., 2012a), with the aim to ultimately encourage directional cell
migration.
Alternatively, gross anisotropy of the compressed collagen gel can be achieved
by topical surface cross-linking (i.e. applying directional stripes) of the collagen
gel (Wong et al., 2013). This resulted in a doubled break stress in one axis of
the hydrogel (parallel to the stripes).
Patterns (i.e. grooves) and channels can easily be embossed onto the
hydrogel surface during plastic compression (Brown et al., 2005) (Alekseeva
et al., 2012b) (Tan et al., 2014); or within the collagen construct (Alekseeva
et al., 2012a) (Cheema et al., 2010). Note that for surface embossing, the
above studies have found that pattern and shape of the mould is replicated
most faithfully at the FLS (Alekseeva et al., 2012b), and surface patterns does
not deform when additional layers are compressed onto the patterned surface
(Tan et al., 2014). Grooves remained stable even in culture (with cell remod-
eling) over a test period of 14 days (Alekseeva et al., 2012b). This can po-
tentially provide directional cues for cell migration and perfusion within thicker
constructs Cheema et al. (2010).
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Chemical cues
Another important consideration for in vitro tissue engineering is the impact
of chemical cues found in the matrix environment, such as growth factors, on
resident cells. Cells produce growth factors and other proteins with culture.
Pre-cultured cellular compressed hydrogel construct can be used to deliver
physiological levels (and combinations) of growth factors (i.e. for angiogensis
in response to hypoxic culture conditions; such as HIF-1α, VEGF and matrix
remodeling proteins such as MMP2 and MMP9) into a second construct. Had-
jipanayi et al. (2011b) demonstrated that angiogenic growth factors (produced
in response to hypoxic conditions; in the pre-cultured gel) diffused towards the
new hydrogel by day 1, resulting in increased mean length of capillary like
structures. Cell density in the initial growth factor delivering gel influenced ex-
tent of vascularisation (i.e. increased cell density (and presumably the amount
of growth factors produced as a result) improved signs of vascularisation).
Others
Multiple layers of collagen hydrogels can be compressed together to build com-
plexity within the tissue model (i.e. test migration of cells or interaction between
two different cell types in adjacent layers). Layers were found to have good in-
tegration when compressed together (Tan et al., 2014). Topical crosslinking
at the layer interface also further improved integration of compressed colla-
gen sheets (Wong et al., 2013). The presence of cells within the hydrogel
also improved layer integration as cells are thought to migrate across the layer
interface whilst bending and carrying collagen fibrils across the interface (Had-
jipanayi et al., 2009a).
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1.7 Aims and objectives
The overall aim of this research is to produce next-generation, 3D hydrogel-
based, soft tissue models with the ability to predict native tissue response to
implant biomaterials. Since type-I collagen is one of the most abundant pro-
teins found in human tissues, it is used as a tissue model substrate to provide
physiological spatial cues for cells (i.e. cell-matrix attachments).
Overall, it is currently possible to generate tissue-like models using plasti-
cally compressed collagen hydrogels with:
• Dense extracellular matrix around various cell types
• Defined microstructures (i.e. FLS with collagen density gradient)
• Controllable matrix stiffness (within a modest range)
• Controllable surface topography
• Multi-layers with good perfusion of cell-essential nutrients
• Construct anisotropy
• Easy in vitro access for monitoring
Nevertheless, for the modeling of some soft tissues, such as skin and ten-
don, a matrix with increased stiffness and complexity will be required; and the
production of the next generation with such features is the aim for the current
study.
The objectives of the current studies are:
1. Increase mechanical properties of the collagen model substrate whilst
retaining initial cell viability
2. Monitor biomaterial and cell response within a tissue-like model over time
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1.7.1 Thesis overview
The aim of this study is to develop 3D soft tissue models with improved rele-
vance to human tissues, and to study biomaterials within the accessible tissue-
like model over time. All tissue models are based on plastically compressed
hydrogels made of type-I collagen, the main structural proteins of most soft
tissues.
This thesis is divided into two main sections. First involves the develop-
ment of an in vitro model tissue with increased mechanical properties. The
key feature of this model tissue is that it must contain an initial live cell pop-
ulation within the construct, have increased mechanical properties compared
to traditional compressed collagen hydrogels, and has the potential for high
through-put testing (in well plates). This was explored in chapter 3 by devel-
oping a novel hydrogel using a pre-crosslinked collagen (polymeric collagen,
blended with traditional gel forming tropocollagen molecules) as the starting
material for gel formation. Chapter 4 continues onto the characterisation of
the resultant polymeric collagen containing gels. It was found that the blend
gels collapsed quickly upon compression, leading to cell-damaging fluid shear
stresses. Chapter 5 explores methods which can control fluid efflux rates from
hydrogels by increasing the filtration effect (using macromolecules) at the FLS
of the hydrogel.
The second part of the study looks into the applications of compressed
collagen hydrogel based soft tissue models. Chapter 6 deals with the modeling
of nanoparticle drug-delivery, and its effect on local tissues. Specifically, the
growth factor, bone morphogenic protein-2 (BMP-2) is thought to be produced
(in bone-like tissues) in response to statin drugs. Temporal changes to BMP2
protein levels was therefore tracked within the model. Chapter 7 studies the
degradation of biomaterials (using fluorescent PLGA as a test material) within
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a tissue-like environment. The degradation rates of the biomaterial in 2D and
3D (with/without cells), and the fate of the degraded biomaterial, are studied.
The methods common to all studies throughout this thesis are detailed in
chapter 2. Finally, the main findings and conclusions of the studied models are
summarised in chapter 8.
Chapter 2
Materials and Methods
Materials and methods used routinely throughout the project are listed in this
chapter. Any variations to the methods (or methods specific to the study) can
be found in the methods section of subsequent chapters.
2.1 Cells
Neonatal human dermal fibroblasts (HDF) and human osteosarcoma cell-line
MG63 were cultured in 1000mg glucose Dulbecco’s modified Eagle’s medium
(DMEM; Sigma, UK), supplemented with 10% (v/v) fetal calf serum (FCS; First
Link, UK) and 1% penicillin streptomycin (Gibco Life Technologies, UK). Cells
were removed from monolayer culture by washing with phosphate buffer saline
(PBS) and incubating with trypsin (0.5% trypsin-EDTA; Gibco Life Technolo-
gies, UK) for 5 minutes at 37°c.
2.2 Collagen hydrogel preparation
Conventional collagen hydrogels were prepared, on ice, by neutralising 80%
(v/v) rat tail acid-soluble type-I collagen (between 2.05 and 2.16mg.ml-1 in
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acetic acid, First link, UK) containing 10% 10x Minimum Essential Medium
(MEM) (Gibco life technologies, UK) using 5M and 1M sodium hydroxide (NaOH).
The drop-wise addition of NaOH gradually changed the colour of the phenol
red pH indicator (included in the 10xMEM), from yellow to fuchsia pink, when
neutralised. The remaining 10% volume was made up with phosphate buffer
saline (PBS) or DMEM (with or without cells). The neutralised collagen solu-
tion was gelled by incubation in 24-well plates at 37°C, 5%CO2, for 30 minutes
(gel volume depended on the study).
2.3 Polymeric collagen extraction
Polymeric collagen was extracted from tendons due to their relatively high poly-
merised type-I collagen content (see chapter 3 for further details). Fresh ten-
dons were frozen at −20°c for storage. 2 - 6g ostrich (2 years old) or calf
tendons were homogenized in liquid nitrogen using a stainless steel mortar
and pestle. The resulting tendon granules were pre-treated overnight at 4°c
in excess (∼150ml per gram of tendon) 0.5M ethylenediaminetetraacetic acid
(EDTA; Sigma-Aldrich) adjusted to pH 7.4, with at least one change (Steven,
1967). Treated tendon granules were washed twice in distilled water prior to
expansion in 0.5M acetic acid (∼100ml per gram of tendon). The solution was
stirred constantly with a magnetic stirrer at 4°C for at least 3 hours and the ex-
panded collagen was recovered as polymeric collagen by stirring with a glass
rod during neutralization (5 and 1M sodium hydroxide (NaOH)). This collected
the polymeric collagen as it shear aggregated onto the glass rod. Collagen
fibrils were suspended in 0.5M acetic acid, and re-precipitated at least twice
to remove impurities trapped between collagen fibrils. Where necessary, the
polymeric collagen solution was sterilized by mixing with an equal volume of
chloroform (BDH Laboratory Supplies, UK). Collagen concentration was ad-
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justed to 2mg.ml-1 in 0.5M acetic acid before use (Wong et al., 2014).
2.4 Plastic compression
Following gelation, collagen hydrogels were plastically compressed based on
previously described methods (Brown et al., 2005). A modified method more
suited for up-scaling processes, namely in multi-well culture plates, was used
for all plastic compression processes (Alekseeva et al., 2011). Briefly, ab-
sorbent paper roll plungers were made by rolling blotting paper (Whatman
grade 1 chromatography paper, 93x4cm) into a coil (∼ 15mm diameter; auto-
claved for sterilisation when required). This was placed onto hydrogels formed
in 24-well plates. The two components were separated by two well-sized pa-
per discs (Whatman, grade 1 paper) to prevent the hydrogel from sticking to
the plunger, and to prevent the unintentional embossing of the coil (plunger)
pattern onto the gel. Weights of 21g per well was used where specified. Af-
ter the completion of plastic compression, the plunger roll was removed. PBS
or cell media were then added to each well immediately to keep the samples
hydrated. The paper discs separating the plunger and hydrogel can then be
removed at this point. Samples were then carefully detached from the base of
the well, and used or cultured as required.
2.5 Rate of plastic compression
Rate of hydrogel compression was measured as the mass gained (fluid ab-
sorbed from the hydrogel) by an absorbent plungers with compression time.
The plunger mass was measured every 30 seconds in the first 5 minutes of
compression, and then every minute subsequently until no further mass gain
was detected. No additional external weights was loaded onto the compres-
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sion system in this part of the study.
2.6 Quantification of cell proliferation and cell tox-
icity
Alamar blue is a redox indicator used to quantify total cell metabolic activity
within the sample. The alamar blue compound is also known as resazurin
which is blue, and mostly non-fluorescent. However, it is reduced by cell mi-
tochondrial activity to form a red fluorescent compound which can then be
detected using a spectrophotometer. At selected time points, samples were in-
cubated with 10% (v/v) alamar blue (AbD, Serotec) solution in phenol red-free
DMEM for 4 h (500µl per well). Duplicates of 100µl of alamar blue solution
from each well was transferred into a 96 multiwell plate, and absorbance was
read with a microplate spectrophotometer (MR700 microplate reader, Dynat-
ech Laboratories) at 510 and 590 nm. Samples were subsequently washed
with PBS and returned to culture after culture media was added to each well.
2.7 Cell viability assay
Cell viability within compressed (or uncompressed) gels was confirmed by fluo-
rescent imaging after a 45 minute incubation of the cellular hydrogel with stains
consisting of 17µl ethidium homodimer (2mM; Invitrogen) and 20µl calcein-AM
(4mM; Fluka Analytical) diluted in 5ml PBS (0.5ml of diluted stain solution in
each well of a 24-well plate). Images were taken on the Olympus BX61. For
each sample, images of three random fields of view was captured for cell count-
ing. The number of live (green, calcein-AM stained) and dead (red, ethidium
homodimer stained) cells were only included if the cells were within a digitally
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superimposed frame (identical for each field of view).
2.8 Histology
Collagen constructs were prepared using a routine protocol. Samples were
fixed with 4% paraformaldehyde for subsequent histological processing. Pro-
cessed samples were embedded in paraffin wax and sectioned to a thickness
of 8 - 10 µm. This was followed by standard haematoxylin & eosin (H&E) stain-
ing protocol. Briefly, sections were dried at 60°c overnight and de-paraffined
the following day before rehydration through an descending alchohol series.
The slides were washed gently in running water and was placed in haemotox-
ilin (Sigma, UK) for 10 minutes. Slides were dipped into acid-alcohol solution
5-6 times, washed and placed in eosin (Sigma,UK) for a further 10 minutes.
The sections were then dehydrated with a ascending alcohol series and finally
mounted in DPX (VWR, BDH Prolabo). Samples were subsequently viewed
on a standard light microscope (Olympus, BH-2).
2.9 Scanning electron microscopy preparation
Samples were fixed in 2.5% glutaraldehyde (in 0.1M sodium cacodylate buffer)
for at least 1 hour, and were subsequently washed with 0.1M sodium cacody-
late buffer. Fixed samples were then dehydrated with a series of ascend-
ing alcohol concentration and hexamethyldisilazane (Aldrich, USA) treatment
overnight. The dried samples were then sputter-coated with gold-palladium
(K550, Emitech) and imaged as detailed below.
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2.10 Microscopy
2.10.1 Light
In early samples, haematoxilin and eosin (H&E) stained sections were visu-
alised and imaged using a Olympus BH-2 microscope and Olympus Camedia
digital camera. Subsequent samples were visualised and imaged on the Zeiss
Primovert microscope (Zeiss Axiocam 105 color camera).
Birefringence
On the Olympus BH-2 light microscope, a rotating light polarising filter was
installed at the light source. Images were then taken using the Olympus BH-2
microscope and Olympus Camedia digital camera.
2.10.2 Fluorescence
Two different fluorescent microscopes have been used. Either the Olympus
BX61 microscope with fluorescent light source from X-cite series 120Q, or
the Olympus BH2-RFCA (with light source Olympus BH2-RFL-T3). In the lat-
ter, images were taken in black and white with a Hamamatsu digital camera
(C4742-95). Images were subsequently processed using ImageJ to adjust
colours to reflect those seen on the microscope.
2.10.3 Scanning electron microscope (SEM)
Sputter coated samples were imaged at 15-25kV on the SEM (JEOL JSE-5000
SEM, Japan)
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2.11 Fluorometry
Fluorescent particles in solution were detected using a spectrophotometer.
Earlier samples were analysed using a Perkin-Elmer LS50B fluorescence spec-
trometer (3ml samples in cuvette). Fluorescent hyaluronic acid nanoparticles
(HA-NP) (from Uppsala University; see chapter 6 for more details) tagged with
fitc were detected at an excitation and emission wavelength of 495nm and
520nm respectively.
An infinite M200Pro (Tecan) plate reader was used for later experiments,
where fitc-tagged HA-NP were now measured at excitation and emission wave-
lengths of 485nm and 535nm. Rhodamine tagged PLGA materials were mea-
sured at excitation and emission wavelengths of 530nm and 590nm.
2.12 Statistical analysis
All studies were conducted with at least 3 samples per experimental variable,
and data were represented as mean ± standard deviation, where appropri-
ate. Unless otherwise stated, t-tests were used to compare two groups, and
one-way ANOVA (analysis of variance; LSD post-hoc) were used in instances
where more than two groups were being compared, assuming a normal distri-
bution of data. The confidence interval was set at P ≤ 0.05.
Chapter 3
Methods development for cellular
polymeric collagen constructs
Mechanical properties of an acellular collagen hydrogel can be improved eas-
ily through the covalent cross-linking of the matrix. However, in order to effi-
ciently create stiff tissue models, cell incorporation is important, and current
challenges generally lie in the increase of hydrogel stiffness in a cell friendly
manner.
In a collagen hydrogel (and other collagen derived materials), its stiffness
depends on 1) the density of collagen, and 2) the extent of bonding (cova-
lent and others) between adjacent collagen molecules. Although issues on
collagen density within hydrogels can be overcome by plastic compression,
current hydrogel materials (described in detail in section 1.5) are formed from
monomeric collagen species, and lack interfibrillar covalent cross-links. This
absence in collagen cross-linking leads to decreased stiffness in a typical hy-
drogel construct compared to the natural tissue.
Generally, improvements of material mechanical properties is achieved by
forming covalent cross-links between collagen molecules. It is, however, im-
portant that cells within the construct remain viable for the use of a hydrogel as
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a substrate to be justified. This rules out the use of most (if not all) chemical
methods of artificial cross-linking, due to their cytotoxicity (chapter 1.4.2). In
this chapter, a new solution to improving collagen material mechanical proper-
ties (without the use of artificial cross-linking) was studied. This is based on
the use of a natural and highly polymerised form of type-I collagen (polymeric
collagen) to produce cell-compatible and cell-supportive materials.
The focus of this chapter is on identifying the optimal collagen source and
extraction process of polymeric collagen to form a stiff and cellular material
at time-zero, so that it can ultimately be used as a 3D in vitro model of stiff
tissues.
3.1 What is polymeric collagen?
All collagenous tissues containing type-I collagen will contain a fraction of col-
lagen soluble in neutral salts and weak acid solutions (tropocollagen). This
leaves a ‘bulk’ collagen mass composing primarily of a polymerised form of
type-I collagen (i.e. polymeric collagen - representing the mature cross-linked
bulk of tissue collagen) and some impurities. The proportion of polymeric colla-
gen will depend on the tissue source (species, age, and tissue type), but often
accounts for the majority of type-I collagen within the tissue.
In commercial collagen extraction processes, much of the polymeric col-
lagen is treated as a waste product after acid-soluble collagen extraction, or
are otherwise pepsin treated to produce smaller units of acid-soluble atelo-
collagen (Rubin et al., 1965) (Drake et al., 1966) which can be reconstituted
to form a hydrogel. This excess in polymeric collagen, and the general lack
in commercially available polymeric collagen, goes to show that soluble col-
lagen isotypes are often the focus of collagen research, as studies into the
nature and uses of polymeric collagen fell out of general interest from 1980s
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onwards (with virtual absence of publication). As a result, polymeric collagen
has not previously been considered as a tissue engineering (TE) material (i.e.
where cell-collagen materials were needed for tissue engineering, collagen
gels based on acid-soluble collagen were used).
3.2 Polymeric collagen as a potential source of
ready-made cross-links
Much of the work characterising polymeric collagen has been published in
the 1960s-70s. However, issues with purity of extracted polymeric collagen
were not solved until 1964, when it was reported that a Japanese technique
(Nishihara method) was used to isolate purified polymerised collagen using
pre-treatment of a tissue in crude α-amylase (Steven, 1964) (only crude prepa-
rations of α-amylase resulted in increased polymeric collagen purity so the re-
sult was attributed to contaminants within this preparation). It is noteworthy
that the polymeric collagen in this report was extracted from aged, previously
insoluble, tissues which comprise almost entirely of covalently cross-linked col-
lagen fibrils. The collagen extracted by this method differed from acid soluble
collagen in that it was an insoluble, highly cross-linked, form of collagen which
could be suspended as a colloid in dilute acid. However, collagen fibrils from
most tissues do not disperse fully in solution even with (crude) α-amylase treat-
ment. It was therefore thought that other interactions must exist between col-
lagen fibrils in the polymerised collagen (Mathews, 1965). Calcium ions were
suggested as a possible further interaction between collagen fibrils as Steven
(1967) later reported that collagen fibrils completely dispersed in a weak acid
following treatment with a divalent cation chelating agent, Ethylenediaminete-
traacetic acid (EDTA). EDTA is thought to remove calcium ions within polymeric
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collagen, which stabilised its linkage with non-collagen protein (Spichtin and
Verzar, 1969), and enabled the full dispersion of collagen fibrils. Indeed during
the polymerisation of soluble collagen fibrils, the presence of small amounts of
calcium ions accelerated the association of fibrils (Evans and Drouven, 1983),
and suggest some involvement of the ion between collagen fibrils.
Observations from current studies concur in that EDTA treatment of less
matured tissues improved the dissipation of collagen fibrils in solution; how-
ever, it was also observed that overly crosslinked tissues (i.e. decellularised
collagen sponges) did not respond to EDTA treatment, as covalent bonds were
unaffected by EDTA.
Once polymeric collagen was suspended in solution, it became possible to
remove impurities from between its fibrils. It therefore represents an attractive
source of collagen materials for biotechnological and tissue engineering as it
is physiologically cross-linked and potentially strong and stable.
3.2.1 Extraction of polymeric collagen
Collagen composition of a tissue (i.e. procollagen, tropocollagen or enzymat-
ically cross-linked polymeric collagen) depend on the age (Miyahara et al.,
1982) (Wu et al., 2005), species (Angele et al., 2004) and the tissue source
(Schofield et al., 1971). For example, polymeric collagen can be extracted
without EDTA treatment from intestinal submucosa (Steven et al., 1969), but
requires additional trypsin treatment for cartilage (Steven and Thomas, 1973).
Choosing the source of polymeric collagen depended on the polymeric col-
lagen yield, which in turn is dependent on the extent of naturally occurring
cross-links between collagen fibrils. In young tissues, cross-linking between
collagen molecules is likely to be immature, involving acid-labile aldimine cross-
links. Such bonds can be found between lysine-derived aldehydes and the e-
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amino group of hydroxylysine, giving dehydro-hydroxylysino-noruleucine (deH-
HLNL) bonds (Bailey and Peach, 1968); or between a free aldehyde of an acti-
vated histidine and an e-amino group of hydroxylysine within the collagen triple
helix (dehydro-histidino-hydroxymerodesmosine (deH-HHMD) bonds) (Robins
and Bailey, 1973). Such immature cross-links associated with recent synthesis
are easily broken (Jackson and Bentley, 1960) (Kang and Gross, 1970), lead-
ing to their extractions as acid soluble collagen (and low yields of polymeric
collagen). Only as the tissue ages, the acid labile cross-links are stabilised
by insoluble bonds between the collagen fibrils (Bailey, 1969) (Miyahara et al.,
1982). However, excessive cross-links between the collagen fibrils would be
equally undesirable for the purposes of extracting polymeric collagen if the
polymeric collagen cannot be suspended in dilute acid (and it would be less
able to remove impurities trapped between fibrils). The ideal source of poly-
meric collagen would therefore likely come from fast growing and relatively
young tissues (i.e. those with a moderate extent of interfibrillar collagen cross-
links).
In terms of tissue types, polymeric collagen has been extracted from vari-
ous soft tissues such as skin, tendon, sclera, cornea and intestinal submucosa
(Schofield et al., 1971). However, in terms of type-I collagen donor source,
tendons represent the optimal choice due to the relatively high proportion of
type-I collagen within the tissue (therefore less impurities).
Tendon Source
Tendon was investigated as a source of polymeric collagen (as opposed to
other tissue types, such as skin) due to its high percentage of type-I collagen,
which could account for up to 85% of the tissue.
It is important to carefully consider the tendon source as the species, age
and tendon type can impact on the extractability and yields of polymeric colla-
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gen. Here, tendons from several different species (and in one case, different
age) have been used for the extraction of polymeric collagen. Tendons under
investigation included ostrich achilles tendons (at 6 and 24 months of age), calf
achilles tendon (exact age unknown, from local butchers) and chicken feet ten-
don (sourced frozen from supermarket). Freeze-dried calf skin (kindly supplied
by Devro, UK) was also tested for the extraction of polymeric collagen. Obser-
vations from each of the tendons under investigation are listed in the table 3.1,
and further discussed after the methods detailing the extraction of polymeric
collagen below.
Homogenisation
Tendons (except freeze-dried granules from Devro) were homogenised to start
the extraction process. Homogenisation increased the surface area to volume
ratio of the tendon for EDTA treatment and collagen fibril suspension in weak
acid. Homogenisation of the tissue is sometimes used in collagen extraction
processes (Liu et al., 2001), though not always necessary for tendons that are
particularly susceptible to acid extraction (i.e. rat tails).
Several methods of homogenisation were tested and compared for their
extraction efficiency, and ease of use.
(a) Cryostat
This method involved the cutting of tendon samples into thin sections to in-
crease the surface area of the tendon exposed to the weak acid solution:
1. Tendons were cut into smaller pieces (measuring approximately
1-1.5 cm) and weighed
2. Each tendon piece was set horizontally in a block of ice (so
that it was cut parallel to the collagen fibers)
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3. The ice block was mounted onto a cutting block using optimal
cutting temperature compound (OCT), and was left to set at
−30°c for at least 30 minutes
4. Tendon sections were cut at ∼ 10µm
The tendons were cut sufficiently fine for polymeric collagen to be extracted.
However, this process was found to be time consuming (and potentially labour
intensive) and so lack efficiency for large scale polymeric collagen extraction.
(b) Blender
An alternative method attempting to increase cutting efficiency was tested (us-
ing a kitchen blender):
1. Tendons were placed in 0.5M acetic acid
2. The tendons were then blended using a standard kitchen blender
until visibly homogensied (i.e. cloudy)
The problem with this method was that some tendons did not expand in the
weak acid, and were difficult to cut. Prolonged blending in this case resulted
in excess heat, which can denature collagen. The resultant collagen solution
was frothy, viscous and solidifies spontaneously over time at 4°c.
(c) Mortar and pestle (*method primarily used in this study)
An alternative homogenisation method was tested based on physical crushing
of frozen tendons using a cold stainless steel mortar and pestle:
1. Up to 2g of tendon was placed in a pre-frozen (−20°c) stainless
steel mortar and pestle
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2. Liquid nitrogen was carefully poured into the mortar so that the
tendons were covered
3. The pestle was slowly dropped onto the liquid nitrogen and
frozen tendon
4. Immediately, a sledge hammer was used to apply force onto
the pestle, which homogenised the tendon
5. This was repeated until the tendon was transformed into a fine
power (in some cases only coarser granules of tendons could
be obtained - e.g. tendons that are suspected to be highly
cross-linked)
The mortar and pestle method was effective and efficient in generating ho-
mogenised tendon granules.
Overall, the use of physical force to crush frozen tendons (methods c) was
more efficient in producing small granules of tendons. The mortar and pestle
was used to homogenise tendons for any further experiments.
Extraction of polymeric collagen from homogenised tendons
The method used in this study for polymeric collagen extraction from tissues
were simplified based on those published by Steven (1967). A flow chart of the
methods used by Steven is displayed here for reference (figure 3.1).
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Figure 3.1: Polymeric collagen extraction method using EDTA-treatment prior
to expansion in weak acid. This flow chart was obtained directly from Steven
(1967).
The main differences between both methods is that, in the revised methods:
• Samples were not de-fatted with acetone
• Samples were not centrifuged to separate the suspended polymeric col-
lagen and insoluble contaminants. Repeated suspension and shear ag-
gregation of polymeric collagen from dilute acid appeared to be effective
in separating polymeric collagen from insoluble contaminants
• Different concentrations of acetic acid and EDTA solutions were used
(solutions were more concentrated in the modified methods to ensure
maximum calcium chelation and yield of polymeric collagen)
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Detailed methods used in this study for the extraction of polymeric collagen
from homogenised tendons are as follows:
1. Homogenised tendons were placed in excess 0.5M EDTA solution overnight
with at least one change of solution. EDTA (Sigma, UK) was dissolved
in distilled water adjusted to pH 8 using NaOH. Once EDTA dissolved,
concentrated hydrochoric acid (HCl) was used to adjust the solution to
pH 7.5
2. Following EDTA treatment, tendon granules were collected by centrifuga-
tion at 2000rpm (2 minutes) and washed in distilled water (at least twice)
3. 0.5M acetic acid was added to the EDTA-treated tendons on a magnetic
stirrer and left at 4 °c for at least 3 hours to allow time for the tendons to
expand
4. On ice, polymeric collagen was collected by shear aggregation (using a
glass rod or similar) during neutralisation of the solution using 5M NaOH
(neutralisation on ice ensured that most acid-soluble collagen remained
in solution). Polymeric collagen precipitated at ∼pH 6-7
5. The polymeric collagen was re-suspended in 0.5M acetic acid and pre-
cipitated at least two further times to reduce impurities trapped within the
collagen fibrils
6. The solution was then sterilised by equal volume of chloroform if neces-
sary, and stored at 4°c for up to 1 week for future use
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Polymeric collagen extracted from different sources
Species Age (months) Tissue source Observations
Ostrich 6 Achilles tendon Very soluble in weak acid (even with-
out homogenisation and EDTA treat-
ment). Low yields of polymeric colla-
gen. Formed hydrogels when at 4°c
over 24 hours when neutralised.
Ostrich 24 Achilles tendon Good polymeric collagen source with
high yields.
Chicken - Feet tendon Polymeric collagen extracted did not
aggregate immediately upon neutrali-
sation, and suggested the presence of
impurities in the solution. Collection of
polymeric collagen was difficult as col-
lagen did not stick to stirring rod.
Calf - Achilles tendon Extracted polymeric collagen visually
appeared similar to that of ostrich ten-
dons. Reduced yields as a proportion
of the tendon did not expand in dilute




- Skin Small yields during initial shear aggre-
gation, but collagens precipitated with
further and continuous agitation (on
magnetic stirrer). Collagen appeared
dense and sticky.
Table 3.1: Observations of polymeric collagen extracted from different sources.
Yields from 6-month old ostrich and chicken tendons were low due to the
lack of polymeric collagen precipitation and difficulty in collecting the collagen.
Some insoluble collagen was extracted from freeze dried calf skin, but the col-
lagens did not aggregate immediately upon neutralisation. This indicated the
possible presence of impurities which hinder the aggregation of the polymeric
collagen. Good yields of polymeric collagen were obtained from both 24-month
old ostrich and calf tendons, but were most reliably extracted from ostrich ten-
don. In some instances, homogenised calf tendons failed to swell in dilute acid
even after EDTA treatment. This might be an indication of either more cova-
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lent cross-links being present within localised areas within the calf tendons, or
that other interactions between collagen fibrils exists (apart from the calcium
ions that are holding and stabilising collagen fibrils within the matrix). There
have been reports of localised, site-specific regions of mineralisation along
the length of tendons (Kerns et al., 2016), which may explain the difficulty in
extracting polymeric collagen from parts of the calf tendon. Although from a
different collagen type and source, observations from cartilage tissues also in-
dicate this differential swelling ability, where most of the tissue will not expand
even with prolonged EDTA treatment, except those in the growth plate region
(Brown and Byers, 1989).
Overall, extraction of polymeric collagen from 24-month-old ostrich ten-
dons resulted in optimal yields, closely followed by calf tendons. Both ten-
don sources have been used to extract polymeric collagen, with initial studies
based primarily on 24-month-old ostrich tendons, and later studies on calf ten-
dons (switch in tendon source was due to the better availability of calf tendons).
3.2.2 Potential applications for polymeric collagen
Aligned polymeric collagen constructs
Shear aggregation of polymeric collagen was an efficient method of collecting
polymeric collagen, and produced a material that was grossly aligned. This
potentially provide directional mechanical cues for the control of cell behaviour.
This was particularly interesting for the prospects of generating a tendon tis-
sue model as it potentially incorporates increased mechanical properties (pro-
vided by the covalent cross-links between the collagen fibril) and the alignment
of the collagen fibres, which mimics the features seen in the natural tendon
(although fibres within the tendon will be further arranged in bundles). Indeed,
Puxkandl et al. (2002) showed that the intermolecular cross-link are essential
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for the normal functioning of the tendon, without which, collagens were shown
to have reduced tensile strength and increased strain to failure (which is also
typical of very young collagen from rats).
Examples of other methods of generating constructs with an aligned matrix
include the electrospinning of collagen fibres (Matthews et al., 2002), which
can then be seeded with cells. But the drawback is that this is cell dependent
and requires weeks of culture for cells to migrate into the construct. Even within
hydrogels, there are ways to generate collagen fibre alignment, such as by cell
induced internal tension on uni-axially tethered collagen hydrogels (Georgiou
et al., 2013), or by external tension through repeated strain/relaxation cycles
(Cheema et al., 2007a). But this also has the drawback (as seen in many
other hydrogel based constructs, in that the collagen fibrils cannot be easily
cross-linked due to the cell toxicity of artificial cross-linking methods.
Here, polymeric collagen contains pre-crosslinked fibrils and can be aligned
(when extracted) from solution. It therefore has potential to address one of
the current challenges of tissue engineering which is to generate a cellular,
anisotropic and strong construct (with aligned fibres) in a short space of time.
This was tested by adding cells in to the polymeric collagen solution, during
neutralisation and shear aggregation to incorporate cells within the construct.
The aim was to produce a cellular and aligned collagen material with increased
mechanical properties (due to the presence of pre-crosslinked collagen), and
a tissue-like structure detected at the cell level.
Optimisation of polymeric collagen collection
First, methods used to collect and align polymeric collagen was optimised. The
main concerns to address here are the alignment and orientation of collagen
fibrils, and the ease of use. For the repeatable collection of polymeric collagen,
an even application of shear force was thought to be necessary; so manual
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stirring was not reliable.
Using a magnetic stirrer attached to a glass rod (neutralisation using dialy-
sis tube), significant proportions of polymeric collagen were collected, but most
remained unaligned and remained stuck to the magnetic stirrer. This resulted
in a mass of polymeric collagen being collected at the bottom of the flask with
little being aligned by wrapping around the glass rod.
To overcome the issue of polymeric collagen collecting at the base of the
construct, and improved alignment of polymeric collagen, a hand held device
based on a simple motorised unit was designed and made as summarised in
table 3.2. The shape of the polymeric collagen collection unit (generation 4b)
eventually developed for use in experiments is shown in figure 3.2.
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Methods for the collection and alignment of polymeric collagen using the
custom made hand-held device. This part of the study was carried out with the
help of Miss Danielle Baptista (summer placement student):
1. In a small glass beaker, 1-part 10xMEM was added to 9 parts polymeric
collagen suspended in 0.5M acetic acid (2mg collagen/ml; at 4°c)
2. A motorised unit attached to a custom made collagen collector (see table
3.2) was switched on after submerging half the length of the collector in
the collagen suspension
3. 5M (and later 1M) NaOH was added drop wise to the collagen solution
until a colour changed from yellow to fuchsia pink (phenol red pH indicator
contained within 10xMEM). Polymeric collagen aggregated between ∼
pH6− 7
4. Once the solution was neutralised, the solution was stirred for an addi-
tional two minutes
5. Polymeric collagen was removed from solution and cut perpendicular to
the fibril orientation to free the collagen sheet from the collector
6. The polymeric collagen was cultured in DMEM (supplemented with 10%
(v/v) FCS and 1% (v/v) penicillin streptomycin), or was fixed for analysis
Shear aggregation of polymeric collagen during neutralisation using the
custom made device (figure 3.2) produced aligned sheets polymeric collagen,
as seen in the SEM and birefringence images (figure 3.3).
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Description Image Observations
Original Magnetic stirrer attached
perpendicular to a glass-
rod using parafilm.
A significant proportion of
polymeric collagen was not
aligned as they collected on
the magnetic stirrer instead




around a circular gear




needles. The gap between




A metal mesh was rolled
into a cylinder on top of a
circular gear piece.
Collagen lacked alignment




Stainless steel wires was
sewn onto the wire mesh
(perpendicular to the
shear force) so collagen
fibrils can ‘grip’ the wires
and wrap around the
cylindrical mesh.
Same problems were en-
countered as generation 2
(polymeric collagen did not
grip on to the sewn wires).
Generation
3
Increased density of nee-
dles was used to shorten
gap between needles.
Some (patchy) collagen
alignment. There was a ten-
dency for collagen to wrap
around the needles, and to
slip from the collector.
Generation
4a
A cap was added to the
exposed end of the nee-
dles, and sealed with
paraffin wax. Metal wire
was wrapped around the
needles to help prevent
collagen slippage.
The additional cap pre-
vented most collagen from
wrapping around individual
needles, and the collagen
from slipping from the nee-
dles. There was visible
alignment of polymeric
collagen. It was difficult to
separate the collagen from
the extra metal wires.
Generation
4b
Similar to generation 4a,
but without additional
metal wire for easier
retrieval of polymeric col-
lagen from the collector
after shear aggregation.
Yields of shear aggregated
was similar to those col-
lected in generation 4a, but
without the added difficulty
in retrieving shear aggre-
gated collagen.
Table 3.2: Development of custom polymeric collagen collector unit for the
shear aggregation and alignment of polymeric collagen fibrils during neutral-
isation of the collagen solution. A motor unit is connected to one end of the
collector (as shown in figure 3.2).
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Figure 3.2: Schematic of custom-made machine and a collector unit made of
stainless-steel needles (generation 4b; please refer to table 3.2) for collection
of aggregated polymeric collagen from a beaker of polymeric collagen solution
during neutralization. The red arrows denote the direction of shear during the
collection of the aggregated collagen material from solution.
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Figure 3.3: Shear-aggregated polymeric collagen. (a) Image of shear aggre-
gated polymeric collagen material (b) SEM image of shear-aggregated poly-
meric collagen with highly aligned collagen fibrils. (c) Birefringence image of
polymeric
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This method was used to generate cellular constructs as cells were added
into the collagen solution during shear aggregation (at step 3 in the methods
below, as the polymeric collagen begins to aggregate).
The results from the H&E stained cellular polymeric collagen sections showed
that apart from the presence of cells at day 0 (immediately after the fabrication
of the construct), no cells were found in constructs with culture (figure 3.4).
This indicated that although cells were incorporated into the construct, cells
did not remain viable within the construct over time. This was thought to be
due to the exposure of cells to acidic conditions (as cells were added to the so-
lution at ∼ pH6 when the polymeric collagen began to aggregate). Therefore
a further test to study cell viability after cell exposure to acidic pH was carried
out.
Fibroblast monolayers cultured in a 24-well plate (pre-cultured for 1 day to
allow for cell attachment to the wells) were treated for a period of 0, 10, 20 or
30 minutes, in PBS adjusted to pH6 or pH5.5 (using hydrocholoric acid). The
cells were stained (live/dead) and counted as described in section 2.7.
Figure 3.5 showed that the rate of cell death increased sharply when the
pH of the cell environment was decreased from pH6, to pH5.5; and that the
extent of cell damage was dependent on the length of exposure to the low pH.
For example, the amount of cell death after exposure to pH5.5 for 10 minutes
was ∼50%, which increased to over 70% at 30 minutes of exposure.
Therefore, it was concluded that the exposure of cells to reduced pH con-
ditions within the aligned construct was damaging to interstitial cells, and cells
found in the H&E images at day 0 may require time as they undergo apoptosis.
Cells are an essential component of the tissue model, and so the aim of
this part of the experiment is to find an alternative method to incorporate cells
into the polymeric collagen material, without exposing the cells to sub-neutral
pH.
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(a) At day 0 in culture
(b) At day 1 in culture
(c) At day 5 in culture
(d) At day 14 in culture
Figure 3.4: H&E images of shear aggregated polymeric collagen. Cells (HDF)
were added during the neutralisation of the polymeric collagen solution. Con-
structs were cultured for up to 14 days.
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Figure 3.5: Cell viability after exposure to a solution of pH5.5 and pH6 for up
to 30 minutes.
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Therefore, an alternative method for incorporating cells and aggregated
(aligned; ∼ 1x1cm) polymeric collagen was tested, and involved the incorpo-
ration of both the cells and aligned polymeric collagen construct between two
pre-formed layers of conventional (acid-soluble) collagen hydrogels (i.e. like a
sandwich), which was then compressed together to form a single, integrated,
construct; and cultured for up to 14 days.
The hypothesis is that cells will preferentially attach to the stiffer collagen
matrix (polymeric collagen), and so respond primarily to the mechanical cues
from the polymeric collagen. Cells added to the hydrogel may, however, mi-
grate towards the stiff polymeric collagen (Hadjipanayi et al., 2009c). Alterna-
tively, if cells do not migrate towards the polymeric collagen, it may also benefit
from the presence of polymeric collagen as cells have been found to respond
to the stiffness of the surrounding matrix (Hadjipanayi et al., 2009b).
H&E imaging (at 1, 7 and 14 days of culture) of constructs with cells applied
directly to the polymeric collagen, showed that cells were primarily attached to
the polymeric collagen, and not the acid-soluble collagen hydrogels, at all time
points (figure 3.6). Cells observed at later time points assumed a spindle-like
morphology, typical of HDFs.
However, it was evident from the images that the distribution of the poly-
meric collagen constructs were highly variable within the construct, and dif-
fered in collagen and cell densities within, and between, samples. This meant
that it would be of limited use as a tissue model.




Figure 3.6: H&E stained histological images of cells and aligned polymeric
collagen sandwiched between two layers of conventional hydrogel. Constructs
were cultured for a) 1 day b) 7 days or c) 14 days.
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Polymeric collagen containing hydrogels
A clue to an alternative method in using polymeric collagen came from initial
studies on polymeric collagen extracted from young ostrich tendons (6 months
old). The young tendons were found to produce collagen suspension which
aggregated only slowly into a gel at 4c. This made it possible to seed cells
into the fibrillar collagen at neutral pH prior to coalescing together into a stable
mesh material. This was similar to conventional collagen gel formation from
monomers except that the component fibrils were cross-linked.
Since the major difference between 6 month-old and 24 month-old tendons
is the extent of stable cross-links between collagen fibrils (i.e. the younger tis-
sues contain a greater proportion of acid-labile collagens), it was hypothesised
that the soluble collagen interfered with the shear aggregation of the insoluble
polymeric collagen, and allowed the polymeric collagen to remain suspended
in solution even after neutralisation.
To replicate this delayed polymeric collagen aggregation effect, acid-soluble
collagen (normally used in hydrogel formation), was blended with polymeric
collagen extracted from older tendon tissues (previously aggregated immedi-
ately upon neutralisation). The aim here was to delay the aggregation of poly-
meric collagen from solution during the neutralisation of the collagen solution,
so that cells can be safely added to the suspension at neutral pH.
Briefly, the methods used to blend collagens for the formation of polymeric
collagen containing hydrogel was:
1. Polymeric collagen (extracted from calf or 24 month old ostrich) were
suspended in 0.5M acetic acid at a concentration of ∼ 2mg.ml-1
2. The polymeric collagen solution was blended, for at least 3 hours on a
magnetic stirrer, with acid-soluble tropocollagen (at a concentration of
∼ 2mg.ml-1) at a ratio of 1:0 4:1, 3:2, 1:1, 2:3, 1:4 and 0:1 (to give a
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polymeric collagen proportion of 100%, 80%, 60%, 50%, 40%, 20% and
0%)
3. 10% (v/v) 10xMEM was added to the solution prior to neutralisation us-
ing 5M and 1M NaOH, until a colour change from yellow to pink was
observed. Neutralised solutions were place at 4°c for up to 24 hours to
gel
With the absence of monomeric collagen, polymeric collagen precipitated/
aggregated immediately during neutralisation. However, with the incorporation
of monomeric collagen, the instant aggregation of polymeric collagen was pre-
vented, and a hydrogel was formed as hypothesised. Samples containing more
than 50% polymeric collagen were visibly less stable, and collapsed when dis-
turbed. Therefore, only samples containing 20, 40 and 50% polymeric collagen
were investigated further.
Shear aggregation of blend hydrogels resulted in some recovery of poly-
meric collagen. Samples discussed here were made with 2mg.ml-1 monomeric
and polymeric collagen solutions, blended to give 0, 20, 40 or 50% polymeric
collagen in solution (total volume of 25ml per sample). Contrary to expectation,
samples with the highest amount of monomeric collagen (and least polymeric
collagen (20%)) did not retain any polymeric collagen when shear aggregated
(11.5mg out of 10mg of polymeric collagen in the hydrogel was extracted;
i.e. all polymeric collagen including potentially some monomeric collagen).
Increasing the polymeric collagen concentration within the gel resulted in in-
creased retention polymeric collagen fibres (10.1mg out of 20mg, and 7.8 out
of 25mg polymeric collagen in gels containing 40 and 50% polymeric collagen;
figure 3.7).
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Figure 3.7: Mass of polymeric collagen shear aggregated during the neutralisa-
tion of blended collagen hydrogels. For all samples, a total amount of collagen
within the sample was 50mg (a concentration of 2mg.ml-1, in 25ml).
As a solution with a 1:1 ratio of polymeric and monomeric collagens was
able to prevent the instant aggregation of polymeric collagen fibres, there was
potential for cell incorporation after neutralisation of the solution, and before
collagen fibril aggregation, at neutral pH.
The findings in this chapter show it is possible to incorporate living
cells in a pre-crosslinked collagen matrix by developing techniques for han-
dling and aggregating polymeric collagen fibrils (in this case by incorporating
acid soluble collagen with the polymeric collagen). Although the use of shear
aggregation did not result in reproducible gels suitable for use as a tissue
model, it was possible to incorporate cells into hydrogel, in a manner simi-
lar to that of fibril formation used in making collagen gels; by blending-in of
monomeric collagen to delay the aggregation of polymeric collagen during neu-
tralisation. The result was a hydrogel with resident interstitial cells surrounded
by a cross-linked, stiff, collagen matrix, as required.
Chapter 4
Results: Stiff skin and tendon
model based on polymeric
collagen
4.1 Introduction
As discussed in section 1.4.3, hydrogel based constructs have the major ad-
vantage of interstitial cell seeding at time zero, when it would otherwise require
many weeks for cells to populate a porous scaffold, by conventional seeding.
Natural proteins such as type-I collagen (which is also abundant in many nat-
ural biological tissues) contains binding sites recognised by cell membrane
integrins. Particularly, for type-I collagen, α1β1 and α2β1 (see chapter 1) plays
an important role in dictating cell behaviour. So, the presence of collagen
molecules in the tissue model increases the biological relevance of the con-
struct, and encourage cells to behave as they would in their native ECM envi-
ronment.
In order to successfully model a tissue, which depends critically on cell-
matrix interactions, it is important to match material stiffness to the stiffness
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of native tissues to ensure cells receive similar environmental cues. Indeed
the stiffness of collagen hydrogels, and many biomaterials, have been shown
to greatly influence cell behaviour, such as proliferation (Hadjipanayi et al.,
2009b), migration (Hadjipanayi et al., 2009c) and results in changes to gene
expression (i.e. matrix remodeling genes) (Karamichos et al., 2008). The stiff-
ness of the matrix is therefore an important consideration for eventual tissue
function.
Mechanical properties/stiffness of a collagen hydrogel can be increased
by plastic compression which increases collagen density (by expelling excess
fluid) to ∼ 11− 18% (v/v) (Brown et al., 2005)(Abou Neel et al., 2006) (Cheema
et al., 2008). This matches collagen densities of some tissues, such as skin
(Brown, 2013a). However, adjacent collagen fibrils in a hydrogel are only
held together by non-covalent associations soon after fibrillogenesis, render-
ing them weaker in terms of mechanical strength compared to native tissues
(where fibrils are typically cross-linked enzymatically). In order for the hydro-
gel matrix to be a potential representative model of stiff tissues, such as skin
and tendons, further improvements in the mechanical properties of the type-I
collagen component of the matrix are needed.
The motivation of this study is therefore to generate a collagen hydrogel
based construct with improved mechanical properties, but importantly, to also
retain initial cell populations seeded within the construct at time-zero. This is
because one of the main advantages for collagen hydrogels is the ability to
create cellular constructs, as the construct is fabricated. In order to preserve
cell compatibility of the hydrogel, artificial cross-linking methods are unsuit-
able as they tend to be cell lethal. Examples include glutaraldehyde, which
is often used for cross-linking in many collagen material processes; for exam-
ple, prior to the extrusion of collagen fibrils (in suspension) during electrospin-
ning (Matthews et al., 2002). Other cross-linking methods include the use of
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Genipin (Mekhail et al., 2011) and photochemical cross-linking agents such as
riboflavin (Ibusuki et al., 2007) (Wong et al., 2013). However, such scaffolds
then need a cell seeding stage which is time consuming, variable and are de-
pendent on the cell type used. There is yet to be a non-cell damaging method
for the cross-linking of collagen fibrils, also with the potential to be up-scaled
for high throughput use.
The proposed solution to the lack of hydrogel mechanical properties (with
the condition that cell viability is preserved) is to make hydrogels from colla-
gens already with pre-existing covalent cross-links between their fibrils; namely,
polymeric collagen. In essence, the proposed method involves use of pre-
crosslinked collagen as a starting material to produce hydrogels; with the aim
to improve overall mechanical properties of the construct and preserved cell
viability.
In chapter 3, details regarding the development of a novel hydrogel made
from a blend of acid-soluble tropocollagen and polymeric collagen has been
described. The purpose of this study is to produce a tissue model which would
be representative of stiff tissues, such as aged skin and tendons. To achieve
this, the physical environment surrounding the ‘living’ cells will be altered by
incorporation of pre-cross-linked type-I collagen. The hypotheses to test are:
• The hydrogel after the incorporation of polymeric collagen can be plasti-
cally compressed
• Polymeric collagen within the hydrogel increases the mechanical proper-
ties of the material
• Cells can be seeded within polymeric collagen containing hydrogels, re-
taining time-zero cell viability
• Cells behaviour, such as proliferation, are similar and representative of a
native stiff tissue
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It is important to note that two distinct processes have been described in
chapter 3 to generate constructs containing polymeric collagen (please refer
to figure 4.1; and result in materials with different physical properties. This
chapter studies only the polymeric collagen containing hydrogels, generated
through the blending of monomeric and polymeric collagens - where cell incor-
poration at neutral pH is possible.
Figure 4.1: Flow-chart outlining the process for polymeric collagen extraction
from a tendon source (box 1), and the use of polymeric collagen to produce
cell-compatible blended hydrogels (box 2). The resultant polymeric collagen
materials are either (A) non-cellular, aligned polymeric collagen fibers or (B)
compressed blend collagen hydrogels (cell-compatible).
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4.2 Methods
Methods listed below are specific to this study. Further methods common to
studies throughout the thesis are listed in Chapter 2.
4.2.1 Polymeric collagen blend gel preparation
Collagen hydrogels were produced and compressed as mentioned in the method
sections 2.2 and 2.4 above. Blended pre-crosslinked collagen hydrogels were
produce by substituting half the volume of acid-soluble collagen with polymeric
collagen (adjusted to ∼2mg.ml-1 in 0.5M acetic acid). Blends of 20%, 40% and
50% polymeric collagen (w/w to acid-soluble collagen) were neutralised, gelled
and compressed as described.
4.2.2 Measurement of construct tensile mechanical proper-
ties
The Young’s modulus of compressed hydrogels with and without polymeric
collagen (50% w/w) was measured by dynamic mechanical analysis (DMA;
DMA7e, Perkin Elmer) through static tensile loading at 50mN.min-1 until fail-
ure. Samples were cut to approximately 2mm x 12mm. To ensure sufficient
grip of the sample onto the DMA clamps, steel meshes were folded onto both
ends of the construct (secured with superglue). Each construct was then mea-
sured using a digital caliper for exact construct dimensions. Throughout tensile
loading, samples were submerged in PBS to ensure they remain hydrated.
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4.2.3 Measurement of collagen density within compressed
gels
The density of collagen fibrils within compressed hydrogels was measured
based on the mass difference between the hydrated and freeze-dried con-
struct. Once the hydrogels were fully compressed within 24 well plates, PBS
was added to each well for easy handling. It was therefore important to gen-
tly and quickly blot the hydrogel on blotting paper to remove excess fluid on
the surface prior to measurement of the hydrated mass. All constructs were
subsequently freeze-dried (Modulyo, Edwards) overnight and weighed for the
weight of the dry solid fraction (i.e. collagen without the water).
4.2.4 Cell viability assay
Cell viability within compressed and uncompressed gels was confirmed by fluo-
rescent imaging after a 45 minute incubation of the cellular hydrogel with stains
consisting of 17µl ethidium homodimer (2mM; Invitrogen) and 20µl calcein-AM
(4mM; Fluka Analytical) diluted in 5ml PBS. Images were taken on the Olympus
BX61. For each sample, images of three random fields of view was captured
for cell counting. The number of live (green, calcein-AM stained) and dead
(red, ethidium homodimer stained) cells were only included if the cells were
within a digitally superimposed frame (identical for each field of view).
4.2.5 Total DNA assay
Total DNA was measured using Hoechst 33258 (Sigma) based on previously
published methods (Rago et al., 1990) (Rao and Otto, 1992). Cells within the
hydrogel were recovered by digesting each collagen construct in 1ml 0.2%
type-I bacterial collagenase (Gibco, USA) dissolved in PBS. Following a diges-
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tion time of 1 hour at 37°c (on a shaker), the suspension was centrifuged at
2000rpm for 5 minutes to collect cells. The cell pellet was re-suspended in
1ml distilled water and was repeatedly frozen (−20°c) and thawed to release
DNA content from within the cells. 100µl Hoechst solution (2µg/ml) was added
to an equal volume of DNA sample in a 96-well plate followed by absorbance
reading at 460nm. A DNA standard curve was prepared using increasing con-
centrations of calf thymus DNA (Sigma, USA) in saline sodium citrate buffer
adjusted to pH7.0.
4.2.6 Measurement of compressed hydrogel thickness
An optical method for measuring construct thickness was used on acid-soluble
collagen derived, or 50% polymeric collagen blend gels. Previous work on
compressed gel and optical thickness measurements have been carried out by
Tan (2015). 2.5ml hydrogels were set and compressed in 24-well plates. PBS
was added to each well to ensure samples remained hydrated prior to thick-
ness measurement (as dehydration will reduce construct thickness). For the
measurement, each sample (n = 4) was placed above a low powered (class
1, λ 1310nm) laser beam of a CTS-2 machine (Lein Applied Diagnostics, UK).
The focal point of the laser (with a range of approximately 1mm) moves through
the thickness of the sample whilst a detector within the machine detects any
reflected light at the gel surface. Changes in the reflection index through the
sampled area were registered as peaks of reflected light (converted into volt-
age) in the scan. A typical scan in this set-up registers two changes in reflective
index; firstly between the plastic well-plate/compressed gel, and also between
the compressed gel/air interface. These two interfaces distinguishes the upper
and lower boundaries of the construct, and so measures the thickness of the
compressed gel.
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4.2.7 Statistics
Data were represented as mean ± standard deviation, and were subjected to
one-way analysis of variance (ANOVA). The LSD post hoc test was used to
identify groups with a significant difference. Confidence internals were set at
P ≤ 0.05.
4.3 Results
4.3.1 Mechanical properties of blend gels containing poly-
meric collagen
The main objective of this study was to produce constructs with improved me-
chanical properties compared to compressed collagen hydrogels derived from
monomeric acid soluble collagen - which has been used in many tissue-like
models and for the study of cell behaviour within a ECM like environment (Had-
jipanayi et al., 2009b) (Hadjipanayi et al., 2009c) (Bitar et al., 2008) (Ardakani
et al., 2014). So, first it was important to establish the mechanical properties of
the novel polymeric collagen containing compressed hydrogels. Young’s mod-
ulus (E) was used as a measure of stiffness, and was calculated as stress






change in length/original length
Plastically compressed collagens without polymeric collagen had a Young’s
modulus of 0.36 ± 0.10 MPa when tested under tensile strain. The Young’s
modulus had increased 3-folds to 1.051 ± 0.377 MPa with the blending in of
50% w/w polymeric collagen (P ≤ 0.001). Note that this compares well with
(and surpasses) the Young’s modulus of artificially cross-linked compressed
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collagen gels as shown in the study by Rich et al. (2014), where constructs
were photochemically cross-linked for 15 minutes in the presence of riboflavin
(a photoinitiator which produces oxygen free-radicals upon activation with blue
light) prior to compression. The Young’s modulus of the riboflavin cross-linked
construct was noted in the literature as 0.650 ± 0.073 MPa (Rich et al., 2014).
Note also that sample dimensions were similar between riboflavin cross-linked
gels and 50% (w/w) polymeric collagen blends where construct thickness (as
shown in results below) were 50-60µm and ∼50µm respectively.
4.3.2 Collagen density within compressed polymeric colla-
gen blend gels
The collagen density of the collagen constructs was measured by the weight
of freeze-dried collagen mass as a fraction of the hydrated compressed hy-
drogel, prior to drying. As expected, the overall mass of freeze-dried collagen
were similar across samples as the collagen concentration of both the acid-
soluble and polymeric collagen were both adjusted to a similar concentration
of ∼ 2mg/ml. However, as the proportion of polymeric collagen increased,
less water was retained by the construct during plastic compression (figure
4.2). Collagen density within the compressed hydrogel increased gradually
from 12.0 ± 1.1% when no polymeric collagen was added, up to 20.8 ± 5.1%
when half the collagen within the hydrogel was polymeric collagen (figure 4.2).
In effect, the high volume of fluid loss from the polymeric collagen blend gels
meant that the overall collagen density was highest in these samples. Collagen
density of 20 and 40% polymeric collagen gels after compression were within
this range, at 12.8± 2.0 and 15.1± 1.7% respectively.
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Figure 4.2: Hydrated and freeze-dried mass (mg) of compressed hydrogel
blends. Collagen density within compressed gels were calculated as dried
solid fraction over hydrated mass of compressed gels.
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4.3.3 Construct thickness with or without polymeric colla-
gen
Optical measurements of construct thickness found that an acid-soluble colla-
gen hydrogel compressed to a thickness of 258 ± 48 µm. A blended gel of
50% (w/w) acid-soluble collagen and polymeric collagen significantly reduced
construct thickness after compression to 49 ± 12µm (P ≤ 0.001) (figure 4.3).
Figure 4.3: Compressed hydrogel thickness of acid-soluble collagen or 50%
polymeric collagen derived hydrogels. Hydrogel thickness were measured op-
tically and without further sample processing (i.e. no further dehydration, and
represent a more accurate thickness value).
4.3.4 Compression profiles of polymeric collagen contain-
ing hydrogels
The rate of fluid loss from hydrogels was measured indirectly via the mass (i.e.
fluid) gained by the absorbent plunger over time (figure 4.4).
Complete compression of acid-soluble collagen derived hydrogels without
additional load (except plunger mass of ∼ 3g and weight of absorbed fluid) was
found to occur over 19 minutes. The rate of hydrogel compression decreased
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exponentially with time, and was the fastest between 0 and 30 seconds of
compression, where the initial compression rate was highest at 0.723 ± 0.103
ml/minute (for non-blended gels).
Figure 4.4: Compression profiles of collagen hydrogels with increasing pro-
portions of polymeric collagen (0, 20, 40 or 50% w/w (polymeric collagen/acid-
soluble collagen)) based on fluid absorbed by plunger during compression over
time. Weight of plungers prior to compression was set as 0 grams. Arrows in-
dicate the average time to complete compression for each blend.
With the substitution of 20% w/w of acid soluble collagen with polymeric
collagen, the initial compression rates increased to 0.959 ± 0.092 ml/minute.
Increased proportions of polymeric collagen within the hydrogel at 40 and 50%
further increased initial compression rates to 1.308 ± 0.270 and 1.325 ± 0.152
ml/minute respectively. Note that the overall time for complete compression
was much shorter in gels containing polymeric collagen, such that a gel con-
taining 20% polymeric collagen was completely compressed by 10 minutes,
and gels containing both 40 and 50% polymeric collagen were compressed by
7 minutes. It was observed that as initial rates increased (as found in gels with
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high proportions of polymeric collagen), the total compression time required
for complete compression decreased (figure 4.5).
Figure 4.5: Average initial compression rates against average time required for
complete compression for blended gels of up to 50% polymeric collagen.
4.3.5 Cell viability within blend collagen hydrogel
Increased compression rates, and therefore fluid shear stress, in polymeric
collagen containing hydrogels was potentially damaging to resident cells. It
was therefore important to study cell viability within blend hydrogels after plas-
tic compression. Cell were either stained green by calcein-AM if it was living,
with an intact membrane, or red in the cell nucleus by ethidium homodimer if
the cell membrane was damaged and the cell was dead. Cells within com-
pressed acid-soluble collagen derived gels were found to have a negligible
proportion of dead cells of 3.1 ± 1.6%. 20% polymeric collagen blends (with
modest increase in compression rates) had 16.0 ± 7.0% cell death at day 1
after compression. However, with further increases in hydrogel polymeric col-
lagen content (i.e. 40 and 50% polymeric collagen), significant cell death was
observed (80.3 ± 2.2 and 92.4 ± 5.6% respectively; table 4.1).







Day 1 average total
live cell count (also




Day 7 average live
cell count (also in %
of total cells)
0 71.8 ± 7.4 69.6 ± 7.5 (96.9%) 37.0 ± 13.8 46.0 ± 8.9 (100%)
20 56.0 ± 7.2 47.0 ± 7.2 (84.0%) 79.0 ± 16.7 78.2 ± 16.0 (99.1%)
40 48.2 ± 20.3 10.6 ± 8.0 (19.7%) 38.0 ± 15.6 36.6 ± 14.4 (96.3%)
50 61.3 ± 17.5 4 ± 2 (7.6%) 53.4 ± 12.0 52.0 ± 11.2 (97.5%)
Table 4.1: Average total number of cells, and number of live cells (in a field of
view; determined by cell staining and counting) within blended collagen hydro-
gels at days 1 and 7 after plastic compression. Samples contain a blend of
polymeric (0, 20, 40 and 50%) and monomeric collagen; with an initial seeding
density of 15,000 cell/gel. Results are quoted as average number cells ± stan-
dard deviation (SD), including the number of live cells as a percentage of the






Compressed sample cell death
(%)
0 0± 0 3.1± 1.6
40 8.1± 7.8 80.3± 2.2
Table 4.2: Percentage cell death (± standard deviation (SD); determined by
cell staining and counting) within blended collagen hydrogels at day 1, with or
without plastic compression. Samples contain a blend of 0 or 40% polymeric
collagen, with monomeric collagen.
CHAPTER 4. RESULTS: POLYMERIC COLLAGEN BASED MODEL 117
It is important to note that this level of cell death within blended gels was
not seen prior to plastic compression (figure 4.6), with only 8.1 ± 2.2% cell
death before plastic compression, and 80.3 ± 2.2% after compression (table
4.2). Cell death within compressed blended gels was therefore attributed to
increased fluid shear stress experienced by cells during compression as op-
posed to the polymeric collagen itself used within the study.
Cell populations were able to recover and populate the compressed blended
gels with culture time as seen in 50% polymeric collagen samples from days 1
through to 14 (figure 4.6). In terms of absolute numbers in the live cell count,
cells increased an average of 66%, 345% and 1300% between days 1 and 7
(p≤ 0.001 for all samples), in samples containing 20, 40 and 50% polymeric
collagen respectively. The highest rates of cell proliferation were observed in
samples containing 40% and 50% polymeric collagen, and can be explained by
the low baseline for change (i.e. low number of surviving cells at day 1), and in-
creased physical space between cells (meaning less cell-cell contact and more
space for new cells to occupy). The only exception was in samples containing
no polymeric collagen, where the total live cell count decreased 34% between
days 1 and 7 (p≤ 0.001; figure 4.7, table 4.1), which could be a result of a over
population of cells at day 1, and so the number of cells adjusted according to
the available space and nutrients. Additionally, by day 7 most samples (apart
from 20% polymeric collagen samples) had a similar total cell count (despite
the difference in the number of initially viable cells) suggest the samples share
a similar limiting factor for cell proliferation (p=0.913 for 40% and p=0.079 for
50% polymeric collagen samples).
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Figure 4.6: Representative images of live/dead stained fibroblasts seeded
within compressed hydrogels at days 1, 7 or 14 days of culture. Hydrogels
were blended with either 20% or 50% polymeric collagen.
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Figure 4.7: The average total amount of cell count within blended colla-
gen samples (containing 0, 20, 40 or 50% polymeric collagen, blended with
monomeric collagen) at days 1 and 7 of culture following plastic compression.
Each column is segmented into two parts, showing the average number of live,
and dead, cells found within the sample.
CHAPTER 4. RESULTS: POLYMERIC COLLAGEN BASED MODEL 120
4.3.6 Cell proliferation within blended gels
The decrease in viable cells within blend gels was also reflected in the de-
creased total cell metabolic activity (as measured by alamar blue) and total
DNA detected from constructs immediately after compression, especially in
gels containing 40 or 50% (w/w) polymeric collagen (figure 4.8). In terms of
cell proliferation within the hydrogel over time (between 1 - 7 and 7 - 14 days),
cells in all samples (except 50% polymeric collagen) displayed a marked in-
crease in metabolic activity (P ≤ 0.001). A smaller increase in metabolic activ-
ity was noted in 50% polymeric collagen samples between days 1 and 7 (p =
0.054), which deceased with further incubation up to 14 days (p = 0.037). This
result would imply a lack of cell proliferation, and indeed cell death, based on
the metabolic activity alone. However, cell viability imaging (as seen in section
4.3.5 and figure 4.6) of 50% blends confirmed that more cells were present
with the construct at days 7 and 14 of culture, and that most cells were alive.
It was therefore important to also consider less variable measures of cell num-
bers such as total DNA within the construct. Indeed, a significant increase in
total DNA was observed with incubation between days 1 and 7 for all samples,
but was only significant for blended samples containing 40 or 50% polymeric
collagen (P = 0.033 and P = 0.006 respectively).
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Figure 4.8: Fibroblast-seeded compressed hydrogels containing a blend of
polymeric collagen (0, 20, 40 or 50% (w/w)) and monomeric collagen were
analysed for a) total cell metabolic activity at 1, 7 and 14 days of incubation and
b) total DNA within blend gels at 1 and 7 days of incubation (spectrophotometer
readings were converted into µg/ml DNA using a DNA standard curve). (∗P ≤
0.05, ∗ ∗ P ≤ 0.005)
CHAPTER 4. RESULTS: POLYMERIC COLLAGEN BASED MODEL 122
4.3.7 Histological sections of cellular blend gels
Histological staining was carried out on 20 and 50% polymeric collagen blends
which were incubated for 5 and 14 days to confirm the presence of living,
adherent cells. Fibroblasts seeded within the hydrogel at time-zero were still
present and visible within the blend hydrogels up to 14 days in culture. This
again supports the observation that fibroblasts can be successfully seeded
within polymeric-collagen-containing hydrogels, and be cultured over time (fig-
ure 4.9).
Figure 4.9: Histological staining (H&E) of cellular, compressed gels. 20 and
50% polymeric collagen blended samples were compared after incubation of 5
and 14 days.
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4.4 Discussion
Currently one factor hindering the development of collagen hydrogel constructs
for tissue engineering is the mismatch between initial cellularity and the general
lack in mechanical strength for it to be physiologically relevant to native tissues.
The main advantage of a collagen hydrogel is their ability to support interstitially
seeded cells - incorporated into the hydrogel as it is formed. However, cells
are known to be very sensitive to their environment, in particular, substrate
stiffness which previously cannot be easily replicated in a hydrogel without
cytotoxic cross-linking treatment. In this study, the aim was to bridge this gap
by introducing pre-crosslinked polymeric collagen fibrils as a starting material,
and in doing so, avoid artificial cross-linking of collagen fibrils.
This work is the first to systematically study the use of polymeric collagen in
a hydrogel to produce in vitro tissue models with intrinsic covalent cross-links
between collagen fibrils, and so improved mechanical properties. Plastic com-
pression was used on blended collagen hydrogels to increase the overall colla-
gen density to tissue levels, which also impacts on the mechanical properties
(i.e. compare hydrogels before (0.02% collagen) and after (∼ 12% collagen)
plastic compression). It was found that as the fraction of polymeric collagen in-
creased (up to 50% w/w to acid soluble collagen), the overall collagen density
within the compressed construct also increased. In a 50% polymeric collagen
construct, collagen density almost doubled from 12.0% to 20.8% (compared to
acid soluble collagen only constructs), which was reflective of their decreased
ability to trap water within the construct. That said, this difference in collagen
density was brought about by an increase in total water loss of ∼ 52µl from
within a blend gel (out of a 2.5ml hydrogel; based on the average difference in
plunger mass at the end of plastic compression). However the relatively small
difference in total volume had significant impact on hydrogel dimensions. In
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terms of construct dimensions, blend gels were much thinner than the con-
ventional hydrogel, despite similar starting volumes and collagen density. This
also points to the reduced fluid trapping ability of the blend gel. Based on the
thickness of the respective hydrogels, the total volume of the compressed gel
can be calculated, as:
Gel volume = pir2h
Where r was the radius of the hydrogel, used to calculate the area of the
circle (pir2); and h was the height of the compressed hydrogel. Hydrogel thick-
ness (height) were found to be 0.0258 ± 0.0045 and 0.0049 ± 0.0012 cm
for compressed acid-soluble collagen and 50% polymeric collagen derived hy-
drogels respectively. Since all hydrogels were set and compressed in 24-well
plates, the well diameter was taken as the gel diameter at 1.56cm (radius of
0.78cm), and the compressed gel volume was calculated:
Acid-soluble collagen gel volume = pir2h
= pi(0.78)2 x 0.0258
= 0.0493cm3
Polymeric collagen blend gel volume = pir2h
= pi(0.78)2 x 0.0049
= 0.0094cm3
The differences in average total volume within compressed acid-soluble col-
lagen derived (0.0493cm3; or 0.0493ml) and polymeric collagen blend (0.0094ml)
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gel was therefore ∼40µl. This was comparable to the differences in plunger
mass after plastic compression for the respective hydrogel samples (∼ 52µm).
Apart from the increased collagen density, the incorporation of polymeric
collagen into compressed hydrogels, as expected, increased material stiffness
(Young’s modulus) by ∼3 folds, to 1.051± 0.377MPa. This was much improved
compared to compressed hydrogels derived from acid-soluble collagen, and
so offers a promising basis for a model of slightly stiffer tissues.
For all samples, the rate of compression was highest during the first 30
seconds of compression (hereafter termed the initial compression rate), and
decreases exponentially with compression time. Initial compression rates in-
creased substantially within gels containing 40 or 50% polymeric collagen. The
increased compression rates in blended gels is likely due to a much diminished
blocking of fluid outflow (from the FLS) as fewer small collagen species were
present, therefore resulting in increased fluid shear stress (Hadjipanayi et al.,
2011a) and cell death. The reasoning behind this is the long-standing suspi-
cion that during collagen hydrogel formation, a proportion of collagen remains
poorly associated and mobile. It was understood that during the early stages
of collagen plastic compression, a dense mat of fibrils would be formed at the
FLS to produce a ‘ultra-filtration membrane’, which would be predicted to catch
(and so be clogged by) smaller mobile collagen aggregates, such as oligomers
and non-aggregated molecules (for schematic representation, see figure 4.10).
Increasing the proportion of polymeric collagen in these blended gels will rad-
ically and proportionally decrease the amount of small mobile species. This
in turn decreased the membrane fouling effect, and so increases fluid efflux
and shear across the stiff polymer fibrils. This is consistent with the measured
increased fluid outflow for polymeric collagen containing (blended) constructs.
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Figure 4.10: Schematic representation of collagen hydrogels during the begin-
ning and later stages of plastic compression. Red lines within diagram rep-
resent mobile collagen species, such as monomeric or oligomeric collagen,
which would be predicted to travel with fluid flow during plastic compression
and becomes retained by the dense collagen layer at the fluid leaving surface
(FLS) - further contributing to the filtration effect.
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In terms of cell viability, cell damage is well known to be minimal during
plastic compression of “conventional” acid-soluble collagen derived hydrogels
(Brown et al., 2005), and a similar 97% cell viability was seen here following
compression of non-blended hydrogels. However, significant cell death was
observed after compression of hydrogels containing a relatively high propor-
tion of polymeric collagen (40 and 50% at 80.3 ± 2.2 and 92.4 ± 5.6% respec-
tively). It was also within these samples where a high compression rate was
observed. The high fluid flow rates during compression of blended hydrogels
were likely to have caused the cell damage by increased fluid shear stress.
Although cells naturally experience some fluid dynamics and flow (i.e. blood-
flow), they are rarely damaged at physiological flow rates. Indeed the fluid
dynamics may be essential to the cell function, such as inflammation or cell
migration/alignment (Ng and Swartz, 2003). The mechanism by which at least
some cell types sense fluid shear stress was via cell surface/membrane defor-
mation and ion (i.e. Calcium) channels (Cunningham and Gotlieb, 2005); via
focal adhesion when cells remain attached to the ECM. (McCue et al., 2004).
The trigger of cell internal pathways can then affect cell essential pathways,
such as MAPK signaling as demonstrated in mesenchymal cells (Glossop and
Cartmell, 2009). However, when the fluid shear stress was sufficiently large,
as thought to be occurring in the polymeric collagen containing hydrogels, cell
membranes can sustain physical damage and undergo necrosis.
It was important to note that the cell population did recover with incuba-
tion time as reflected in the total DNA assay (figure 4.8), where an increase
in total DNA within all samples was observed between days 1 and 7. This in-
crease was however only significant for 40 and 50% polymeric collagen blends,
suggesting a higher proliferation rate within the polymeric collagen containing
gels. However, this finding was not consistent with the Alamar blue assay
(for total cell metabolic activity within a sample), which has commonly been
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used as a measure of cell proliferation. The Alamar blue assay indicated an
increase in total metabolic activity for all samples except 50% polymeric col-
lagen blends between 1 - 7 and 7 - 14 days. However, for 50% blends, there
was a non-significant increase in cell metabolic activity between days 1 and
7, and a subsequent significant decrease in metabolic activity between days
7 and 14. Visual data of blended gels i.e. live-dead cell imaging (figure 4.6)
would however indicate that total number of cells have increased with incuba-
tion time in 40 and 50% polymeric collagen blend gels (note also the change
in cell morphology in 50% polymeric collagen blends). The presence of live
cells within 50% polymeric collagen blend gels, coupled with the finding of de-
creased total metabolic activity may indicate the presence of quiescent cells.
However, whether this change was indeed due to increased matrix stiffness or
exposure to high fluid shear stress remains to be determined. Nevertheless,
both assays agree that a higher proportion of polymeric collagen within the hy-
drogel caused a drop in initial cell viability immediately after plastic compres-
sion. Since this cell death was only observed after the compression of blended
(fast-compressing) hydrogels, and that a rapid proliferation over 14 days was
observed post-compression, it was concluded that polymeric collagen itself is
cell compatible, and that the problem was the increased fluid shear.
Chapter 5
Results: Control of hydrogel
compression rates using large
molecules
5.1 Introduction
The generation of a novel, stiff and cellular collagen hydrogel matrix was de-
scribed in chapter 4, where it has been studied for its potential use as a stiff
tissue model.
This model is generated by including pre-crosslinked collagen into the struc-
ture of the hydrogel (so that the matrix is made of a mix of covalently cross-
linked polymeric collagen and acid-soluble (conventional gelling) collagen. Plas-
tic compression of these blended gels resulted in a construct with a three-fold
increase in matrix stiffness relative to gels derived from acid-soluble collagen
only (results in the previous chapter showed an increase in Young’s modulus
from 0.36 ± 0.10 to 1.05 ± 0.38 MPa). These blended hydrogels also sup-
ported the culture of resident cells in vitro over time. For a cell-rich gel, this
improves the physiological relevance of the hydrogel as a 3D tissue model,
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especially when the target tissue is relatively stiff.
However, as concluded in the previous chapter, the problem associated with
the novel polymeric collagen blend gels was the unusual cell death that was
observed during their fabrication. The cause of the cell death was pin-pointed
to the increased fluid shear stress (i.e. increased flow rates) during the plastic
compression of the new blended hydrogel; but it is important to stress that this
cell death is not normally observed during the plastic compression of conven-
tional, acid-soluble collagen, derived gels (Brown et al., 2005). Since plastic
compression of the hydrogel is an essential step in generating a physiologically
relevant model, this part of the study aims to devise a method to reduce shear
stresses on interstitial cells, and prevent cell damage. For this, the relationship
between fluid outflow during plastic compression and the factors that influence
fluid flow within the hydrogel needs to be further investigated.
5.1.1 What influences fluid flow rates within a hydrogel?
The ability of the collagen matrix to hold water is interesting because the differ-
ence in size between the interfibrillar space (∼ 10− 50nm2 or less, depending
on the compressive load (Serpooshan et al., 2011)) and the water molecule
(1.37A˚ (∼ 0.14nm) (Zhang and Xu, 1995)) is at least 70 fold; and water should,
according to its size, be able to easily flow through the hydrogel.
However during the plastic compression of collagen hydrogels, water only
leaves the hydrogel partially, and slowly, across several minutes (even with
external load). This suggests the presence of other factors from within the
hydrogel is preventing the free flow of water from the hydrogel.
External factors that are already known to impact hydrogel compression
rates include the amount of external load placed on the compression system,
and the total surface area of the fluid leaving surface (FLS) (Hadjipanayi et al.,
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2011a). However it is the factors within the gel that are thought to have the
greatest influence on the ability of water, which is encased within the matrix, to
escape.
Water within the hydrogel is held within a mesh of loosely associated col-
lagen fibril. This means that water trapped within the hydrogel must leave the
matrix through the spaces formed between collagen fibres during fibrillogene-
sis. Consequently the size of the interfibrillar space may affect the rate of water
efflux from the gel. A typical hydrogel is made of ∼ 99.8% (w/w) water, with the
remaining mass that might potentially block fluid flow comprising of collagen
molecules (∼ 0.2%) and some neutral salts (negligible amounts).
Salts within the hydrogel typically include soluble salts (such as sodium and
potassium chlorides) and molecules such as D-glucose, all of which are rela-
tively small compared to the estimated size of the interfibillar space (ions are
in the pico-meter range and glucose has a hydrodynamic radius of ∼ 0.46nm
(Lim et al., 2014)). These molecules are therefore unlikely to contribute to the
blockage at the FLS. Instead, it is thought that some collagen molecules are
not fully incorporated into a single-bodied matrix during fibrillogenesis, but re-
mained as monomers (or aggregated into small oligomeric collagen species),
which are mobile within the hydrogel, and can then block interfibrllar spaces
from within the hydrogel during compression (Hadjipanayi et al., 2011a).
Imaging of a fully compressed hydrogel sheet (cross-sectional SEM image
adapted from Brown et al. (2005) (figure 5.1) shows that a collagen density gra-
dient is formed within the hydrogel. The fact that collagen density was greater
at one surface of the collagen sheet suggest a collection of mobile collagen
molecules at the FLS (which acts as a ultrafiltration membrane). More specif-
ically it is thought that at the first signs of compression, collagen fibrils at the
surface of the hydrogel (at the fluid leaving surface) becomes compacted, min-
imising the interfibrillar space between these fibrils. This then acts as a filtra-
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tion membrane whereby collagen monomers or oligomers, not small enough to
squeeze through the narrowed space between the collagen fibrils at the FLS,
are trapped at the ‘filter’ and contributes to the progressive blocking and re-
duced fluid outflow. A lamellar structure within the hydrogel is also interesting
and may shed light onto the mechanism of micro-structure generation during
plastic compression (further discussion section 8).
Figure 5.1: Cross-sectional SEM image of a fully compressed hydrogel
adapted from Brown et al. (2005) (figure 4). Note the lamellar structure parallel
to the FLS within the hydrogel.
Other potential ways to reduce fluid flow
Changes to the hydrogel structure may provide the necessary increase in the
blockage at the FLS to reduce fluid flow. One possible change to the hydrogel
structure is the fibre thickness. Collagen fibril diameter have been found to
be ∼ 30nm when fibrillogenesis occured at 37°c over 30 minutes (Cheema
et al., 2007b). However, studies have found that collagen aggregation at lower
temperatures resulted in increased fibre thickness (Wood and Keech, 1960).
Increasing fibre thickness within a ‘closed system’ will be at the expense of the
limited amount of collagen molecules and is likely to result in fewer, but thicker,
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fibres and increased interfibrillar space.
Collagen density also potentially alters the fluid flow rate within the hydro-
gel, as increasing the amount of collagen fibrils will increase occupied space
by the collagen fibrils, and result in smaller ‘pores’. This would also lead to an
increase in mobile collagen species that can contribute to the FLS clogging.
Indeed, a collagen hydrogel containing 6mg.ml-1 atelocollagen required, on av-
erage, more time for complete compression compress (1ml gel, 41 minutes),
compared to a 2mg.ml-1 collagen hydrogel of the same volume (6 minutes).
For the novel blend gel, reduced amounts of mobile collagen monomers/
oligomers (as half of the soluble collagen molecules were substituted with pre-
crosslinked polymeric collagen) is expected to reduce FLS clogging, and would
explain the rapid fluid outflow reported in the previous chapter. It was therefore
hypothesised that replacing the molecules which contribute to the clogging of
interfibrillar space (i.e. increase the clogging/filtration effect) will decrease fluid
outflow rates, and so decrease the amount of fluid shear stress placed on
resident cells during the compression of fast-compressing hydrogels; such as
that seen in polymeric collagen containing hydrogels.
The main purpose of this study is to develop and understand methods for
decreasing the rate of fluid efflux from hydrogels, particularly where compres-
sion is unusually rapid. The approach is to improve the FLS barrier forma-
tion (clogging) using artificially introduced mobile macro-molecules. Two basic
mechanisms were tested within this aim. In the first, the tropocollagen (acid-
soluble collagen) of the gel itself was progressively cleaved by incubation with
pepsin, to generate potentially clogging atelocollagen species. In the second,
selected polymer macromolecules were added to the gelling collagen mix as
potential clogging agents.
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Figure 5.2: Schematic representation of fluid flow during plastic compression,
within cellular a) conventional hydrogel b) polymeric collagen blend hydrogel
and c) blend hydrogel containing large, FLS clogging, macromolecules (blue
circles). Non-associated (mobile monomeric and oligomeric) collagen species,
cells and water are normally enmeshed within the collagen hydrogel matrix
following fibrillogenesis. However, the (intrinsically present) mobile collagen
species are found in reduced quantities in blend hydrogels with a high poly-
meric collagen content (environments B and C). This causes a high fluid flow
rate (though to be damaging to cells; environment B), but can be reversed
when these mobile collagen species are replaced by large macromolecuels
which contribute to the blockage to fluid outflow at the FLS.
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5.1.2 Polymer macromolecules as clogging agents
The large polymers incorporated into the hydrogel, and tested in this study for
its efficiency in blocking the FLS are as follows:
Fibrinogen
Fibrinogen (Sigma, UK) is a naturally occurring plasma protein normally in-
volved in blood coagulation. The protein has a molecular weight of 340kDa . It
can be converted into a fibrous mesh (Fibrin) by thrombin action.
Dextran
Dextran is a polysaccharide of polymerised glucose molecules made up to a
size of 2000 kDa. In this study, Dextran with an average molecular weight of
500kDa was used (Fisher Scientific, UK).
Poly(ethylene)glycol (PEG)
PEG is a polymer made of polyethylene oxide, and are found in molecules of
up to 8000 kDa (or more). PEG 400kDa and 1000kDa (both from Sigma, UK)
were used in this study.
Ficoll™
Ficoll is a branched polymer made from the co-polymerisation of sucrose and
epichlorohydrin. The molecules typically come in a size of either 70kDa or
400kDa. In this study, Ficoll™ 400kDa was used as a pore blocking agent.
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The hydrodynamic size of the above mentioned polymers ranged from ∼
11− 42nm, which are within the range of the interfibrillar space found between
collagen fibrils within the hydrogel. Therefore they were chosen for use as a
potential pore-clogging species.
5.2 Methods
Methods listed below are specific to this study. Further methods common to
studies throughout the thesis are listed in Chapter 2. All hydrogels (both con-
ventional acid-soluble collagen derived and polymeric collagen blended gels)
were set within 24-well plates, with each well containing a gel volume of 2.5ml
(except where specified). The rate of fluid efflux (i.e. compression rate) for all
samples were measured as detailed in chapter 2.5.
5.2.1 Pepsin treatment of tropocollagen to produce atelo-
collagen
Pepsin treatment was used to convert tropocollagen (conventional gelling acid-
soluble collagen) into atelocollagen, which is a potential source of mobile col-
lagen species. Collagen molecules without telopeptides associate less readily
with adjacent collagen molecules during fibrillogenesis (Snowden and Swann,
1979) (Brennan and Davison, 1981), and so potentially increases the propor-
tion of monomer/oligomer collagens which would remain mobile within the hy-
drogel at the time of compression.
Pepsin (porcine derived; Sigma-Aldrich) was dissolved in 0.5M acetic acid
(2.5mg.ml-1) and added in a ratio of 1:99 (w/w) to acid soluble type-I collagen
at 4 °c (on stirrer). At 0, 1.5, 3, 4.5, 24, 48 and 72 hours after pepsin treatment,
the collagen solution was neutralised and gelled following the method for acid
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soluble collagen derived hydrogels (detailed in chapter 2). Compression rates
for all gels were subsequently measured.
5.2.2 Macromolecules as clogging agents within the hydro-
gel
Macro-molecules (as mobile, clogging species) were incorporated into the hy-
drogels to increase blockage at the FLS. Fibrinogen (340kDa; Sigma-Aldrich)
in 0.9% saline, dextran (500kDa; Fisher Bioreagents) or poly(ethylene oxide)
(PEG; 400kDa or 1000kDa, Sigma-Aldrich) in deionised water, were made
to a concentration of 0, 2, 5, 10 or 20mg.ml-1. Ficoll™ 400 (Sigma-Aldrich)
was made to 10, 50 or 100mg.ml-1 in deionised water. 10% (v/v) of the poly-
mer solution was added to a neutralised collagen mixture containing 10% (v/v)
10xMEM and 80% (v/v) acid soluble collagen prior to incubation at 37 °c for 30
minutes. Compression rates of the hydrogels were subsequently measured.
5.2.3 Rate of fibrillogenesis
The rate of hydrogel formation (gelation), with or without the presence of large
macromolecules, was measured using the change in light scattering of the
hydrogel over time (gels became opaque as fibrillogenesis progresses).
3ml of the collagen solution, neutralised at 4°c, was transferred into a cu-
vette. It was immediately placed in a luminescence spectrometer (LS 50B,
PerkinElmer, UK), where the solution would begin to form a hydrogel as it was
exposed to room temperature. The absorbence of the solution was measured
at an excitation wavelength of 450nm, and an emission wavelength of 700nm,
every 30 seconds until no substantial changes in the values was observed.
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5.2.4 Additional fibrin mesh at the FLS
Since fibrinogen was successfully introduced into the hydrogel as a interfibrillar
‘pore’ clogging agent, it was hypothesised that the topical application of throm-
bin (Sigma, UK; in water), a protease which converts fibrinogen into fibrin, to
the FLS will result in a mesh-like structure which can contribute to the matrix’s
ability to retain water (i.e. increase matrix density at the FLS).
Fibrinogen containing hydrogels were produced as described above, where
5mg.ml-1 fibrinogen (in 0.9% saline) (10% v/v) was added to the neutralised
collagen solution. After gelation of the hydrogel, 50µl of 1mg.ml-1 thrombin
was applied to the hydrogel indirectly, by first applying the thrombin to a well-
sized paper disc, before transferring the disc onto the hydrogel. The thrombin
remained in contact with the hydrogel for 5 minutes prior to hydrogel compres-
sion. Compression rates of the resultant gels were measured and compared
to fibrinogen containing gels without thrombin application.
5.2.5 Cell viability test in gels containing additional macro-
molecule
The effectiveness of macro-molecule incorporation on slowing compression
rates, and consequently on preserving interstitial cells viability was tested within
conventional (acid soluble collagen derived slow-compressing) or polymeric
collagen blend (fast-compressing) hydrogels. Hydrogels were made from 10%
volume of 10mg.ml-1 PEG 400kDa (final concentration of 1mg.ml-1 within hy-
drogels), 10% (v/v) DMEM (Sigma-Aldrich) supplemented with 10% foetal calf
serum (First Link, UK) and 1% penicillin streptomycin (Gibco, Life Technolo-
gies) containing human dermal fibroblasts (HDF; passages 8-9), 10% 10 x
MEM and 70% (v/v) collagen solution.
After hydrogel formation (1.5ml gel; 15,000cells/gel) and compression, cell
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activity within the gels was measured by Alamar blue assays as described in
chapter 2.6.
5.2.6 Statistics
Statistical significance was determined by one-way ANOVA (LSD post-hoc) for
data on compression rates. For all other experiments, an independent sample
t-test was used. Confidence intervals were set at p ≤ 0.05.
5.3 Results
The purpose of the study was to decrease compression rates of fast compress-
ing hydrogels with the ultimate aim to preserve interstitial cell integrity. The
approach adopted here was to increase the blockage of interfibrillar space,
particularly at the FLS.
The typical compression profile of a hydrogel over time included a fast initial
rate of fluid loss (in the first 30 seconds of compression), followed by a period
of steady rate of fluid loss until it finally reached a plateau, when no further
water left the gel (i.e. compression was complete) (figure 5.3a). When results
from this compression profile was converted into rate of fluid loss from the hy-
drogel during compression (figure 5.3b), the initial time point (first 30 seconds)
represented the highest rate throughout the compression process (in this case
at more than double that of all other time points). Compression rates then
decreased exponentially over time.
For polymeric collagen blended gels, the initial compression rate could be
as high as 1.325 ± 0.152 ml/minute (as opposed to 0.691±0.083 ml/min in con-
ventional (cell-friendly slow compressing) acid-soluble collagen gels. Although
compression rates quickly dropped with the progression of the compression
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process, the short exposure of cells to high fluid flow rates was found (in the
previous chapter) to be sufficient to damage resident cells.
(a) Profile of fluid loss from hydrogel during plastic compression
(b) Rate of fluid loss from hydrogel
Figure 5.3: Example showing the compression profile of a 2.5ml hydrogel set
in a 24-well plate. a) Shows the cumulative amount of fluid loss (ml) from the
hydrogel over time. b) A derivative graph showing the results in terms of rate of
fluid loss (ml/minute) at each time point over the compression period. Note that
the rate of fluid loss (compression rate) was highest at the beginning of hydro-
gel compression, and decreases exponentially as compression progresses.
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5.3.1 Fluid flow rates after pepsin treatment
Pepsin treatment of collagen solutions did not result in decreased early stage
(initial) flow rates. Instead, the rate of collagen compression increased with
length of pepsin treatment, with a peak initial compression rates of 1.089 ±
0.152 ml/minute at 24 hours of pepsin treatment (p≤0.001) (figure 5.4; table
5.1). In addition, gels made from 24-48h pepsin digested collagen also pro-
duced increased outflow rates during later stages of compression (measured
at 5 minutes into the compression process), at 0.184± 0.046 and 0.230± 0.152
ml/minute respectively, as opposed to 0.135± 0.024 ml/minute when no pepsin
treatment was involved. With further pepsin treatment time, at 72 hours, the
compression rates appeared to fall slightly relative to the peak rates seen in
gels with 24-48 hours of pepsin treatment. These results suggest that any mo-
bile species generated by pepsin digestion of tropocollagen (i.e. atelocollagen
monomers/oligomers) did not block interfibrillar “pores” of the FLS, although it
clearly did alter filtration rates in a complex manner.
Since pepsin treatment of tropocollagen produced atelocollagen which as-
sociate less readily with adjacent collagen molecules, the pepsin treatment
may therefore have a greater effect on enlarging the “pores” within the hydro-
gel; potentially due to reduced fibril formation by the remaining tropocollagen
and reduced amount of collagen species that are sufficiently large to clog pores
(i.e. oligomers).














No pepsin treatment 9 0.691 ± 0.083 0.135 ± 0.024 26
0 6 0.616 ± 0.148 0.148 ± 0.024 25
1.5 6 0.743 ± 0.077 0.160 ± 0.025 20
3 6 0.791 ± 0.081 0.168 ± 0.010 17
4.5 3 0.983 ± 0.248 0.115 ± 0.092 14
24 9 1.089 ± 0.152 0.184 ± 0.046 13
48 9 1.027 ± 0.160 0.230 ± 0.152 20
72 6 0.970 ± 0.173 0.146 ± 0.043 19
Table 5.1: Average compression rates of hydrogels derived from acid-soluble
collagen treated with pepsin for an increasing amount of time. Rates over
the first 30 seconds (initial rate) and 5 minutes of compression are quoted as
mean ml/minute ± standard deviation (SD). Time to complete compression are
noted as the time where compression rates reached zero. Compression rates
significantly different to non-pepsin treated gels are listed in bold font.
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Figure 5.4: Box-and-whisker plot of initial (first 30 seconds) compression rate
of hydrogels within increasing pepsin treatment time. Compression rate was
significantly increased relative to control from 4.5 hours of treatment onwards
(p ≤ 0.05*)
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5.3.2 Fluid flow rates with macromolecule incorporation
Macro-molecule incorporation was more effective in slowing initial compression
rates compared to the use of pepsin to produce mobile collagen monomer/oligomer














No macromolecules 9 0.691 ± 0.083 0.135 ± 0.024 26
Fibrinogen 2mg.ml-1 15 0.660 ± 0.114 0.139 ± 0.026 28
Fibrinogen 5mg.ml-1 15 0.582 ± 0.119 0.141 ± 0.026 27
Fibrinogen
10mg.ml-1
9 0.698 ± 0.097 0.138 ± 0.034 26
Fibrinogen
20mg.ml-1
6 0.915 ± 0.107 0.177 ± 0.025
Dextran 2mg.ml-1 14 0.650 ± 0.085 0.124 ± 0.015 31
Dextran 5mg.ml-1 15 0.615 ± 0.090 0.131 ± 0.022 32
Dextran 10mg.ml-1 12 0.618 ± 0.075 0.115 ± 0.013 36
Dextran 20mg.ml-1 9 0.631 ± 0.053 0.125 ± 0.027 36
PEG 400kDa
2mg.ml-1
9 0.691 ± 0.085 0.144 ± 0.014 26
PEG 400kDa
5mg.ml-1
9 0.566 ± 0.080 0.123 ± 0.017 35
PEG 400kDa
10mg.ml-1
9 0.456 ± 0.121 0.107 ± 0.018 43
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PEG 400kDa
20mg.ml-1
6 0.636 ± 0.054 0.097 ± 0.005 50
PEG 1000kDa
10mg.ml-1
6 0.524 ± 0.028 0.103 ± 0.017 50
PEG 1000kDa
20mg.ml-1
6 0.564 ± 0.051 0.095 ± 0.019 71
Ficoll™ 400kDa
10mg.ml-1
6 0.846 ± 0.084 0.165 ± 0.038 20
Ficoll™ 400kDa
50mg.ml-1
6 0.908 ± 0.089 0.172 ± 0.024 16
Ficoll™ 400kDa
100mg.ml-1
9 0.665 ± 0.153 0.146 ± 0.022 31
Table 5.2: Average compression rates of hydrogels with increasing concentra-
tions of macromolecules. Rates over the first 30 seconds (initial rate) and 5
minutes of compression were quoted as mean ml/minute ± standard deviation
(SD). Time to complete compression was noted as the time where compres-
sion rates reached zero. Compression rates significantly different to gels with
no macromolecules are listed in bold font.
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Optimal initial compression rates (for each macromolecule type) was ob-
served at a polymer concentrations of 5mg.ml-1 for fibrinogen (0.582 ± 0.119
ml/min), 5mg.ml-1 or 10mg.ml-1 for dextran (0.615 ± 0.090 and 0.618 ± 0.075
ml/min) and 10mg.ml-1 for larger polymers such as PEG at 400kDa (0.456 ±
0.121 ml/min) and 1000kDa (0.524 ± 0.028 ml/min) compared to gels with no
macromolecules (0.691 ± 0.083 ml/min). Importantly, the effectiveness of the
blocking agent was generally found to be correlated with its Stokes radius (fig-
ure 5.5); and not the polymer molecular weight (figure 5.6). The hydrodynamic
radius for fibrinogen, dextran, PEG 400kDa, PEG 1000kDa and Ficoll™ 400
were 10.95, 15.9, 26.56, 41.63 (adapted from Armstrong et al. (2004)) and
10nm respectively; with PEG 400kDa (26.56nm) (at 10mg.ml-1) being most
effective, of the polymers tested, in slowing the initial compression rates of hy-
drogels ((p ≤ 0.001; figure 5.7). Note that polymers were added to the hydro-
gel at a concentration of 1:9 (macromolecule : neutralised collagen solution),
meaning a PEG concentration within the hydrogel of 1mg.ml-1.
Smaller polymers (hydrodynamic radius) were less able to slow the com-
pression rates due to the reduced blockage at the FLS. For example, PEG
400kDa (∼ 26nm) was able to slow initial compression rates more effectively
from a rate of 0.691 ± 0.083ml/min (where no macromolecules were present)
to 0.456 ± 0.121 ml/min. Whereas dextran, a smaller polymer (∼ 16nm), re-
sulted in a maximum decrease of initial compression rates to 0.615± 0.090ml/min.
Polymers larger than PEG 400kDa (i.e. PEG 1000kDa) did not further de-
crease the initial compression rate (p=0.147). Ficoll™ 400 was the only excep-
tion to the above observation, and increased compression rates when incorpo-
rated into the hydrogel (i.e. 10mg.ml-1; p=0.002).
The data correlated with the line of best fit (y = −0.007x + 0.764) with a
correlation coefficient of ρ2= 0.5372, suggesting a moderate correlation to the
line of best fit.
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Figure 5.5: Correlation between polymer hydrodynamic radii and their respec-
tive initial (first 30 seconds) compression rates. All polymer concentrations
were 10mg.ml-1.
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Figure 5.6: Initial compression rates (rate of fluid flow from the hydrogel)
against polymer molecular weight. Correlation between initial flow rates and
molecular weight of the macromolecule was weak.
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Figure 5.7: Compression profiles of hydrogels (2.5ml) containing 10mg.ml-1
polymers. Control gels with no macro-molecule additives are represented by
the solid line. The extent of fluid loss from hydrogels during compression was
measured as mass of fluid gained by the absorbent plungers (i.e. fluid loss
from hydrogels) over time.
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5.3.3 Gelation rates of hydrogels with macromolecules
Collagen hydrogels with no macromolecules showed first signs of fibrillogen-
esis after 2.5 minutes at room temperature. This was delayed until 3 minutes
in samples containing PEG 400kDa. However, by 7 minutes into the gelation
process for both samples, the absorbance reading (opacity of the gel) began
to plateau suggesting fibrillogenesis was mostly complete (figure 5.8). In sam-
ples containing Ficoll™ 400, fibrillogenesis began sooner (from 1.5 minutes),
and reached a higher absorbance reading compared to both plain and PEG
containing gels by 5.5 minutes.
Whilst the incorporation of PEG 400kDa appeared to only affect the rate
of hydrogel fibrillogenesis, Ficoll™ 400 may be altering the structure of the
hydrogel, and led to a gel with a slightly higher opacity.
Figure 5.8: Absorbency of collagen solution over time during fibrillogenesis.
Hydrogels either contained an overall concentration of 1mg.ml-1 PEG 400kDa
or Ficoll™ 400; or contains no macromolecules.
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5.3.4 Effect of additional fibrin at the FLS
The application of thrombin to the surface of the hydrogel (for the formation of
a fibrin mesh) did not result in reduced compression rates. Instead, initial com-
pression rates increased up to 0.943 ± 0.070 ml/minute compared to samples
containing only fibrinogen (in its macromolecular form; 0.582±0.119 ml/minute)
(figure 5.9).
Figure 5.9: Compression rates of collagen gels containing 10% (v/v) 5mg.ml-1
fibrinogen, with or without added thrombin treatment on the gel surface. Where
thrombin was use, 50µl of 1mg.ml-1 thrombin (in water) was added indirectly to
the FLS via paper discs soaked in thrombin.
5.3.5 Proof of principle - protecting cells from damage within
fast compressing hydrogels
10mg.ml-1 PEG (400kDa) (final concentration of 1mg.ml-1 within the hydrogel)
resulted in optimal decrease in the initial compression rate, and was tested for
its effectiveness in slowing compression rates within blended collagen gels (i.e.
containing pre-polymerised collagen) containing interstitially seeded cells. Ala-
mar blue readings of conventional (acid-soluble collagen) gels, with or without
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PEG were similar at 25.35± 3.33 and 23.77± 1.20. Cell activity within blended
(fast-compressing) gels was significantly reduced (as also seen previously in
chapter 4 and in Wong et al. (2014)) in the absence of PEG (Alamar blue read-
ing of 16.53 ± 1.98; p=0.017). However, interstitial cells were shielded from
damage with the addition of PEG, resulting in a cell metabolic activity reading
similar to conventional hydrogels after compression (figure 5.10). In effect, the
addition of the PEG protected the resident cells from flow-related damage.
Figure 5.10: Total cell activity in polymeric collagen blend gels 1 day after com-
pression. Cell activity within blend gels, with or without 10% PEG incorporation
was compared to conventional (no macromolecules) monomeric collagen hy-
drogels.
5.4 Discussion
Results from chapter 4 showed improved material strength after the incorpo-
ration of polymeric collagen (and potentially any stiff fibres, as suggested pre-
viously (Deng et al., 2014)) into the hydrogel. However, initial cell viability
was compromised within the compressed hydrogel by increased fluid shear
stresses during hydrogel compression of the novel blend gel (Wong et al.,
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2014). The aim of this study was therefore to reduce fluid shear stress on
resident cells, and improve initial cell viability within the compressed hydrogel
construct.
It was clear from the results of this study that some interventions were able
to reduce fluid flow, such that fluid shear stresses remained within a physiolog-
ical range. More specifically, this study found that compression rates can
be controlled through the utilization of the filtration effect at the FLS, to
prevent loss of initial cell viability.
Although simply increasing the density of collagen molecules within the hy-
drogel significantly reduced compression rates (i.e. by increasing the amount
of mobile collagen species, and reducing pores size), it also resulted in a con-
struct which was far more opaque compared to compressed hydrgels made
from a collagen density of 2mg.ml-1 tropocollagen molecules; and potentially
reduces the accessibility of in vitro assays to monitor cells within the hydrogel
over time. Additionally, the increase in collagen density would also make it diffi-
cult to recover cells from the hydrogel, and prolonged digestion of the construct
with a solution of 0.2% collagenase-I will be needed due to digest the collagen
substrate. These problems associated within a high density gel may potentially
hinder the use of a dense gel as an in vitro tissue model, and other methods
for reducing fluid flow will need to be considered.
The two methods used to increase mobile macromolecular species capable
of contributing to the clogging of the FLS within the hydrogel included the use
of pepsin, or large macromolecules (which do no associate with the collagen
matrix during fibrillogenesis. The former method involved the pepsin digestion
of acid-soluble collagen solutions converted tropocollagen into mobile atelo-
collagen species, which could travel towards the FLS and contribute to the
blockage.
It has been noted in the literature that loss of telopeptides from tropocolla-
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gen (i.e. by pepsin action) impedes the rate of collagen self-assembly (Snow-
den and Swann, 1979), so an increasing amount of collagen molecules, in
theory, remained as mobile monomers within the hydrogel at the time of com-
pression. Since atelocollagen associates less readily with adjacent collagen
molecules, the less extensive interfibrillar branching of the collagen oligomers
(Whittington et al., 2013) may therefore explain the decreased efficiency in
clogging the FLS; as the molecules are less likely to be trapped between
interfibrillar spaces. As a result, even with the increase in mobile atelocol-
lagen molecules, compression rates did not decrease as expected, but in-
creased with pepsin treatment time (at least up to 24 hours; table 5.1). This
increase in compression rates may be exacerbated by the reduction in gel-
forming tropocollagen species (as it is converted into atelocollagen), leading to
a looser fibril network.
Interestingly, the rate of initial compression did not increase linearly with
pepsin treatment time. Instead, a slight fall in initial compression rates was
observed with further pepsin treatment beyond 48 hours (figure 5.4). A study
in 1970 by Leibovich and Weiss has shown that fibril morphology changes with
pepsin digestion, where prolonged treatment resulted in increased symmetri-
cal tactoidal fibrils/aggregates (Leibovich and Weiss, 1970) (Bard and Chap-
man, 1968). This suggests the time dependent change of pepsin treatment
on hydrogel compression rates may also be due to fundamental change in
collagen fibril assembly, instead of purely changing the amount of mobile col-
lagen species within the hydrogel. However, since the use of pepsin treatment
to produce interfibrillar space clogging species was not effective as a method
to control fluid flow rates within the hydrogel, the use of other ‘pore’ clogging
species was considered.
Artificially introduced pore-blocking macromolecules, such as PEG or dex-
tran, were added to hydrogels to contribute to the ultrafiltration membrane at
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the FLS.
In terms of the effectiveness of artificially introduced macromolecules in
controlling initial compression rates, the size and concentration of the blocking
agent influenced the extent of reduction in compression rates. More specifi-
cally, the polymer Stokes radius (hydrodynamic size), rather than its molecular
weight, was generally found to correlate with the initial compression rates.
Small molecules, such as water and oxygen, are known to be able to dif-
fuse freely through the thin compressed hydrogel layers (Cheema et al., 2008),
whilst larger molecules (in the micrometre scale; including cells) can be caught,
and entirely retained, by the collagen fibril network (Hadjipanayi et al., 2011a).
Hence the size of the optimal FLS clogging species will likely be within this
range (i.e. large macromolecules that can be trapped within the collagen ma-
trix) - with some consideration on the balance between fluid flow rates and the
time required by the hydrogel for complete compression.
From figure 5.4, it appears that the range in which the macromolecule af-
fects compression rates was between ∼ 11 − 27 nm. This was within the esti-
mated size range of interfibrillar space from Serpooshan et al. (2011). In this
study, polymers with stokes radius less than ∼ 11nm (fibrinogen) did not effec-
tively contribute to the accumulation of molecules at the FLS, so only moderate
effects on initial hydrogel compression rates was observed (rates were similar
to samples with no added macromolecules). Increasing the macromolecule
size between ∼ 11nm and ∼ 27nm appeared to linearly reduce initial com-
pression rates of hydrogels. PEG 400kDa (Stokes radius 26.56nm) resulted
in optimal rates, but further increases in polymer size beyond ∼ 27nm did not
yield further reduction in compression rates, potentially because these species
are generally less mobile and are trapped in the interfibrillar space of the ma-
trix, far from the FLS (as demonstrated in larger molecules (Hadjipanayi et al.,
2011a)).
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Late stage compression rate results do suggest some influence of macro-
molecule size, on its mobility within the hydrogel during compression. For ex-
ample, it was observed that the rate of fluid flow was higher at initial compres-
sion stages (first 30 seconds) for gels with PEG 1000 kDa (at 0.524 ± 0.028
ml/min instead of 0.456 ± 0.121 ml/min observed with 400 kDa PEG); despite
its larger size. This would mean that more fluid was leaving through the FLS
in the first 30 seconds of compression when 1000kDa PEG was present within
the hydrogel. However, by 5 minutes into the compression process, samples
with either PEG 400kDa and 1000kDa had almost identical compression rates
(i.e. the blockage at the FLS have reached a similar level). This suggests that
the PEG1000kDa may be beyond the size at which polymers were freely mo-
bile through the collagen network (i.e. slower to move through the hydrogel),
and so was less efficiently accumulated at the FLS. The effects of larger poly-
mers was still observed further downstream of the compression process (i.e.
at 5 minutes), suggesting a longer travel time for PEG 1000kDa to reach the
FLS.
Note that the total compression of a sample containing PEG 1000kDa was
longer (50 minutes instead of 43 minutes when PEG 400kDa was present);
and suggests that overall, the larger macromolecules may eventually offer a
more complete blockage of interfibrillar space at the FLS. However, the delay
in the macromolecules traveling towards the FLS meant that fluid flow rates at
the initial time point remained high, and so was not useful for the purposes of
decreasing exposure of cells to high fluid flow rates.
Although the results did suggest an increased molecular size generally re-
sulted in the decrease in initial compression rates, it was not possible to rule
out whether the presence of macromolecules may affect the structure of the
collagen matrix (i.e. by occupying space within the collagen solution) during
fibillogenesis. The presence of PEG 400kDa appeared to only increase the
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lag time prior to fibrillogenesis, but other macromolecules such as Ficoll™ 400
appear to change the hydrogel structure at a more fundamental level, as the
gelation time and resultant opacity after filbrillogenesis differed in comparison
to plain samples (without macromolecules).
Since the macromolecules were essentially providing physical blockage of
the interfibillar space to fluid flow, the effectiveness of each macromolecule can
be measured in terms of the hydraulic resistance of the FLS to fluid outflow
(RFLS; i.e. caused by the blockage of interfibrillar space at the FLS). (RFLS) of
samples, containing interfibrillar space clogging species, was mathematically
modeled based on Darcy’s law (Hadjipanayi et al., 2011a) (Tan, 2015). The




The hydraulic resistance (RFLS), measured as FLS surface area (A) and
transmembrane pressure (TMP) over the dynamic viscosity (µ) of water at 20°c
(1.001x10−3Pa) and Q, rate of flow in millilitre per second. Here, the change in
mass of the fluid absorbing plunger is assumed to be very close to the TMP,
and so the increase in plunger mass is substituted for the TMP function.
Figure 5.11: Average RFLS during plastic compression of hydrogels containing
artificially introduced macro-molecules over the first 5 minutes of compression.
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Resistance to fluid outflow generally increased with hydrogel compression
time, as more and more macromolecules (or other pore-clogging species) were
caught at the ultrafiltration membrane (FLS). During initial stages of compres-
sion (first 30 seconds), RFLS was highest in gels containing 10mg.ml-1 400kDa
PEG, although the difference did not reach significance compared to plain gels
(p=0.090) (figure 5.11). However, when RFLS was modeled in terms of rate
of change, PEG 400 (P≤0.001) and PEG 1000 (P=0.013) had significantly in-
creased RFLS gradients compared to plain hydrogels at 0 - 1 minute (figure
5.12). The high RFLS for PEG 400kDa containing samples corresponded to a
optimal decrease in initial compression rates.
Hydraulic resistance to fluid leaving the hydrogel continued to increase 4.5
- 7 fold between 30 seconds and 5 minutes of compression for all samples
(p ≤ 0.001), with RFLS at 5 minutes being highest in samples containing PEG
400kDa (p=0.002) and 1000kDa (p=0.009) compared to plain gels. Only hydro-
gels containing PEG 400 maintained an increased RFLS rate of change com-
pared to plain hydrogels between 2.5 - 4 minutes (P=0.026). The high initial
rate of RFLS was thought to be due to the low baseline for change in the FLS at
the start of the compression process, where there was no increased density of
collagen molecules at the beginning. It was only after the start of the compres-
sion process, and throughout the early stages of compression, that previously
mobile macromolecules have traveled with the fluid flow, and collected at the
FLS - causing an increase in resistance to fluid outflow.
The modelled rate of change in RFLS within the first 4 minutes of compres-
sion for all samples suggest blockage at the FLS was built up at different rates,
with the fastest being at the FLS of PEG400 and PEG1000 containing hydro-
gels in the first stages of hydrogel compression (figure 5.12). Importantly, this
increase in resistance to fluid outflow corresponded to a decrease in compres-
sion rate as expected.
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Figure 5.12: Comparisons of RFLS rate of change at 0-0.5, 1-2.5 and 2.5-4
minutes in samples containing different macromolecules.
Figure 5.13: Box and whisker plot showing the time required for RFLS to reach
500,000m−1 at later stages of compression, in the presence of different macro-
molecules. Samples were compared against RFLS of hydrogels within no addi-
tion of macromolecules.
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Figure 5.14: Time required for RFLS to reach 500,000m−1 in the presence of
macromolecules with different hydrodynamic size. This high RFLS reflects later
stage compression of the hydrogel.
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The time for resistance to fluid flow to reach 500,000m−1 (nominal RFLS
value all samples reached towards the end of compression) was measured
as an indication of the RFLS response at late stages of compression. Within
a plain hydrogel, the time for RFLS to reach 500,000m−1 was 24.2±3.6 min-
utes. The presence of dextran, PEG 400 and PEG 1000 increased the time
to 34.5±3.9, 41.3±4.7 and 43.2±4.3 minutes respectively; which meant that
the time for the FLS to acquire the same level of blockage was longer in the
presence of these macromolecules. This corresponded with the size of the
macromolecules, suggesting the mobility of the molecules within the hydrogel
affected the time it requires for RFLS build-up at the FLS (figure 5.14). Only
hydrogels containing Ficoll™ 400 decreased the time it took for RFLS to reach
the nominal end value to 18.0 ± 3.9 minutes (i.e. Ficoll containing gels were
completely compressed much sooner; figure 5.13). This may be a result of
ficoll effects on collagen fibrillogenesis described as molecular crowding agent
(Dewavrin et al., 2014) (Lareu et al., 2007)
Overall, the incorporation of large polymers were therefore found to be ef-
fective in slowing compression rates of blended gels, apparently by replac-
ing the mobile collagen molecules initially present within the standard, non-
blended hydrogels. Artificially added polymers (i.e. PEG) replaced the absent
monomer/oligomer collagen, and contributed to the blockage of the FLS. The
resultant filtration through the clogged FLS slowed compression rates (to cell
compatible levels) and shielded cells from damage during plastic compression
(figure 5.10).
It was found that compressive load was the primary determinant of fluid
efflux during initial stages of compression (Hadjipanayi et al., 2011a). However,
with further compression, FLS collagen density was linearly correlated with
RFLS where increases in hydraulic resistance resulted in decreased fluid efflux
rates.
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Anomalies within the trend for compression rates, against macromolecu-
lar size (hydrodynamic radius) was Ficoll™ 400. Due to its relatively small
hydrodynamic radius (∼ 10nm), it was predicted to have little or no effect on
compression rates. However, Ficoll™ 400 in fact caused an increase in com-
pression rates, compared to (control) gels without macromolecules, when in-
corporated into hydrogels. This was surprising because if it simply did not
contribute to the clogging effect at the FLS, the compression profile of the Fi-
coll™ containing gels should be similar to that of the plain collagen gel. The
increase in compression rates was therefore thought to be caused by a change
in the fibrillogenesis of the hydrogel (Dewavrin et al., 2014). Indeed, alteration
of fibrillogenesis by the added polymers was a possible factor in many cases,
especially where they are present at high levels.
This highlights the point that changes to the matrix will likely alter the re-
quirements, in terms of blocking agent size, for efficient FLS blockage (i.e. as
seen by the contradictory behaviour of Ficoll™ as a blocking agent, and the
highest levels of added polymers (20mg.ml-1)). Therefore there will be a need
to consider, and control, factors which alters fibril diameter; and consequently
interfibrillar spacing. Other factors discussed in chapter 1.4.3, including tem-
perature, ionic strength and pH during fibrillogenesis, are some of the factors
known to affect collagen matrix structure, and will need to be controlled for
constant matrix structures.
Since the aim of the study was to improve initial cell viability within fast
compressing hydrogels (i.e. to protect cells from damaging fluid shear stress),
PEG 400kDa was introduced into cellular fast-compressing hydrogel (blend
gel) for optimal reduction in initial compression rates. It was found that in the
absence of PEG 400kDa, a significant amount of cell death was observed
immediately following compression (reflected in the reduced total cell metabolic
activity detected from the samples). However, when PEG 400kDa was added
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to the blend hydrogel, cell viability remained close to 100%, similar to that of
the conventional hydrogels as observed through the level of total cell metabolic
activity detected from the gels after plastic compression.
This was the most important finding from this study, where it was found
that it was possible to reverse the effects of high initial compression
rates/fluid flow rates (as seen in polymeric collagen blend gels) by in-
corporating FLS clogging large macromolecules; and such interventions
was sufficient to protect interstitial cells from damage by reducing fluid
shear stress. This enabled the fabrication of tissue models, with increased
stiffness (provided by the pre-crosslinked polymeric collagen) and interstitial
cells (which will remain viable through the compression process).
This finding is significant in that it may also be applicable to other materials
based on a fibrous matrix as the sensitivity to cell damage under rapid fluid flow
is likely to be common to many protein materials with interstitial cell seeding.
Chapter 6
Results: Model of cell response to
drug delivery in nanoparticle cargo
6.1 Introduction
Targeted delivery of drugs are increasingly studied to improve efficacy (i.e.
lower drug dose and improve tissue response) of drug treatment, and reduce
systemic effects on non-target tissues/organs.
Nanoparticle drug carriers (and other carrier materials i.e. liposomes, poly-
meric micelles) can offer advantages such as:
• Targeted delivery (i.e. by selective attachment to cells, or by an enhanced
permeability and retention (EPR) effect)
• Time-controlled delivery
• Drug dosage control
• Minimise required dose for effect (reduce undesirable side-effects)
Nanoparticles used in cancer treatment, for example, are gaining popularity
due to the ‘enhanced permeability and retention effect (EPR)’ in highly vascu-
164
CHAPTER 6. RESULTS: DRUG DELIVERY MODEL 165
larised tissues (i.e. tumors), which enhances nanoparticle-drug specificity to
cancerous tissues. Drug carrier can also often be produced with time-release
properties for a regulated and constant delivery of drugs to the tissue over time
(see (Vllasaliu and Singh, 2014) for a review of the characteristics of nanopar-
ticles used in drug delivery systems).
Here, compressed collagen hydrogel is used as a 3D in vitro model to study
the effects of drug delivery (as a nanoparticle cargo) on cells; more specifically,
the stimulation of growth factor production. This model will test hyaluronic acid
nanoparticles (HA-NP) as a biomaterial carrier for the delivery of drugs.
The objective is to study the delivery of the nanoparticle cargo into the
model tissue, and later to study cell response (i.e. growth factor production) to
drug (i.e. simvastatin) delivered to the tissue in hyaluronan nanoparticles (HA-
NP). The study will include information on the retention of the nanoparticle in
the model tissue, the effect of the NP biomaterial, and drug-cargo on local cells.
Subsequently the amount of BMP2 produced in the presence of Simvastatin
was measured using ELISA assays to quantify BMP2 protein in the cell matrix
and culture media.
6.1.1 Hyaluronan-nanoparticles (HA-NP) for drug delivery
Hyaluronic acid (HA; or hyaluronan) is a linear, high molecular weight polysac-
charide made of repeating units of N-acetyl-D-glucosamine and D-glucuronic
acid. This glucosaminoglycan is a major component of the ECM, and is impor-
tant in cell adhesion to the ECM amongst other cell functions. Cell receptors
such as CD44 recognises and interacts with HA (Kim et al., 2008); which is
incidentally over-expressed in some cancer cells, making HA an attractive ma-
terial for targeted drug-delivery.
Cross-linked HA has been shown to be good carrier of drugs and proteins
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(such as growth factors) in different tissue models (i.e. bone (Bae et al., 2011),
cartilage (Ramesh et al., 2014)). Cross-linking of HA is often necessary to
reduce its rate of dissociation/degradation and resorption because their natural
turn-over rate can be very short (hours to days; depending on the tissue type).
Here, a fluorescent hyaluronan-nanoparticle (HA-NP) drug carrier material
is tested for drug-delivery efficacy, and cell response (triggered by these drugs)
within plastically compressed collagen hydrogels (i.e. the tissue model). These
HA-NP carriers are developed and supplied by a group in Uppsala university;
with the HA-NP particles without the drug cargo (i.e. empty HA-NP particles;
average of 485.3nm diameter) supplied by D. Ossipov; and HA-NP containing
9% (w/w) simvastatin cargo supplied by O. Varghese (average 680nm diame-
ter).
The HA-NP material is formed by functionalising the HA molecule with thiol
and hydrazide groups. Cross-linking between the hydrazide functional group,
and an aldehyde group in an adjacent HA molecule, led to the formation of a
hydrozone network/hydrogel (Varghese et al., 2009). This hydrogel (with a 2%
solid content) can be formed within 30 seconds. A hydrophobic cargo (which
is necessary for later stages of nanoparticle assembly), such as the fluores-
cent marker (fluorescein isothiocyanate; FITC) or pyrene (an aromatic hydro-
carbon), is cross-linked to the hydrogel via thiol groups (Ossipov et al., 2010)
(Yang et al., 2011). For the material to form nanoparticles, the hydrogel must
be enzymatically digested into smaller units by hyaluronidase. Nanoparticles
then form by hydrophobic interaction, with the cargo now on the interior of the
nanoparticle surrounded by a HA shell (which can be cross-linked to improve
stability). Previous reports have shown that aromatic durgs (i.e. doxirubicin)
can be incorporated into the HA-NP by electrostatic or hydrophobic associa-
tion/aromatic stacking of the nanoparticle pyrene cores (process depending on
the electrostatic charge on the drug) (Yang et al., 2011). The resultant HA-
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NP is then sized by dynamic light scattering (DLS) or SEM imaging, and are
lyophilised for storage.
6.1.2 Simvastatin HA-NP and BMP2 production
Simvastatin is a drug (prodrug) currently used to lower blood concentrations
of low-density lipoproteins (bad cholesterol) and triglycerides. When hydrol-
ysed into its active form (β-hydroxuacid/simvastatin acid) (Aarthy et al., 2014),
it functions by inhibiting the enzyme 3-hydroxy-3-methylglutaryl Coenzyme A
(HMG-CoA) reductase (Garrett and Mundy, 2002).
Interestingly though, the drug also appeared to increase bone mineral den-
sity and turnover (among other side-effects such as muscle myopathy) in pa-
tients (Montagnani et al., 2003) (Maritz et al., 2001), through the production of
BMP-2 (Mundy et al., 1999) (Garrett and Mundy, 2002).
The growth factor, Bone morphogenic protein (BMP)-2, is known to be os-
teoinductive and enhances bone formation and repair. Prolonged exposure
to BMP-2 led to bone-like structure formation with associated increase in os-
teoblast differentiation and improved mineralisation of constructs (Kisiel et al.,
2013). However, in systems where BMP-2 are not natrually produced (or are
in insufficient quantities), the growth factor must be administered frequently for
optimal bone-like formations. This mode of administration (i.e. directly via the
culture media (in vitro), or systemically (in vivo)) is less efficient, meaning ex-
cess growth factors are needed for therapeutic concentrations of BMP-2 within
the scaffold. Potential issues for the above method are:
• Cost
• High dosage
• Potentially uneven exposure of in vitro scaffolds to BMP-2 if construct not
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permeable
• Scaffolds potentially exposed to cyclical BMP-2 concentrations over time
(peak at each administration, with BMP-2 subsequently used up/degraded
before next dose)
New methods of nanoparticle (NP) preparation (mentioned in section 6.1.1
above; Uppsala University) means that aromatic drugs, such as Simvastatin,
can be loaded within nanoparticles made from the natural protein - hyaluronic
acid. These HA-NP can then be incorporated into the bone-like scaffold for
slow and sustained release of drugs; in effect, used as an indirect method of
BMP-2 delivery within the scaffold (i.e. BMP-2 produced when simvastatin is
gradually released as the HA-NP degrades).
Local administration of the drug (in NP format) potentially lowers the dose
required to generate significant osteogenic properties. Additionally, the sus-
tained levels of BMP-2 contact with bone-scaffolds may be more represen-
tative of the in vivo environmental BMP-2. This may provide a better model
for testing the efficiency of bone scaffold materials as an in vitro model. The
osteogenic cells can then mineralise the scaffold to generate a bone-like struc-
ture. It is postulated that extended and sustained BMP-2 contact with cells
will improve speed, and extent of mineralisation (and eventually calcification),
of bone-scaffolds compared to manually administering BMP-2 growth factors.
However, this is outside the scope of this study, as the NP are tested as a po-
tential delivery method for drugs. The aim here is to monitor cell activity via the
level of growth factor produced within these model tissues.
It is hypothesised that HA-NP will be retained by the tissue model during
plastic compression (based on previous work by Tan (2015); which found a
19% retention of HA-NP after plastic compression), which can be improved
by alterations of the compression process/hydrogel; also that the HA-NP-S
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(with simvastatin cargo) will lead to BMP-2 production by resident bone-derived
cells. Importantly, it is hypothesised that the ‘single-dose’ of HA-NP-S will grad-
ually and sustainably release simvastatin within the scaffold, which will stimu-
late a steady level of BMP-2 production over time.
6.2 Methods
Methods listed below are specific to this study. Further methods common to
studies throughout the thesis are listed in Chapter 2.
6.2.1 HA-NP preparation for use
Two different hyaluronan-nanoparticle (HA-NP) formulations were used. For
initial studies, lyophilised HA-NP (485.3nm diameter) was prepared and pro-
vided by D.Ossipov from Uppsala University. Subsequent functional studies of
NP within compressed collagen hydrogels was carried out using HA-NP con-
taining a ‘cargo’ of simvastatin drug (HA-NP-S) (9% (w/w) of material mass;
680nm diameter), which was provided by O.Podiyan of Uppsala University. All
NP were conjugated with fluorescein isothiocyante (FITC), which enabled de-
tection through their fluorescence.
Lyophilised HA-NP material were stored at 4 °c in the dark (within a dissica-
tor). Prior to use, HA-NP were re-suspended in sterile filtered deionised water,
to give a concentration of 1mg.ml-1. A rolling machine (at 37°c; dry incubator)
was used to disperse NP evenly in solution (for 30 minutes). Immediately prior
to use, the NP solution was mixed gently by inverting the container.
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6.2.2 Cells
Human osteosarcoma cell-line (MG63 cells) were cultured in 1000mg glucose
Dulbecco’s modified Eagle’s medium (DMEM; Sigma, UK), supplemented with
10% (v/v) fetal calf serum (FCS; First Link, UK) and 1% penicillin streptomycin
(Gibco Life Technologies, UK).
To transfer cells into collagen hydrogels (for the creation of cellular tissue
models), detached cells were counted and suspended in a known amount of
supplemented DMEM, and incorporated into neutralised (HA-NP containing)
collagen solution as described below.
6.2.3 Collagen constructs containing HA-NP
Methods for incorporating HA-NP into collagen hydrogels was based on that
described by Tan (2015).
Acellular collagen hydrogels were produced by neutralising 80% (v/v) acid
soluble collagen (2mg.ml-1) and 10% 10xMEM using 5M and 1M NaOH. 10%
(v/v) 1mg.ml-1 HA-NP particles in sterile deionised water were added to the
neutralised collagen solution. The final concentration of HA-NP within the col-
lagen solution was 0.1mg.ml-1.
1ml samples of the HA-NP-collagen solution were set in 24-well plates by
incubation in 37 °c, 5% CO2 for 30 minutes.
Cellular gels were produced similarly with a further 10% of the acid-soluble
collagen being substituted for cells (500,000 cells.ml-1 of hydrogel) suspended
in DMEM.
The resultant hydrogels were plastically compressed within their wells using
upward flow compression described in section 2.4.
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6.2.4 Detection of HA-NP from gels
Readings of fluorescence intensity have previously been found to reliably quan-
tify concentrations of HA-NP (Tan, 2015, p.80).
Collagen samples were digested with 0.2% collagenase-I (Gibco, USA) at
37 °c for 20-40 minutes to release fluorescent HA-NP nanoparticles from the
collagen matrix. Samples were either measured for fluorescence (fitc conju-
gated to the HA-NP nanoparticles) on a fluorescence spectrometer (Perkin-
Elmer LS50B; 3ml samples in a cuvette) at an excitation and emission wave-
length of 495nm and 520nm respectively; or when specified, on a microplate
reader (Infinite M200Pro; Tecan) at excitation and emission wavelengths of
485nm and 535nm.
6.2.5 Improving HA-NP retention within compressed hydro-
gel constructs
Nanoparticle retention in the ‘porous’ hydrogels during plastic compression
had been previously found to be at 19% (Tan, 2015). This was thought to
be due to their small size relative to interfibrillar pores, allowing outflow of
nanoparticles from the hydrogel.
In order to improve retention of HA-NP nanoparticles, and hence efficiency
of nanoparticle delivery into the tissue model, changes to the collagen matrix,
nanoparticle solution (non-chemical changes) or the plastic compression pro-
cess were studied for their effectiveness in improving NP retention. Details of
the test variables are listed below.
CHAPTER 6. RESULTS: DRUG DELIVERY MODEL 172
Changes to the collagen hydrogel
• Gelling temperature of 4°c (instead of 37°c) was likely to result in a
collagen matrix made of thicker fibrils (Christiansen et al., 2000). It was
hypothesised that the matrix formed at 4°c will decrease the extent of
nanoparticle outflow by providing an improved filter for small particles
(i.e. HA-NP) during plastic compression.
For this study, HA-NP containing hydrogels were produced as described
in the methods section above, except hydrogels were incubated for 24
hours in 4°c.
• Incubation environment can potentially affect fibrillogenesis and matrix
architecture due to pH changes (although buffers are found in the MEM
solution). Hydrogels were routinely incubated in 5% CO2 during fibril-
logenesis. CO2 solubilisation can lead to a slight reduction in pH as it
dissociates in solution into H+ and HCO3-. To test if this change in pH
within the hydrogel will affect hydrogel matrix structure (and hence HA-
NP retention), samples were incubated at atmosphereic CO2 levels at
37°c.
• Density of the collagen solution used in standard hydrogels was origi-
nally 2mg.ml-1. 6mg.ml-1 (type-I atelocollagen; Collagen Solutions) was
used in this test to increase collagen density, and reduce interfibrillar
space between fibrils. It was hypothesised that the increased collagen
matrix density will produce a greater filtration effect at the FLS during
plastic compression, and lead to a greater proportion of HA-NP retention
within the compressed gel.
• Presence of macromolecules was found in chapter 5 to control plastic
compression rates of hydrogels by increasing the filtration effect at the
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FLS. 400kDa poly(ethylene) glycol (PEG) dispersed in water was added
(10% of the total hydrogel volume; final concentration of PEG at 1mg.ml-1)
to a neutralised solution of type-I collagen (70% (v/v)), 10% (v/v) 10xMEM
and 10% (v/v) HA-NP solution. For direct comparisons, control hydrogels
were produced by substituting the PEG solution with deionised water.
Changes to the compression process
• Plunger material with different densities and fluid absorption rates was
tested to see if this affected nanoparticle retention. Plant fibre plungers
(TAP Biosystems, UK) were cut to 4 cm cylinders, and used in place
of the paper plungers from the standard compression protocol (made of
Whatman grade-I chromatography paper).
• 0.22µm filter discs (Millipore, UK) were used in place of Whatman paper
to separate the hydrogel and the plunger. Paper discs in the compression
setup was in direct contact with the hydrogel during compression, so the
addition of a fine filter layer between the hydrogel and the plunger was
thought to potentially contribute to the filtration effect (on top of the effect
observed at the FLS).
Changes to the HA-NP solution
• Nanoparticle size of HA-NP-S (with simvastatin cargo) was compacted
during treatment in a basic solution. Briefly, lyophylised HA-NP-S was
suspended in a solution of PBS (1mg.ml-1) already brought to pH12 by
addition of NaOH. After 30 minutes on a rolling machine, 0.2M HCl was
used to neutralised the solution. The 30 minute treatment in a pH12
buffer altered the nanoparticle diameter, and compacted the nanoparti-
cle to ∼200-250 nm. Samples containing the larger non-pH12 treated
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HA-NP-S (680nm diameter) were used as direct comparisons. Reten-
tion of the nanoparticles was thought to be affected by the nanoparticle
diameter, and larger nanoparticles was hypothesised to have improved
nanoparticle retention within the compressed gel.
6.2.6 Cellular HA-NP-S drug cargo containing constructs
Constructs containing HA-NP-S nanoparticles, with simvastatin drug cargo,
were produced as described for cellular hydrogels above. Each 1ml construct
contained 500,000 MG63 cells (passage 9-14). Construct were cultured in
1ml supplimented DMEM at 37 °c and 5% CO2 for up to 14 days. The cul-
ture media were collected (snap frozen in liquid nitrogen and stored at -80°c)
and replaced every 2 days. For studies of BMP2 trapping within the tissue-like
constructs, collagen gel samples were snap frozen separately from the cul-
ture media samples and were stored at -80°c. Prior to the ELISA assay, the
compressed collagen samples were homogenised and suspended in 1ml PBS.
6.2.7 ELISA assays for BMP2
A sandwich ELISA assay (Quantikine BMP2 assay; R&D Systems) was used
to detect and quantify the levels of BMP2 proteins trapped within the collagen
construct, or released into the surrounding culture media over time. The assay
was carried out as per the manufacturer’s instructions. All additional materials
required for the ELISA assay were obtained from the DuoSet ELISA ancillary
reagent kit (R&D Systems). All steps were carried out at room temperature
with a washing step between each reagent (3 washes with a wash buffer made
of 0.05 % Tween®20 diluted in water).
Briefly, 96-well plates were prepared by coating the wells with 100µl BMP2
capture antibody (1µg/ml; in PBS) overnight. All wells were then emptied and
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washed before 300µl of 1% bovine serum albumin (BSA) was added to each
well as a blocking reagent.
Samples (culture media or homogenised collagen construct in PBS; 100 µl
per well) were added to the wells for 2 hours. The wells were washed before
100µl BMP2 detection antibody (1µg/ml in 1% BSA) was added to each wells
for incubation (2 hours).
In the dark, working concentrations of streptavidin-HRP (100µl; diluted in
1% BSA) was added to each washed well for 20 minutes. Wells were then
washed and treated with equal volumes of hydrogen peroxide and tetramethyl-
bezidine (total volume of 100µl per well) for 20 minutes to develop colour (which
can be detected on a plate reader) in reaction to the horse radish peroxidase
(HRP) molecule from the previous step. Finally, without emptying and washing
the wells, an additional 50µl of stop solution (sulphuric acid) was added to stop
further colour development.
Plates were immediately measured on a microplate reader (Infinite M200Pro,
Tecan) at a wavelength of 450nm (with wavelength correction at 540nm).
BMP-2 standard curves were produced using serial dilutions of the BMP-2
protein from initial concentrations of 3000pg/ml (in 1% BSA). The BMP-2 solu-
tions (at 3000, 1500, 750, 375, 188, 93.8, 46.9 and 0 pg/ml) were plated in the
extreme right and left columns on each plate together with the samples. Each
well is subsequently processed and measured as described above. The read-
ings were plotted against BMP-2 concentration in order to obtain a standard
curve for each plate.
6.2.8 Statistics
One-way ANOVA was used to compare data on HA-NP retention using different
interventions. For all other experiments, an independent sample t-test was
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used to test for statistical significance. Confidence intervals were set at p ≤
0.05.
6.3 Results
Preparation of HA-NP and HA-NP-S involved dissolving lyophilised pellets of
the nanoparticles in deionised water to form a bright yellow solution of known
concentrations (i.e. 1mg.ml-1). Hydrogels were produced as described sec-
tion 6.2 above. The resultant hydrogels were visibly yellow-orange in colour
(instead of fuchsia pink), which gelled within 30 minutes when incubated at
37°c.
6.3.1 Retention of HA-NP within constructs after plastic com-
pression
The first step in producing the tissue model with nanoparticles is to establish
the presence and retention of HA-NP nanoparticles within the hydrogels during
plastic compression.
As an example, in one set of experiment quantifying the retention of HA-NP
after compression, the uncompressed hydrogel was found to have an average
fluorescence intensity of 154.64 ± 26.54 arbitrary units (a.u.) in solution after
the hydrogel was digested in collagenase. As seen in figure 6.1, this dropped
to 17.70 ± 1.01 a.u. after plastic compression (p= 0.001).
The average percentage of HA-NP retention within the hydrogel after the
plastic compression process was therefore:
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% HA-NP retained within gel =
fluorescence within compressed gel







Repeats of this experiment set showed that HA-NP retention ranged be-
tween 10.1 ± 1.7 and 16.6 ± 1.2 % after plastic compression. The overall
average percentage retention of HA-NP nanoparticles was 13.5 ± 1.5%, which
was used as the baseline retention of HA-NP to asses the effectiveness of in-
terventions used to increase nanoparticle retention within the hydrogel (unless
otherwise stated).
Figure 6.1: Average fluorescence intensity of fitc conjugated HA-NP within
hydrogels, before and after plastic compression. Prior to fluorescence mea-
surement, all hydrogels were digested in 1ml type-I collagenase. Volume of
digested compressed gels were adjusted prior to measurements to account
for the water lost during compression.
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6.3.2 Attempts to improve HA-NP retention within compressed
gels
Plastic compression was a key process in producing collagen constructs with
physiological ECM density. However, the high rate of HA-NP loss from the
hydrogel during compression was not desirable, especially when materials dif-
ficult to synthesise or isolate were used. To improve HA-NP retention within the
compressed collagen hydrogel, various adaptations of the methods regarding
the compression process, the hydrogel composition (structural and chemical)
and the HA-NP solution were tested.
Changes to compression setting
Changes to the plunger material did not result in any changes to HA-NP re-
tention within the compressed hydrogel (p= 0.549). However the replacement
of paper discs with 0.22µm filter discs between the hydrogel and plunger ap-
peared to have a small, but significant (p= 0.027) effect on HA-NP retention
during plastic compression; which increased from 13.5 ± 1.5 % to 20.1 ± 2.8
% (figure 6.2).
Figure 6.2: Average percentage retention of HA-NP after plastic compres-
sion of hydrogels with changes to the compression process. The use of fibre
plungers did not affect the amount of HA-NP trapped within the gel. But placing
0.22µm filter discs between the hydrogel and plunger successfully increased
HA-NP retention by about 7% (p=0.027).
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Changes to hydrogel
Changes in gelling conditions such as temperature and environmental CO2
concentrations did not result in a significant increase in HA-NP retention (p=
0.269 and p= 0.211 respectively; figure 6.3). However, a 2.5-fold increased
HA-NP retention (from 13.5 ± 1.5 % to 33.5 ± 12.7 %) was observed when the
density of the starting collagen material was increased from 2mg to 6mg (p ≤
0.001).
Figure 6.3: Average percentage retention of HA-NP after plastic compression
with variables in the collagen hydrogel or fibrillogenesis conditions. Hydrogels
set in atmospheric CO2 and 4 °c did not improve HA-NP retention. However,
increased collagen density improved HA-NP retention (p≤0.001).
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Figure 6.4: Average percentage retention of HA-NP within the compressed
hydrogel, with or without PEG 400kDa incorporation. No significant differences
were observed between either sample group (p=0.448).
Contrary to expectation, the incorporation of PEG 400kDa did not signifi-
cantly increase nanoparticle retention within hydrogels during plastic compres-
sion (p=0.448). The variability within the sample group was high, with HA-NP
retention averaging 14.4 ± 7.6 % in samples without PEG,and 16.7 ± 13.3 %
in samples with PEG incorporation (figure 6.4).
Changes to HA-NP solution
HA-NP size also had an effect on the retention within the compressed gel. HA-
NP-S (with simvastatin cargo; 680nm diameter) had improved retention rates
(41.6%) compared to ‘empty’ HA-NP particles (p≤ 0.001). The trapping rates
of HA-NP-S were also significantly higher, compared to their smaller, pH12
treated HA-NP-S counterparts at 35.4% (200-250nm diameter; p=0.005; figure
6.5).
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Figure 6.5: Average percentage retention of HA-NP-S, dissolved in pH7 or
pH12 solutions, after plastic compression. pH12 treatment for 30 minutes led
to alterations in the nanoparticle diameter and reduced retention of the com-
pacted HA-NP-S within the hydrogel.
6.3.3 BMP2 production within tissue model
Measurements from the ELISA assay was converted into BMP2 protein con-
centration using a standard curve with a line of best fit across, where recombi-
nant BMP2 of known concentration were plotted against spectrometer readings
(separate for each plate) (for an example see figure 6.6a).
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(a) BMP2 standard graph against
spectrometer readings
(b) Samples tested for BMP2 protein using the ELISA assay
Figure 6.6: Samples with or without HA-NP-S biomaterial were tested for
BMP2 protein levels within the collagen tissue model construct, and the sur-
rounding culture media using an ELISA assay. a) an example of the standard
graph of BMP2 concentration against readings on the plate reader, b) amount
of BMP2 detected from samples over 9 days in culture.
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Initial studies have found that no BMP2 was detected in either the media
or constructs of control samples only containing MG63 cells (figure 6.6b). Im-
portantly, a steady amount of BMP2 was detected from within the HA-NP-S
containing constructs, and culture media from days 5 and 9 respectively. Since
simvastatin and BMP2 were known to have a very short half-lives (2 hours;
(Aarthy et al., 2014)), the presence of the protein suggests the BMP2 was
produced as the simvastatin was being slowly being released by the HA-NP.
However further repeats of the experiment did not yield consistent results,
with some BMP2 protein detected from samples containing HA-NP-S, or con-
trol samples with MG63 cells only (figure 6.7).
Figure 6.7: ELISA assay results for the BMP2 protein over 14 days in cul-
ture. This set of experiment was a repeat of that seen in figure 6.6. Results
were however, not reproducible, with an extremely low amount of BMP2 pro-
tein detected from the culture media of both control and HA-NP-S containing
samples.
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6.4 Discussion
The efficiency of HA-NP entrapment within the hydrogel after plastic compres-
sion varied between 10.1 and 16.6%, with on average 13.5 ± 1.5 % HA-NP
remaining within the collagen construct after plastic compression. This was a
few percentage less than the average observed by Tan (2015) (19% HA-NP
retention).
Attempts to improve the low retention rates of HA-NP in this study included
changes to the collagen hydrogel fibrillogenesis conditions (i.e. pH (via CO2),
temperature), and therefore the collagen matrix architecture, to create hydro-
gels with an increased capacity to physically increase blockage to fluid and
small particle (i.e. HA-NP) outflow. Both the lowered gelation temperature,
and changes in environmental CO2 levels did not results in changes to the
hydrogel HA-NP trapping efficiency.
The incorporation of large mobile macromolecules (i.e. molecules that do
not bind to the collagen matrix) was previously found (in chapter 5) to increase
the filtration effect on fluids attempting to leave the hydrogel through the FLS.
Although the incorporation of PEG 400kDa was hypothesised to increased HA-
NP entrapment within the hydrogel, this was not found to be the case, as sam-
ples with, or without, PEG resulted in a similar HA-NP retention of 14.4 ± 7.6
% and 16.7 ± 13.3% respectively (p=0.448). However, note that the variation
(standard deviation) within the results in PEG containing samples was high,
which suggests that the incorporation of PEG may be efficient in increasing
retention of HA-NP in at least some samples. However, why this result did not
extent to all samples was unclear. Perhaps, the sensitivity of the hydrogel to
gelling conditions, affected the matrix architecture in some samples, altering
the extent of interfibrillar ‘pore’ blockage by the PEG 400kDa, allowing HA-NP
escape in some cases.
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The increase in initial collagen density from 2mg.ml-1 to 6mg.ml-1 improved
HA-NP retention. This effect was likely due to an increased blockage at the
FLS by tightly packing fibrils, and resulted in limited fluid and molecule outflow
rates. In this case, HA-NP retention increased from 13.5% to 33.5% with the
increase in collagen density of the hydrogel. Other factors (other than colla-
gen density of the solution) may also contribute to this increased NP retention.
For example, here the 6mg.ml-1 collagen solution was made up of atelocolla-
gen (instead of tropocollagen used in the 2mg.ml-1). The difference between
both types of collagen molecules lie in the presence (or absence) of a short
protein segment (telopeptide) on both terminals of the collagen molecule. Col-
lagens without this telopeptide will aggregate less readily with adjacent colla-
gen molecules (Brennan and Davison, 1981), meaning more collagen will be
mobile, and available to clog the FLS at the time of compression - potentially
enhancing HA-NP retention. The hydrogels made from 6mg.ml-1 also had an
increased overall thickness, suggesting that a proportion of the HA-NP may
be retained ‘passively’ through the increase in overall volume, and not solely
through physical entrapment between the interfibrillar space. A combination
of the above factors has likely contributed to the increased HA-NP retention
observed in samples containing increased collagen density.
Interventions with a positive effect on HA-NP retention also included the
alteration of the HA-NP biomaterial size, where HA-NP with a diameter of 680
nm or ∼200-250 nm were retained at a rate of 41.6% and 35.4% respectively
(p=0.005); showing that significantly more large HA-NP material was retained.
The changes in NP size was brought about by incorporating a drug (simvas-
tatin) cargo, or by chemical rearrangement and compaction of the HA-NP par-
ticles at pH12.
The effect of particle size and mobility within the collagen hydrogel has
previously been discussed in chapter 5, where it was concluded that small
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molecules below a critical size, measured according to the amount of space
between collagen fibrils within the matrix, were freely mobile (until it reached
the FLS). Larger particles however may become trapped in between the col-
lagen fibrils, and remain within the hydrogel; as demonstrated by (Hadjipanayi
et al., 2011a).
All HA-NP biomaterials were within the range of 200-680nm, which was
at least 10 times larger in size than the macromolecule hydrodynamic radius
discussed in chapter 5, meaning in theory, most HA-NP should remain trapped
within the collagen matrix during plastic compression. However contrary to this
expectation, most HA-NP were lost to fluid flow during plastic compression.
Potential reasons for this discrepancy include erroneous estimation of in-
terfibrillar pore size, or nanoparticle size. The collagen matrix pore size have
previously been estimated to be ∼30nm through imaging (visual estimation);
additionally, macromolecules at this size range affected plastic compression
rates, and so at least some blockage of the interfibrillar ‘pores’ was achieved
using macromolecule measuring ∼25nm (hydrodynamic radius). HA-NP size,
on the other hand, was measured using either dynamic light scattering or vi-
sually through the scanning electron microscope, both being reliable methods
to size nanoparticles. Therefore other reasons are more likely to be behind
the low retention rates of the nanoparticles, and may lie in the nanoparticle
surface charge and surface chemistry (Vllasaliu and Singh, 2014); although
further tests will be necessary to determine HA-NP surface charge and sur-
face chemistry characteristics.
Another paradox observed in this study, which may be attributed to the HA-
NP chemistry was the improved trapping efficientcy of the compacted (pH12
treated; ∼200-250nm diameter) HA-NP-S compared to ‘empty’ HA-NP carriers
(486nm diameter).
Nevertheless, HA-NP was highly mobile within the hydrogel model, and
CHAPTER 6. RESULTS: DRUG DELIVERY MODEL 187
escaped the construct with the fluid flow. The implication of this high mobility
identified using this model suggest a high potential for the biomaterial to travel
through the systemic system when implanted in vivo. The systemic effects of
nanoparticles will therefore be especially important, and require further study
to determine safety and biomaterial fate of the biomaterial over time in vivo.
Especially when the HA material can be taken up by binding to cell-surface
receptors, such as CD44 (Xian Xu, 2012). Other responses in vivo to HA also
included the mediation of inflammatory responses (i.e. inhibit macrophage
migration and aggregation (Laurent and Fraser, 1992)), to name a few.
The concentration of HA-NP-S within the hydrogel was 0.1mg.ml-1, with 9%
(w/w) of the particle composed of the simvastatin drug cargo; therefore:






This concentration of simvastatin in comparison with other systems for sim-
vastatin delivery was comparitively low. For example, a study also using HA
material (hydrogel) to delivery simvastatin found that 1mg (rather than 0.1mg)
simvastatin resulted in osteogenesis in vivo when bone defects were studied
using x-ray radiography (Bae et al., 2011). However, the release rates of the
simvastatin should also be taken into consideration as about 30% of the drug
carried with in the hydrogel was released as an initial burst leaving less drug for
subsequent sustained release in culture. However, targeted delivery systems,
in theory, should require less drugs-dose for the required therapeutic effect,
therefore an initial concentration of 0.009mg.ml-1 was a good starting point for
screening effects of drug-doses. In vitro tissue models can eventually be used
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to look at dosing of drug for optimum BMP-2 production and eventual bone
production.
The main hypothesis this model was set out to test was the delivery of
simvastatin, via HA-NP-S particles, to induce a sustained level of BMP2 protein
production. BMP2 protein was detected from HA-NP-S containing constructs
in initial ELISA studies. The first sign of BMP2 production was observed at day
5, at an average concentration of 24pg.ml-1 (figure 6.6). This level of BMP2
within the construct was maintained until the end of the experiment at day 9.
By this time, BMP2 was also detected from the surrounding culture media at
a concentration of 36 pg.ml-1. It was important to note that BMP2 was only
detected in samples containing HA-NP-S particles; and not control hydrogels.
Results suggest that BMP2 protein detected at day 5 was triggered by the
release of the simvastatin drug cargo from the HA-NP-S within the construct.
MG63 cells were then stimulated to produce BMP2, which diffuses out of the
construct (into the culture media) with time. The fact that a BMP2 was con-
tinuously detected within the construct between days 5 and 9 suggests that
the simvastatin was released gradually over time from their HA-NP carrier, be-
cause simvastatin has a half-life of ∼2 hours (Aarthy et al., 2014).
However, subsequent repeats of the experiment were not able to reproduce
results; for example BMP2 was detected within the HA-NP-S constructs at day
6 and 14, but only at extremely small quantities, suggesting the BMP2 detected
may be background ‘noise’ from the ELISA assay.
Nevertheless, the differences between experiments meant that the results
of growth factor production in response to the delivery of drug was inconclu-
sive; and the hypothesis cannot be proven at this stage. It was not possible to
rule out batch variances of the HA-NP-S material as the cause of the variable
results. However other possibilities for the lack of BMP2 production in sub-
sequent experiments include variation in cell activity, variation in simvastatin
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availability (i.e. amount of simvastatin delivered within the HA-NP, or released
by the nanoparticle over time); or the interaction between the BMP2 and col-
lagen proteins which may render it unavailable to the sandwich-ELISA assay.
This model may also be over simplified (environment may need more bone-like
features i.e. hydroxyapatite, increased stiffness, topography, etc.), and so did
not efficiently stimulate MG63 cell production of BMP2.
A review of the delivery methods of simvastatin and BMP2 protein can be
found by Aarthy et al. (2014) and Anderson and Shive (1997). Durg delivery
using fitc-containing silk NP (further trapped within a silk based hydrogel) had
demonstrated a similar constant release of drugs over several days (at ear-
lier time points) (Numata et al., 2012) (Numata and Kaplan, 2010). Although
degradation of the hydrogel led to an initial burst release of the trapped mate-
rial within the first hour, the NP was then released gradually, and constantly,
over 5 days. In the study involving HA-NP here, a burst release of the delivery
drugs was not likely (although not conclusive),as no initial BMP2 was detected
from either the hydrogel and surrounding culture media.
In vivo, the action of statins appear to promote osteogenesis (osteoblast
differentiation), inhibit osteoblast apoptosis and suppress osteoclastgenesis
via molecules such as farnesyl pyrophosphate (FPP), which affects expression
of BMP2 and Runx2 downstream (Ruan et al., 2012).
Further studies will be necessary to test whether this model was able to
elicit a response representative of the in vivo environment, when simvastatin
was administered locally. The development of a ‘non-invasive/non-end-point’
imaging method to track nanoparticle distribution in vitro will be beneficial for
studying drug delivery and their localised therapeutic effects (Ricketts et al.,
2014).
Chapter 7
Results: In vitro tissue model for
biomaterial fate
7.1 Introduction
Biomaterials implanted into the body are usually remodeled (natural materi-
als) or replaced by cell-produced ECM (synthetic biomaterials) over time. As
discussed in section 1.3.3, synthetic biomaterials are commonly used as im-
plant materials due to the ease of manipulation of the construct mechanical
properties and physical features. However, since these implant materials are
not natural to the human body, the effect of the biomaterial or its degradation
products at the implant site may not be completely clear, and may influence
the eventual implant success; particularly when the effect of the biomaterial on
cells resident at the implant site is not always fully understood.
The role of an implanted biomaterial can range from a supporting scaffold
for cell culture, to the delivery of drugs or other bioactive molecules. The rate
of material degradation therefore affects the functional aspects of the material
(i.e. material integrity, release rates of the bioactive molecules). This makes
the understanding of material degradation rate a main target (especially in the
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long-term) in biomaterial testing.
The ability to define and control biomaterial degradation rate is especially
important, when the success of the tissue replacement depend on closely
matched biomaterial degradation and cell-produced ECM deposition rates within
the construct. 2D in vitro assays are commonly used to assess biomaterial
degradation rates, but as previously discussed (see section 1.3.2), they may
not always reflect in vivo conditions. Animal models on the other hand often
only provide the partial picture of material degradation, owing to the lack of
material (and surrounding tissue) accessibility during the culture period. An
accessible model tissue is therefore required for real-time biomaterial assays
within a physiological tissue-like environment.
Here, a dense ECM-like structure (plastically compressed collagen hydro-
gel) is formed with encased cells and biomaterials; used to assess the material
in an in vitro tissue-like model. Cell involvement in the fate/destination of the
biomaterial over time will also be studied. A fluorescent PLGA biomaterial (fur-
ther discussed below) is used in conjunction within the compressed hydrogel
model to track biomaterial degradation rates, and biomaterial fate with culture.
7.1.1 Degradation of biomaterials
Degradation of biomaterials can be defined as the “molecular change due
to chemical chain scission within a polymer chain” (Yildirimer and Seifalian,
2014).
One of the current challenges is to precisely measure and control bioma-
terial degradation within a tissue environment. Cells within the scaffold need
to remain physically supported to encourage cell-matrix interactions leading to
the biosynthesis of the ‘new’ ECM (ideally with associated ECM components
and tissue response in the correct sequence i.e. collagen synthesis, inflam-
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mation, angiogenesis and innervation). It is also essential to evaluate each
component/degradation product of the biomaterial to ensure safety on cells
and tissues.
Degradation rates of biomaterials can be affected by external conditions
such as temperature, pH and fluid dynamics around the biomaterial; but also
the intrinsic properties of the material, such as the surface area of the construct
exposed to degradation (directly influenced by construct dimensions, pore size,
porosity and overall design). Additionally, the chemistry of the biomaterial (i.e.
hydrophilicity/hydrophobicity, mode of degradation (erosion, enzymatic, hydrol-
ysis, etc.) also have a major role in determining material degradation rates.
Therefore, biomaterial degradation rates can vary from hours (e.g. hyaluronic
acid (Laurent and Fraser, 1992)) to years (e.g. silk (Cao and Wang, 2009)).
Many biomaterials are designed with multi-functionality to support both tis-
sue structure, and to deliver cells and biologically active molecules (such as
drugs, growth factors, cytokines, genes) within a biodegradable matrix. The
ability to modulate the release kinetics of these bioactive factors is important
for the tissue to adapt to their new environment and gain function over time
(Chen et al., 2011).
Changes to implanted biomaterials and surrounding tissue with time may
include:
• Degradation of material
• ECM production and remodeling of existing tissue matrix by resident cells
• Changes to material physical properties (i.e. dimensions, porosity)
• Fate/destination of degraded products (i.e. uptake by cells, resorption or
remain in surrounding tissue)
In the current tissue model of material degradation, a simple reductionist
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matrix made of collagen (type-I) with physiological density and interstitial cells,
is used to study biomaterial degradation rates.
7.1.2 Biomaterial tested in current model: what is PLGA?
Poly(lactic-co-glycolic acid) (PLGA) is a type of thermoplastic aliphatic poly(ester)
that has been approved for drug delivery use by the FDA. The material is
a polymer of poly(lactic acid) (PLA) and poly(glycolic acid) (PGA) as seen
schematically in figure 7.1 below. They have good biocompatibility, material
strength and can be made into any shape or size; ranging from nanoparticles
to 3D constructs capable of bridging large tissue gaps. The range of PLGA
manufacturing techniques (using different types of solvents) also means that
drugs, proteins or cells with very different properties can be incorporated into
the material (reviewed by (Jain, 2000)).
Figure 7.1: Chemical formula of the PLGA polymer adapted from (Yildirimer
and Seifalian, 2014). The polymer chain can involve different proportions of
poly(lactic acid) and poly(glycolic acid).
PLGA degradation
Degradation of PLGA occurs via hydrolysis by cleaving ester linkages in the
polymer backbone. Whether enzymatic degradation is involved in PLGA degra-
dation (due to the differences in vivo and in vitro degradation rates (Lu et al.,
2000)) is controversial.
In the review by Jain (2000), the three phases of PLGA degradation was
summarised as:
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1. Random chain cleavage, where the molecular weight of polymers de-
creased with no overall loss of mass
2. Further cleavage of polymer with rapid loss of mass as soluble oligomeric
and monomeric products are formed (i.e. degradation products small
enough to be mobile)
3. Soluble monomers are formed from the smaller fragments until polymer
is completely solubilised
Once degradation begins, more water soluble carboxylic end groups will
be exposed, further catalysing biodegradation (Schliecker et al., 2003) (Oh
et al., 2006). As hydrogen ions dissociate from these end groups, the pH in
the surrounding solution/tissue drops, and further catalyses the degradation
of PLGA. The end products of the degradation process are lactic and glycolic
acids which are eventually metabolised, in vivo, into carbon dioxide and water.
Since PLGA degrades (at least primarily) by hydrolysis, water permeability
of the construct (i.e. its porosity, size/shape, surface-to-volume ratio) will affect
the rate of PLGA degradation. Large constructs >300µm were found to have
heterogenous degradation rates where the core of the construct will degrade at
a higher rate compared to the surface (Anderson and Shive, 1997). However,
small particles under 300µm degrades at a homogeneous rate throughout the
particle.
Additionally, PLGA has a glass transition temperature (Tg) above body tem-
perature, and so has a glassy appearance and high mechanical strength at
physiological conditions. This Tg, and their polymer degradation rates is highly
dependent, and predictable, based on the composition of the polymer (i.e.
proportion of lactic and glycolic acids; among other factors discussed below).
Generally, increases in PGA content will decrease the crystallinity of the PLGA
polymer. Crystallinity can affect the material strength, swelling properties and
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degradation rates; with a highly crystallised polymer degrading over a longer
period of time. Additionally, glycolic acid is more hydrophilic than lactic acid,
and so a PLGA construct with high amounts of PGA which will absorb more
water, and encourage its diffusion through the scaffold (Xu et al., 2013); result-
ing in a material with increased degradation rates. The exception is a polymer
made of a ratio of 50:50 PLA and PGA, which has the highest degradation
rates.
Fluorescent PLGA
Fluorescent poly(lactic-co-glycolic acid)(PLGA) tagged with rhodamine B isoth-
iocyanate was provided by Ms K.Barnsley of Keele University, UK. The material
consisted of equal proportions of lactic and glycolic acid which are known to
have high degradation rates. The fluorescent rhodamine is evenly and cova-
lently bound to the PLGA, so degradation products can be traced by measuring
fluorescence within the construct or in the surrounding ECM-like structure or
culture media.
The ability to track the biomaterial is fundamental in assessing its long term
consequence in a tissue-like environment. The aim of this study is to test and
track biomaterials as they degrade within an in vitro 3D tissue model. The
model tissue is based on the rapid fabrication of cellular compressed hydro-
gels, which can be formed around a biomaterial. Fluorescent PLGA µ-particles
(50-150µm diameter) were tested in this system.
Since PLGA materials are known to undergo hydrolysis and form smaller
mobile units, it is hypothesised that with time, these degradation products will
diffuse away from their implant site, and can be found in the tissue construct
and culture media. Additionally, the reports of cell uptake of PLGA nanoparti-
cles (Cartiera et al., 2009) led to the hypothesis that smaller degraded PLGA
will be taken up by resident cells with culture.
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7.2 Methods
Methods listed below are specific to this study. Further methods common to
studies throughout the thesis are listed in Chapter 2.
7.2.1 Preparing fluorescent PLGA materials for use
The rhodamine B isothiocyanate-tagged PLGA were supplied in two formats,
namely µ-particles (50-150 µm) and 2mm porous discs (pore size 100-200µm).
All PLGA material were stored at 4°c in a desiccator and wrapped in foil to
prevent the hydrolysis of the material and blanching of the fluorescence during
storage.
Rhodamine-tagged PLGA was sterilised by treatment with isopropanol for
15 minutes and subsequently washed in sterile PBS three times. PLGA in its µ-
particle form were recovered by centrifugation at 12000rpm for 2 minutes after
isopropanol treatment and each of the 3 washes. Finally the PLGA particles
were suspended in PBS at a concentration of 1mg.ml-1. The suspension was
sonicated for 10 minutes to obtain a homogenous suspension.
7.2.2 Detection of rhodamine-tagged PLGA
Fluorescence of rhodamine-tagged PLGA were measured from the PBS (in
2D assays) or the culture media surrounding the 3D model. Unless otherwise
specified, samples were measured in 24-well plates at room temperature with
excitation and emission wavelengths set at 530nm and 590nm respectively
(Infinite M200Pro microplate reader, Tecan).
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7.2.3 PLGA degradation rate in PBS (2D system)
PLGA samples used within the model were first tested in 2D to ensure the
degradation products can be detected in the surrounding media, and to test
the material degradation rates in solution. 2mm rhodamine-tagged PLGA discs
were weighed and submerged in in 4ml PBS for incubation at 37°c. The
amount of fluorescence (degradation products) was measured from the PBS
over 34 days (at 0 and 1 hours; 1, 7, 8, 12, 21 and 34 days). For the measure-
ments, PBS samples were was transferred into a cuvette, and measured on
a fluorescence spectrometer (LS 50B; Perkin-Elmer) at 530nm excitation and
590nm emission wavelengths. The same PBS solution was returned to the
respective PLGA sample for continuous incubation. Therefore, fluorescence
detected from the PBS was cumulative for each sample.
7.2.4 Trapping efficiency of PLGA µ-particles within the hy-
drogel
The ability of the collagen hydrogel to retain PLGA µ-particles after compres-
sion was measured by comparing the amount of fluorescence (from the PLGA
material) in gels, pre- and post-compression.
Hydrogels for this study were produced by adding 10% (v/v) 1mg.ml-1 PLGA
µ-particle solution to ice-cold neutralised collagen solution, consisting of 80%
(v/v) type-I acid-soluble collagen and 10% (v/v) 10xMEM (neutralised using 5M
and 1M NaOH). 1ml of this PLGA collagen solution was transferred to each
well of a 24-well plate, and incubated at 37°c, 5% CO2 for 30 minutes for hy-
drogels to set. Gels either remained uncompressed, or were fully compressed
as described in section 2.4. All gels (both compressed and non-compressed)
were subjected to collagenase-I digestion (0.2% solution in PBS; Gibco, USA)
for 20-30 minutes at 37°c (on a shaker) until the gels were fully digested. Sam-
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ples were then measured for fluorescence as described in section 7.2.2.
7.2.5 PLGA µ-particle degradation rates in 3D (with or with-
out cells)
Compressed collagen hydrogels were formed around the PLGA biomaterial,
and incubated for up to 21 days to study biomaterial degradation over time.
The main variable in this test was the incorporation of cells (human der-
mal fibroblasts (HDF)), to see if their presence will affect the kinetics of PLGA
degradation and release from their implant site. A two-layered compressed col-
lagen hydrogel model was used to place cells and fluorescent PLGA µ-particles
in separate, but adjacent, layers (figure 7.2). In the first layer, 1ml collagen hy-
drogel containing either no cells, or 500,000 HDFs were set within each well of
a 24-well plate (produced as described in 2.2). Once the hydrogel has gelled
after 30 minutes of incubation (37°c, 5% CO2), a second layer containing 10%
1mg.ml-1 sterile PLGA µ-particles (added to the neutralised collagen solution
instead of cells) was gelled above the first layer. After another 30 minutes of
incubation, both super-hydrated layers were compressed together using up-
ward flow plastic compression, until compression was complete (please see
section 2.4 for detailed method). 1.5ml DMEM (supplemented with 10% fetal
calf serum and 1% penicillin steptomycin) was added to each well to prevent
the dehydration of the compressed gel. All resultant compressed gels were
detached from the base of the well (i.e. so that it is free-floating), and were
incubated at 37°c, 5% CO2 for up to 21 days. At days 0, 3, 7, 11, 14 and
21, the media surrounding the construct was collected and frozen at -20°c for
subsequent fluorescence detection.
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Figure 7.2: Schematic representation of the 2-layered model used in bioma-
terial testing. PLGA microparticles were set in collagen hydrogels containing
fibroblasts (A) or a plain hydrogel (B; as a control). Layers 1 and 2 were com-
pressed together to ensure good contract between both layers.
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7.2.6 Histological analysis of model
Samples were fixed, histologically processed and embedded in paraffin wax
for sectioning. 8 µm sections were collected and viewed under a Olympus
(BH2-RFCA) microscope with a corresponding filter to detect red rhodamine
fluorescence within the construct. Images were captured in black and white on
a digital camera (C4742-95, Hamamatsu) attached to the microscope. ImageJ
was used to superimpose colour, onto the black-and-white images captured
on the camera. Samples were fixed, histologically processed and embedded
in paraffin wax for sectioning. 8 µm sections were collected and viewed under
a Olympus (BH2-RFCA) microscope with a corresponding filter to detect red
rhodamine fluorescence within the construct. Images were captured in black
and white on a digital camera (C4742-95, Hamamatsu) attached to the mi-
croscope. ImageJ was used to superimpose colour, onto the black-and-white
images captured on the camera. Samples were fixed, histologically processed
and embedded in paraffin wax for sectioning. 8 µm sections were collected
and viewed under a Olympus (BH2-RFCA) microscope with a corresponding
filter to detect red rhodamine fluorescence within the construct. Images were
captured in black and white on a digital camera (C4742-95, Hamamatsu) at-
tached to the microscope. ImageJ was used to superimpose colour, onto the
black-and-white images captured on the camera.
7.2.7 Cell uptake of PLGA degradation products in the 3D
environment
In order to study the effects of biomaterial degradation products on surrounding
tissues, it is necessary to establish the fate/destination of these molecules. It
was clear some PLGA degradation product was released into the surrounding
matrix and culture media due to the fluorescence detected spectrophotometri-
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cally, and visually (from histological samples).
Cell uptake of fluorescent material with prolonged culture was tested in a
3D, plastically compressed hydrogel, environment.
Collagen solutions were prepared similarly to methods described in 2.2,
with slight alterations in volumes of solutes were used to account for the in-
corporation of both cells and PLGA µ-particles. Briefly, 75% type-I acid sol-
uble collagen and 10% 10xMEM were neutralised with 5M and 1M NaOH.
Once neutralised, 5% DMEM suspending 500,000 HDF/well and 10% PLGA
µ-particles were added to the collagen solution. 1ml/well of the suspension
was placed in a 24-well plate and gelled at 37°c, 5% CO2 for 30 minutes. Gels
were compressed and incubated with 1ml DMEM.
Cells were recovered at days 0 and 10. The hydrogels were digested with
0.2% type-I collagenase (Gibco, USA; in PBS) at 37°c and with constant agi-
tation for 30 minutes. Cells from the samples were then recovered by centrifu-
gation (2000rpm, 5 minutes) and supernatant were discarded. The recovered
cells were then washed twice by re-suspension in PBS. Finally the HDF were
re-suspended in 1ml PBS and transferred to a 24-well plate for 24 hours until
cells were attached onto a flat surface for imaging. Fluorescence from PLGA
was measured as described above.
Control gels containing only HDF (and no PLGA) were set up in parallel to
the above samples.
7.2.8 Statistics
Statistical significance was determined by an independent sample t-test for
data on PLGA trapping efficiency within the hydrogel. For all other experi-
ments, one-way ANOVA (LSD post-hoc) was used. Confidence intervals were
set at p ≤ 0.05.
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7.3 Results
7.3.1 PLGA degradation in PBS (2D)
Sample size of the 2mm PLGA discs averaged between 1.7 - 3.4 mg. Since
the samples varied in mass, the results were reported in fluorescence (a.u.)
per mg of sample material. Also, to account for burst release (if any) of the
fluorescently tagged particles, all results were subtracted from the average
baseline of 0.093 ± 0.013 a.u., detected at 0 hours (i.e. as soon as the PLGA
was added to the PBS). Almost no fluorescent material was detected in the
PBS at 0 and 1 hour after submerging the samples in PBS, suggesting the
fluorescent rhodamine molecules were bound covalently to the PLGA material.
Some fluorescence was detected in the PBS by 24 hours in culture (figure
7.3). Significant cumulative increases in the fluorescent material was detected
by day 21 of incubation (p=0.038). Degradation of the material continued until
the end of the study period at day 34. By the end of the experiment, samples
were visibly swollen and disintegrated in solution.
The degradation rates appear to be influenced by the physical size of the
sample, as samples with a high surface area-to-volume ratio (sample 2) de-
graded at an increased rate compared to other samples - which progressed at
an exponentially increasing rate (figure 7.4).
CHAPTER 7. RESULTS: TISSUE MODEL FOR BIOMATERIAL FATE 203
Figure 7.3: PLGA degradation rates in PBS (2D assay) over 34 days. PLGA
degradation was determined by the fluorescent intensity of rhodamine tagged
degradation products of PLGA material, found in the PBS solution, over time.
Figure 7.4: Fluorescence readings from individual PLGA 2mm disc samples
submerged in PBS over 34 days with respective sample mass.
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7.3.2 Trapping efficiency of PLGA µ-particles within hydro-
gels
Next stages in developing the material degradation model involved the incor-
poration of the biomaterial (in µ-particle form) within the compressed collagen
hydrogel to form in vitro tissue-like models for the assay of material degradation
rates and material fate.
The trapping efficiency of PLGA micro-particles within the collagen hydro-
gel was measured by comparing the amount of fluorescent PLGA particles
within (otherwise identical) hydrogels, before and after plastic compression.
Gels (both compressed and non-compressed) were digested in collagenase-I
to re-suspend the µ-particles in solution prior to spectrometric measurement
of the solution. The amount of fluorescent signal detected from uncompressed
and compressed gels were almost identical, at 2814 ± 300.1 and 2848 ± 86.6
respectively (p=0.860). This suggests that most, if not all, of the fluorescent
micro-particles have been retained within the hydrogel after plastic compres-
sion.
7.3.3 The effect of cells on material release from tissue mod-
els
Since µ-particles were retained within the compressed hydrogel after plastic
compression, the next step was to track and quantify the amount of PLGA
degradation products released from the 3D tissue model over time.
The cumulative amount of fluorescence detected in the media (subtracted
from the baseline media-only readings) from cellular and acellular gels over 21
days have been plotted in figure 7.5.
Fluorescence was detected in the culture media surrounding both cellular (p
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≤ 0.001) and acellular (p=0.004) matrices from day 7 of culture. However, the
cumulative level of fluorescence detected from cellular gels was approximately
2.5 times more than that of the acellular gel, at 23166.5 a.u. and 8601.5 a.u (p
≤ 0.001) respectively. At all time points, except day 21 (p=0.244), a significant
difference between cellular and acellular samples was observed.
The cumulative results show that fluorescent material was continuously re-
leased into the surrounding media in both sample types between days 7 and
21. However, the rate of release was highest between days 7 and 14 (at 2856.8
a.u. and 5883.1 a.u. per day respectively for acellular and cellular samples),
which subsequently lowered to 1120.3 a.u. and 1628.5 a.u. per day respec-
tively beyond 14 days in culture.
Figure 7.5: Cumulative average release of fluorescent material into the me-
dia surrounding the PLGA containing compressed hydrogel over 21 days. The
amount of fluorescence detected from the media in cellular and a cellular con-
structs were compared to study cell influence over biomaterial degradation
product release kinetics.
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7.3.4 Histological analysis of two-layered model
Histological images of the cellular and acellular model at days 0 and 14 of
culture also support the difference in material release rates from cellular and
acellular gels (figure 7.5). Note the loosened construct structure of the cellular
hydrogel layer in cellular samples at 14 days.
Both acellular and cellular samples at day 0 (figure 7.6) show the concen-
trated red fluorescence of µ-particles within one of the auto-fluorescing colla-
gen layers. By day 14, the fluorescence from these µ-particles had diffused
into the surrounding collagen construct in both acellular and cellular samples.
This was most pronounced an visible in cellular samples (figure 7.6). Vacuoles
(with a fluorescent outline) which appears to be the remnants of the PLGA µ-
particle were observed in the biomaterial containing layer of the cellular bi-layer
construct. Within the adjacent cellular layer, pockets of highly fluorescent clus-
ters, which coincides with the shape and size of the interstitial cells (HDFs),
suggests that cells may be able to take-up the degradation products of PLGA.
These pockets of intensely fluorescent particles, away from the micro-particles,
were not observed within the acellular samples.
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Figure 7.6: Histological sections of the bi-layer model, where cellular or acel-
lular gels were compressed with a separate hydrogel containing PLGA micro-
particles. Samples cultured for 0 and 14 days were compared.
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Cell uptake of PLGA degradation products
To test whether cells take-up PLGA degradation products, cellular compressed
hydrogels (with or without PLGA) were incubated for 10 days, and subse-
quently digested to extract cells. Cells were recovered, washed and seeded
on tissue culture plastic to enable visualisation on the microscope. Due to the
faint fluorescence from the degraded PLGA material, it was not possible to
visualise the particles using the camera during fluorescence imaging. The ma-
terial could however, be observed in white light (as dark coloured dots; which
were not present in samples without PLGA).
Particles were clearly visible within the cells in samples cultured with PLGA
after 10 days (figure 7.7a). As expected, cells not cultured with PLGA material
did not exhibit the clusters of material (figure 7.7b).
CHAPTER 7. RESULTS: TISSUE MODEL FOR BIOMATERIAL FATE 209
(a) Cells incubated with PLGA
(b) Cells incubated without PLGA
Figure 7.7: Human dermal fibroblasts extracted from collagen gel model after
10 days in culture a) with or b) without PLGA, were subsequently seeded on
tissue culture plastic for imaging.
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7.4 Discussion
The ability to predict and detect the rate of material degradation within a tissue-
like environment can have implications on the design and use of degradable
biomaterials (Artzi et al., 2011). This was achieved in vitro within an op-
tically permeable (plastically compressed) collagen matrix with the help of
fluorescently-tagged PLGA material.
Degradation rates of rhodamine loaded PLGA material made of a 50:50
polymer of PLA:PGA was high as expected, with evidence of this degradation
observed within 24 hours in the 2D model, and 7 days in 3D. This continued
for the 34 and 21 days in 2D and 3D cultures respectively.
In the literature, the half-life of 50:50 PLGA scaffolds have been quoted as
∼15 days (Anderson and Shive, 1997), or ∼2 weeks and ∼3 weeks in vivo
and in vitro respectively (Lu et al., 2000). The degradation rates of the PLGA
used in this experiment appear to fit into this time frame. However the release
rates of degraded fluorescent material in the 2D and 3D model occurred with
different patterns. PLGA material in the 2D model was released steadily into
the PBS between 1 and 21 days in culture, with further increases in degra-
dation rates at later time points between 21 and 34 days. This degradation
pattern was more clearly observed from individual samples (figure 7.4), where
rate of fluorescent material deposition into the PBS increased exponentially
at later stages of incubation. This was not completely unexpected, since the
accumulation of PLGA degradation products in the PBS can decrease local
pH levels, which then further encourages hydrolysis of the material (Yildirimer
and Seifalian, 2014). The fact that the same solution was used to incubate
the PLGA samples during the experiment may explain the late-stage increase
in degradation rates through pH changes, observed in the 2D model. Also as
hydrolysis progressed within the sample, it was natural for the PLGA material
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to have an increased exposure of carboxylic end groups, further increasing
degradation rates (Schliecker et al., 2003) (Oh et al., 2006). Note also that
by the end of the 34 days in culture, the samples were swollen (and mostly
dissolved), meaning the surface area available for hydrolysis increased with
time.
Release of fluorescent degradation products in the 3D model, however, was
not observed until later in time (at day 7). PLGA µ-particle in the 3D sample
were surrounded by a dense matrix which may explain the delayed release of
the fluorescent particles into the surrounding culture media. The compressed
collagen matrix was known to retain large particles (in relation to the “pore-
size”, or interfibrillar space between collagen fibrils) (Hadjipanayi et al., 2011a),
so it was perhaps not surprising that the fluorescent particles were not detected
immediately in the surrounding culture media. Since PLGA degradation began
with the random cleavage of ester linkages within the material; loss of mass
only occurs at later stages as smaller, soluble monomeric/oligomeric products
were formed (Jain, 2000). So, further degradation of PLGA into smaller mobile
particles was likely necessary before the degradation products can diffuse out
of the hydrogel.
The difference in degradation rate could also potentially be due to the differ-
ences in size and shape of PLGA used in the 2D (2mm discs) and 3D models
(µ-particles); more specifically, a larger surface area-to-volume ratio was likely
to lead to an increased rate of PLGA degradation i.e. increase in surface ex-
posed to surrounding fluid, and therefore hydrolysis.
One notable finding from the model was that a significantly higher amount of
fluorescent PLGA particles was released into the surrounding culture medium
from the cellular model (figure 7.5). If PLGA exclusively degraded by hydrolysis
(and not by enzymatic activity as some report suggested (Lu et al., 2000)), the
difference between the cellular and acellular models in the release profile of flu-
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orescent degradation products will have been mediate by cell-induced changes
to the extracellular matrix (i.e. remodeling); especially when fibroblasts were
known to be capable at this task. Another sign that remodeling had taken place
in the cellular construct was found in the histological studies, where the colla-
gen matrix was transformed into a ‘lacy’ structure, with an increase in overall
hydrogel thickness observed by 14 days (as seen in figure 7.6 and figure 7.8).
Figure 7.8: Cross section of the bi-layered 3D model at 14 days in culture.
Layers either contained PLGA microparticles or cells (HDFs). Note that the
thickness of the cellular layer was approximately 2.5 times that of their adjacent
acellular (PLGA) layer.
In terms of the total amount of PLGA µ-particle within each hydrogel sam-
ple, a brief calculation showed that 0.1mg of the PLGA material was in each
1ml hydrogel (i.e. 10% volume of the hydrogel was made up of 1mg.ml-1 PLGA
µ-particles). The overall mass of the samples used in the 3D assay was there-
fore much lower than those of the 2D assay (i.e. a smaller initial depot of 0.1mg,
instead of ∼2mg of the material). Histological sections also revealed partially
empty vacuoles in the PLGA layer (especially prominent in the cellular sam-
ples) by day 14 in culture (figure 7.6). Since the PLGA µ-particles had a size of
∼50-150µm, the degradation rates was expected to be uniform throughout the
µ-particle (Anderson and Shive, 1997). However, the vacuoles with a brightly
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fluorescent edge suggest degradation may have occurred starting from within
the µ-particle.
Both the immobility of the large degradation products, and the small initial
depot of fluorescent PLGA, may explain the pattern of degradation product re-
leased within the 3D model (i.e. delay in PLGA detection from the surrounding
media and subsequent decrease in fluorescence detected beyond 14 days in
the 3D samples (i.e. used up PLGA material)). There was a possibility that the
µ-particles (considering their small size and high surface-to-volume ratio) were
mostly degraded by the later stages of the culture period, before the degra-
dation products had a chance to diffuse out of the hydrogel with subsequent
culture. If indeed this was the case, it would be interesting to see if the incorpo-
ration of a bioreactor to induce fluid flow surrounding the construct will create
a constant diffusion gradient for the PLGA degradation products, and improve
the estimation of biodegradation rates compared to in vivo conditions.
Another variable studied was the fate of the degraded product. Cell uptake
of the degraded particles was evident from images of cells isolated from the
3D constructs after incubation with PLGA material. In their nanoparticle form,
PLGA have been shown to be taken up by endocytosis into endosomes, golgi
apparatus and sometime the endoplasmic reticulum (in epithelial (2D) cell-lines
(Cartiera et al., 2009)); but the destination of the NP, and the rate/extent of
the uptake was dependent on the cell type. In the 3D model, involvement of
cells was likely two folds. Cells firstly remodeled the matrix to encourage the
dissipation of degradation products from the biomaterial implant site; and also
(in the case of PLGA) internalised small degradation products.
The mode of PLGA uptake were previously studied in cell types such as
epithelial cells (Cartiera et al., 2009) and macrophages (Tabata and Ikada,
1988). Cell-uptake of PLGA particles via phagocytosis was found to be size-
sensitive, where particles over 10 µm (in macrophages) were not internalised
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until further hydrolysed. When internalised, the phagocytosed microsphere
degraded within the cell over time; and this degradation rate was controlled by
the chemical composition of the PLGA material (i.e. the fast-degrading 50:50
PLGA was found to be completely degraded within the macrophage by 7 days)
(Tabata and Ikada, 1988) (Tabata and Ikada, 1989) (Tabata et al., 2000).
Here, cell uptake of the degraded PLGA was also likely by phagocytosis as
fibroblasts are phagocytic cells (Lee et al., 1996). However, the distribution of
the PLGA particles within cells was not uniform (figure 7.7), with clusters of the
material found in some cells. This may be because of the spatial arrangement
of the cells and PLGA material in 3D, such that some cells will be in closer
proximity to the PLGA material, and so experience a higher concentration of
degradation material for their uptake. Alternatively, this difference in PLGA
up-take between cells may be due to natural variances in cell activity.
Other considerations of PLGA degradation include the effect of decreased
local pH levels on resident cells; especially when PLGA material have also
been reported to cause the formation of local aseptic sinuses and can result
in osteolytic changes and intermittent joint swelling when implanted (Athana-
siou et al., 1996). Razaq et al. (2003) found that slight acidic conditions (at
pH6.4) reduced cell matrix turnover and production of some essential proteins.
Other studies have shown a similar effect of acidic extracellular pH on fibroblast
growth, and gene expression of related proteins (Bumke et al., 2003). Acidic
pH may even cause cell death, as observed in tumor-derived cells by 96 hours
in pH6-7.5, and even sooner at pH5.5 (Lan et al., 2007). However, further
studies into the difference between 2D and 3D will be needed to see if acidic
conditions affect cells to the same extent in 3D, as the ECM may provides
some shielding from acidic conditions or potentially harmful degradation prod-
ucts (Dobaczewski et al., 2010).
Potential systemic effects of mobile degradation products has also been a
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source of concern in material development. Although systemic effects have
been traditionally tested in vivo (i.e. toxicity of PLGA particle build-up in liv-
ers and kidneys). In vitro 3D models can potentially be used to study the
effect of the biomaterial on individual cell types isolated from the target tissue
(in separate models). For example, in the case of a full skin model of bio-
material degradation, 3D models containing HDFs (i.e. the present model),
keratinocytes, macrophages, adipocites, etc. can be carried out in parallel
(and co-culture systems) for a fully comprehensive study of the biomaterial in
a target tissue. Although this will not completely replace the need for in vivo
assays for material degradation, this will allow for improved accessibility, and





For the development of tissue models, it is essential to identify key functional
variables that can influence the target cell behaviour; and subsequently refine
the model until it is representative of tissue/cell response in the natural tissue
(Brown, 2012, p.38).
To justify the effort in producing in vitro tissues models, it is important to
obtain usable data from the model, which correlates with, and can represent
the natural responses of human tissues to an external stimuli. The model
will also need to be simple enough to isolate test variables; and accessible
to evaluate tissue response to biomaterials (or other stimulus).
For example, important questions during biomaterial development may in-
clude:
• Is the biomaterial toxic to cells (both within the biomaterial and the sur-
rounding tissue)?
• Do cells migrate between the biomaterial and the surrounding tissue (and
other cell-biomaterial interactions)?
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• Do cells synthesise new ECM within the biomaterial, and/or remodel ex-
isting natural matrix material?
• How long does the biomaterial persist within a tissue-like environment
with culture?
• What is the optimum cell seeding density (if any) within the biomaterial for
improved material-tissue integration? (and for optimum ECM deposition
rates)
3D in vitro biomaterial testing platforms (i.e. plastically compressed colla-
gen gel) has the advantage of suspending biomaterials in a tissue-like matrix
(with relevant cell-matrix and cell-cell interactions), and enables real-time as-
sessment of the accessible construct. Although there are limitations to these
testing platforms, such as the relative simplicity of the model, and lack informa-
tion on systemic effects; they can be useful as pre-clinical tests of biomaterials,
for toxicity and localised tissue effects, over time.
However, even with the range of in vitro and in vivo test systems available
to test biomaterials, the precise effects of implant materials on human tissues
are often only fully understood in retrospect. An example of this can be seen
in the case of joint replacement implants where previously unexplained tissue
inflammation surrounding joint tissue implants was only later understood (from
recovered implants/tissues) to be caused by material erosion and wear parti-
cles (Cuckler, 2012) (Knight et al., 2011).
In vitro 3D model tissues (developed here and elsewhere) can be used to
improve our understanding of cell responses to these eroded/degraded bio-
materials by isolating and simplifying test variables, and to study their effect on
local cells. Ultimately, this can help improve material safety, and understand
the underlying causes of material success, or failure, over time.
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In order for cells to behave physiologically in this reductionist ECM-like scaf-
fold, it is important to identify and reproduce the key cell-directing feature(s) of
the target tissue within this in vitro model. This is because it is increasingly
recognised that tissue models of the future have at least some reliance on
cell activity to achieve functional tissue recovery; which is influenced by cell
perception of their surrounding matrix.
In most natural tissue environments, type-I collagen is the main structural
protein of the ECM. Therefore the in vitro tissue model used here was based
on type-I collagen hydrogels; which has for many decades been used to study
cell-matrix interactions (Grinnell, 2003) (Grinnell et al., 2005). The collagen
material was derived from xenogenic sources, but the protein, including cell
recognition sites are highly conserved throughout evolution (Boot-Handford
and Tuckwell, 2003) (Garrone, 1999), and so can be recognised by human
cells.
The ability to incorporate cells and chemical factors into the tissue model
(i.e. drugs, growth factors) improved the versatility of the model platform for the
production of tissue specific models. Plastic compression was used to increase
collagen hydrogel density cell/biomaterial containing construct to increase the
physiological relevance of the hydrogel for local cells.
In this study, all gels were compressed using the upward flow method (for
details please see chapter 1.5) within culture well-plates, and therefore have
good reproducibility, and the potential to be up-scaled for high throughput tests.
The main aim/goal of this study is to create next generation 3D in vitro
model systems, based on a type-I collagen hydrogels, with particular focus
on increasing matrix mechanical properties; and to investigate the use of 3D
compressed collagen hydrogel soft tissue models in the testing of biomaterials.
This was done in two distinct sections, by:
1. Developing a hydrogel with increased mechanical stiffness, also capable
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of encapsulating live cells from time-zero of construct fabrication
2. Testing biomaterials in soft tissue models to study their degradation rates
or drug-delivery propensities
The overarching hypothesis throughout this study was that models made
from plastically compressed hydrogels, with cells and other cell-behaviour di-
recting tissue features, will be able to predict and monitor (at least better than
standard 2D in vitro cell-monolayer models) biomaterial behaviour and cell re-
sponses to biomaterials/drugs.
Part 1:
One of the issues next generation collagen hydrogel modeling platforms should
address is their lack of mechanical properties; such that instant, live cell popu-
lations can be introduced into a stiff scaffold.
In the first part of the study (chapters 3 and 4), a novel collagen hydrogel
with increased mechanical properties - which can encapsulate live cells as it
is formed - was developed and tested for its cell compatibility and mechanical
properties. The key characteristic of this novel material is that it is both stiffer
than existing plastically compressed collagen hydrogels, and can encapsulate
cells within the hydrogel from time-zero. Most previous approaches will have
had to sacrifice either hydrogel mechanical properties (Brown et al., 2005) or
interstitial cells (Wong et al., 2013) during construct fabrication.
This was achieved by using pre-crosslinked type-I collagen (polymeric col-
lagen) as a starting material for hydrogel production. A critical finding dur-
ing material development was that although polymeric collagen sponta-
neously aggregated in solution at physiological pH, this can be delayed
by blending acid-soluble collagen monomers into the polymeric collagen
solution; possibly by steric hinderance.
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This delay allowed sufficient time for cell incorporation at physiological pH,
prior to fibrillogensis. The resultant compressed polymeric collagen blend hy-
drogel had a 3-fold increase in material stiffness (compared to traditional plas-
tically compressed collagen hydrogels).
There was, however, a problem associated with this compressed blend col-
lagen hydrogel. A proportion of cells was damaged (extent dependent on the
proportion of polymeric collagen within the hydrogel) during the plastic com-
pression process. This result can be explained by the increased compres-
sion rates seen in polymeric collagen hydrogels, where a higher proportion of
polymeric collagen corresponded to an increase in compression rates. High
compression rates meant that fluid flow rates within the hydrogel (and so fluid
shear stress on cells) was high, leading to cell damage. The increased in fluid
flow rates in polymeric collagen containing samples was thought to be due to
the reduced proportion of acid-soluble collagen, and so reduced mobile col-
lagen monomers/oligomers which can contribute to the filtration effect at the
FLS during plastic compression. This theory was supported by the finding that
incorporation of mobile macromolecules into the hydrogel (i.e. to replace said
monomers/oligomers, added to the collagen solution prior to fibrillogenesis)
resulted in a reduced fluid flow rate within the hydrogel. The hydrodynamic
size and concentration of the macromolecules were found to affect their abil-
ity in controlling compression rates. Optimum reduction in compression rates,
and protection from cell damage was achieved by incorporation of 10mg.ml-1
poly(ethylene glycol) 400kDa into the hydrogel.
The methods for the production of this blended cellular hydrogel is sum-
marised in the standard operating procedure (SOP) that can be found at the
end of this chapter.
All-in-all, it was possible to create cellular hydrogels with increased me-
chanical properties using pre-crosslinked polymeric collagen as a starting ma-
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terial as hypothesised; however there were slight deviations from the hypoth-
esis in that although cells were encapsulated within the hydrogel, some cell
damage was sustained in the subsequent plastic compression process (extent
of damage depended on proportion of polymeric collagen within the hydrogel).
This cell damage can be prevented by reducing compression rates by incorpo-
rating large, mobile macromolecules, into the hydrogel.
However, batch variation was high in these blend constructs, and since
polymeric collagen blend hydrogels were too variable for use as a model tis-
sue (where reproducibility between each sample is important), well-established
plastically compressed hydrogels, made from acid-soluble tropocollagen, was
used instead of the blend gels for studies in biomaterial degradation and drug-
delivery.
Part 2:
The second part involved testing biomaterials (developed by other groups)
within the tissue model to study their effect on local cells/matrix with culture.
Fast-degrading, fluorescently tagged, PLGA material was used to study bio-
material degradation in a tissue-like environment, and the subsequent destina-
tion of the degraded material. The hypothesis under test was that the PLGA
material will diffuse away from their implant site, into the surrounding construct
and culture medium; and that cells in the surrounding matrix will engulf small,
partially degraded PLGA materials. This was investigated by incubating PLGA
within the tissue model for the study of cell influence on the release rate of
the fluorescent degradation products into the surrounding culture media. The
results suggest that these degraded products traveled at a higher rate from the
model tissue when cells were present within the tissue model, as cells were
thought to ‘loosen’ the construct structure by remodeling the collagen matrix.
On a different note, imaging studies found evidence of cell-uptake of the
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PLGA biomaterial. This was expected due to the known use of PLGA as a
nanoparticle carrier which relies on cell-uptake for its function (Cartiera et al.,
2009). Both results combine to support the hypothesis that PLGA degraded,
and that its degradation products were mobile within the tissue model; ulti-
mately detected in the surrounding culture media, and within cells.
For the modelling of drug delivery in tissues using HA-NP as a carrier, the
first step was to increase nanoparticle retention within the model tissue fol-
lowing plastic compression. It was hypothesised that HA-NP retention can be
improved by alterations to the compression process or the hydrogel. Also, that
HA-NP-S can stimulate BMP-2 protein production in MG63 cells, where the
‘single-dose’ of simvastatin will be gradually released into the cell environment
to stimulate a constant level of BMP-2 production. Results here found that the
low HA-NP retention efficiency was improved by increasing collagen density
within the hydrogel, and by introducing a filter layer between the hydrogel and
plunger during plastic compression. This was thought to be potentially due to
increase in the filtration effect at the FLS for fluids leaving the hydrogel during
plastic compression.
Growth factor production (BMP-2) in response to the simvastatin drug cargo,
however, was not reproducible between experiments, meaning no conclusions
can be drawn at this stage, apart from the fact that growth factors can be de-
tected using ELISA assays when the protein was present within the model.
Finally, note also that the efficiency of biomaterial encapsulation within
the plastically compressed collagen hydrogel varied depending on biomaterial
size; where the µ-particular PLGA had almost complete biomaterial retention,
whilst the smaller nanoparticle HA-NP had a retention of between 10.1 ± 1.7
and 16.6 ± 1.2 % (again depending on size). This size dependence for re-
tention of particles within the hydrogel was also previously demonstrated and
discussed by Hadjipanayi et al. (2011a).
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Enabling the recovery of lost tissue function was one of the main motiva-
tors in regenerative medicine. Although tissue engineering is not the only way
to achieve this; i.e. with bionic prosthesis a successful alternative in recover-
ing gross limb functions (with promises to recover some complicated biological
senses such as sight (Lewis et al., 2015) and tactile senses (Saal and Bens-
maia, 2015) in the future); true tissue regeneration with the capability to con-
trol/remodel/regulate tissue function over time, will be ideal in the long run (i.e.
no need for maintenance or immunosuppression). However, the current extent
of tissue function restoration using TE implants is only partial (or with caveats)
at best, and genuine tissue regeneration complete with a vasculature, nervous
system, function and seamless integration with the existing tissue (as seen in
some amphibians (Brown, 2012)), is still a goal for the future. 3D in vitro tissue
models, such as those developed here will be important to further our under-
standing of cell processes, and biomaterial interaction with the surrounding
tissue over time.
8.1 Conclusions
The aim of this study was to develop next-generation 3D soft tissue models for
the in vitro testing of biomaterials. Plastically compressed collagen hydrogels
have been used here as a model tissue to study biomaterial degradation rates,
their fate within a tissue-like environment and the delivery of drug-carrying
nanoparticles.
The first part of the study demonstrated that it was possible to generate a
cellular hydrogel with increased mechanical properties (at time-zero) using pre-
crosslinked collagen extracted from natural sources. Although these hydrogels
were less stable, and can collapse quickly during compression, it was found
that the presence of mobile macromolecules (i.e. PEG) prevented cell damage
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by reducing compression rates, and fluid shear stress on cells.
The second part of the study tested biomaterials in soft tissue models made
from the conventional (acid-soluble collagen derived) compressed gels. It was
found that the extent of PLGA degradation product diffusion from the tissue-like
model depended on the presence of local cells which can remodel the matrix.
These cells were also able to take-up degradation products.
The delivery of drugs using HA-NP particles into the tissue model was found
to be improved by increased collagen density within the hydrogel, and the in-
corporation of a fine filter layer between the hydrogel and plunger. The simvas-
tatin drug cargo stimulated the production of a low amount of BMP2 protein.
However the overall effectiveness of the drug carrier, and indeed the tissue
model, require further study.
8.2 Further work
The findings of this study have furthered understanding of hydrogel plastic
compression processes. The ability to control the physical characterisics of
the construct was key to direct cell behaviour within the model. One of the
main purposes of the tissue model is to improve the efficiency and reliability of
in vitro biomaterial testing; and in doing so, reduce reliance on in vivo models
(which can be complex, variable and have limited accessibility).
Further increasing the reproducibility of polymeric collagen containing con-
structs will be necessary before the can potentially be used as a biomaterial
testing platform. As shown in the findings of this study, pre-crosslinked type-
I collagen extracted from natural tissue sources can be used in hydrogels to
increased their mechanical properties, without resorting to cytotoxic chemical
crosslinking treatment. Further studies will need to look at of the composi-
tion/impurities in the initial collagen source which can potentially affect the ag-
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gregation of collagen, and cause the variation between batches observed in
the current study.
With regards to the study of implantable biomaterials, models have studied
both the degradation, and drug-delivery potentials, of biomaterials. For future
studies, particularly for degradation models, the incorporation of microfluidics
(i.e. bioreactors) into the model during in vitro culture will likely affect release
rates of biomaterial (or their degradation products) from the hydrogel. Other
potential tests include assays to monitor cell and tissue response to the de-
graded product. For example, the PLGA material have been known to cause
the production of fibrous capsules around the implant material. A model tis-
sue may improve the understanding of underlying cell mechanisms, and rate
of fibrosis in response to different concentrations and formulation of the bioma-
terial (e.g. change in hydrogel opacity with changes to the matrix density over
time).
Furthermore, since cell uptake of the degradation products have been evi-
dent, it will be important to test for its effect on cell activity in the long run.
Since plastically compressed constructs can be built into more complex
models, through layering and co-culturing with different cell types, it is possible
to test for complex cell-cell interactions which was not currently possible in
2D cell models, or in vivo. Further tests may include temporal changes in
protein/growth factor production in response to drugs or biomaterials within a
complex model.
However, ultimately the results gained from the in vitro 3D models will need
to be correlated with in vivo data, to establish the effectiveness of the cur-
rent model in predicting natural cell responses to biomaterial (or other external
stimuli). The results from in vivo assays will be able to feedback into the model
for further refinement (with chemical/physical cues), in order to encourage res-
ident cells to behave in a physiological manner.
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8.3 Standard operating procedure (SOP) -
Polymeric collagen containing hydrogels as
tissue models
Standard operating procedure (SOP) for the production of a tissue model based
on compressed polymeric collagen blended hydrogels for biomaterial testing.
8.3.1 Purpose
To describe the procedure for producing hydrogels with a blend of polymeric
and monomeric collagens, to create cell-compatible hydrogels with pre-existing
collagen cross-links (traditionally only obtainable by cytotoxic cross-linking meth-
ods).
8.3.2 Supplies
For the polymeric collagen solution:
A stock solution of polymeric collagen, diluted to 2mg.ml-1 in 0.5M acetic
acid(or to match concentration of monomeric collagen used) (procedure further
described in section 3.2.1), and will require:
• Tendon granules (i.e. potential sources are calf tendon and other young/growing
tendons)
• EDTA
• 0.5M acetic acid
• Magnetic stirrer
• Beaker




• Acid soluble collagen
• 10X minimum essential media (MEM) (containing phenol red)
• Sodium hydroxide (NaOH; 1M and 5M) (in 1ml syringes with fine needles)
• Cell culture media
• 400kDa polyethylene glycol (PEG) (20mg.ml-1 in distilled water)
• Ice
• Plastic compression kit (with sterile well sized absorbent plungers and
tweezers




Note. Biomaterials can be in nano- or micro-particle form, or larger discs
(up to a diameter of 1cm (to ensure a comfortable fit in 24 well plates)
and a depth of ∼2mm (to ensure a good level of plastic compression of
the surrounding hydrogel)
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Blended collagen solution (upto 50% polymeric
collagen)
10 10xMEM
5 400kDa PEG solution
5 Cell culture media (with or without cells)
- Sodium hydroxide
Table 8.1: The proportion of each reagent used to produce blended collagen
hydrogels. The amount of sodium hydroxide required to neutralise the collagen
solution (i.e. until a colour change is observed in the solution) varies between
batches, and so is not specified here.
8.3.3 Scope
This procedure applies to cellular and acellular hydrogel soft tissue models
made from a blend of polymeric and monomeric collagens.
8.3.4 Procedure
Note. All procedure must be prepared in a sterile environment, on ice, unless
otherwise stated.
1. Chill a flat-based container on ice
2. Pipette equal volumes of polymeric collagen (2mg.ml-1; in 0.5M acetic
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acid) and acid-soluble (monomeric) collagen (2mg.ml-1) (for a 1:1 ratio
blend) into the chilled container, with a sterile magnetic stirrer
3. Seal container and transfer onto a stirrer, at 4°c, for at least 3 hours - until
the solution is visually homogeneous
Note. It is recommended that the proportion of polymeric collagen within
the solution to not exceed 50% for stability of the hydrogel
4. Add required volume of blended collagen (from step 3), 10xMEM and
PEG solutions (for proportions of each reagent, see table 8.1) into a sep-
arate chilled wide-based container
5. Gently swirl to mix the solution, and neutralise using 5M and 1M NaOH
(dropwise) until the point is reached where a colour change from yellow to
fushia pink is observed (due to the phenol red indicator contained within
the 10xMEM solution)
Note. Take care to avoid excess NaOH incorporation, as this will prevent
proper gellation of the hydrogel
6. Add cell culture media (with or without cells) to the neutralised collagen
solution, and swirl to mix
7. Pipette 1ml of the solution into each well of a 24-well plate whilst taking
care to minimise air bubbles within the solution
Note. Each well of a 24 well plate can take up to 2ml of the neutralised
collagen solution (for a thicker hydrogel)
8. Seal and transfer to a 37°c, 5% CO2, incubator for 30 minutes
9. (Optional. Place biomaterial onto the surface of the hydrogel (produced in
step 8), and repeat steps 7 and 8, to ’sandwich’ the biomaterial between
two layers of collagen hydrogel)
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10. Compress the hydrogel layer(s) with a sterilised absorbent plunger until
fully compressed (typically ∼ 20 − 40 minutes for gels containing PEG
solutions - depending on the thickness of the hydrogel and the proportion
of polymeric collagen within the blend)
11. Immediately add 1ml of cell culture media (pre-warmed) to each well to
prevent the dehydration of the compressed hydrogels
12. Detach hydrogels from the base of the wells using sterilsed tweezers
13. Seal and incubate at 37°c and 5% CO2 for required length of time
Incorporation of biomaterials into the model can be carried out at step 4, 6
or 8, depending on the chemical and physical structure of the biomaterial, and
on the required distribution of biomaterial within the model.
• Nano- and micro-particles can be incorporated into the hydrogel directly
as the hydrogel is formed. This can be done by adding the biomate-
rial suspension to the collagen solution before (step 4) or after (step 6;
providing the biomaterial is suspended in a solution of neutral pH) neu-
tralisation of the collagen solution
• Larger 3D biomaterials can be incorporated into the model by ”sandwich-
ing” the material between two layers of collagen hydrogel (step 9) which
are then compressed together
Note. Some nanoparticles or small microparticles can be lost during plastic
compression, and this loss will need to be taken into account - the extent of
particle loss will depend on biomaterial size and the extent of blockage at the
fluid leaving surface of the collagen matrix (see section 5.1.1 for further infor-
mation).
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8.3.5 Troubleshooting






gether of polymeric and
monomeric collagen so-
lutions.
Discard the partially neu-
tralised solution. Stir the
collagen blend for longer




into acetic acid - possibly
a problem with the ten-
don source with exces-






not form after 30
minutes at 37°c
Solution not at a neutral
pH (possibly too much
NaOH added during neu-
tralisation).
Discard and start again.
Use 1M NaOH for bet-
ter control of neutralisa-
tion, as soon as hints of
pink/orange (from the pH
indicator) is observed in
the collagen solution.
Table 8.2: Common problems and solutions encountered during the production
of blended, polymeric collagen containing hydrogels.
Note: Commercial compression kits (RAFT 3D Cell Culture System; in 24-
well plate or 96-well plate formats) are available from TAP Biosystems. Other-
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wise refer to section 2.4 and figure 1.3 of this thesis for details on the compres-
sion process.
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